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ABSTRACT 
This project involves the study of heat shock protein 47 (HSP47), which is a 
molecular chaperone crucial for collagen biosynthesis. It exhibits a high degree of sequence 
homology with members of the serine protease inhibitor (serpin) superfamily, though HSP47 
does not possess the inhibitory activity. It is a single-substrate chaperone, and binds only to 
collagen. ‘Knock-out’ of the hsp47 gene impairs the secretion of correctly folded collagen 
triple helix molecules leading to embryonic lethality in mice. Thus the aim of this project was 
to elucidate the specific mechanism that governs the binding to and release from collagen at 
the molecular level, known as the ‘pH-switch mechanism’. Emphasis is given on histidine 
(His) residues as the HSP47-collagen dissociation pH is similar to the pKa of the imidazole 
side chain of His residues. Site directed mutagenesis was used to mutate surface His residues, 
based on a mouse HSP47 homology model. The effects of the mutations on the behaviour of 
HSP47 were then assessed by collagen binding assays and structural analyses with circular 
dichroism (CD). All mutants were found to have good solubility and retain their binding 
ability to collagen like wild-type HSP47 in batch assay, but perturbed behaviour was seen in 
column experiment. Mutation of His residue at position 191 (H191) causes the shift in the 
collagen dissociation pH, while mutation of H197 and/or 198 disrupt the specific HSP47-
collagen interaction. H191, 197 and 198 are predicted to be located in the region near the C-
terminus of strand 3 of β-sheet A (s3A) in the homology model, a region specifically known 
as the ‘breach cluster’ in serpin nomenclature. The extent of conformational rearrangement of 
this region was further investigated by means of intrinsic tryptophan fluorescence 
spectroscopy using a series of single tryptophan (Trp) mutants. Results from analyses 
performed on the mutants did not contradict the observation seen in His mutational work, as 
Trp residues in the ‘breach’ cluster are likely to be located in the dynamic region of HSP47 
pH-triggered conformational change. In conclusion, this study establishes the importance of 
His residues in the ‘breach cluster’ to HSP47 pH-switch behaviour. Finally, a model for 
HSP47 pH-switch mechanism was proposed from data obtained via mutagenesis 
experiments. The model is hoped to assist future research into HSP47 cellular behaviour and 
will also be of great use in therapeutic applications involving the molecular chaperone. 
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CHAPTER 1: INTRODUCTION 
 
The extracellular matrix (ECM) is a complex of proteins that defines the structural integrity 
and carries various physiological functions in organisms. Collagen, being the most abundant 
protein in ECM, has been extensively studied structurally and physiologically. This includes 
its biosynthesis and secretion to ECM (Bornstein, 1974; Canty and Kadler, 2005; Prockop et 
al., 1979). It has been discovered that a group of proteins, called molecular chaperones, assist 
the formation and transport of collagen triple helix in the endoplasmic reticulum (ER) and the 
Golgi compartment. Among the most important, but yet least understood of those chaperones 
is heat shock protein 47 (HSP47). Knock-out of the hsp47 gene disrupts the formation of 
collagen triple helices, consequently basement membrane formation leading to embryonic 
death (Nagai et al., 2000). These demonstrate the importance of this chaperone for the normal 
development of mice. Although the general function has already been suggested, a specific 
mechanism that governs the binding to and release from collagen, at the molecular level, is 
still being debated. Hence, it is the aim of this project to shed light on this mechanism by 
constructing mutants targeting important residues of HSP47 to investigate the consequent 
effects on the behaviour of the chaperone.    
 
1.1 Aims of the Project 
HSP47 research at the cellular level has been expanding rapidly with the increasing number 
of abnormalities and physiological processes reported to have connection with HSP47 
expression. Despite the fact that understanding HSP47 mechanism at molecular level is 
crucial for more advanced research and applications, studies on its molecular behaviour so far 
seem inadequate. This is especially true for the pH-switch mechanism, which is the only 
mechanism known to govern the binding and release of the chaperone to collagen. The 
importance of this mechanism to HSP47 function has previously been established, but has not 
been fully understood at the structural level. As the release of HSP47 from collagen is an 
ATP-independent process, His residues have been hypothesised to play a major role in this 
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mechanism. Thus, the contributions of several His residues to the pH-switch function were 
therefore set for investigation. Site directed mutagenesis, which is a tool commonly used by 
molecular biologists, is employed to construct a series of HSP47 mutants targeting His 
residues of interest.  Coupled with circular dichroism (CD) and fluorescence spectroscopy, 
the importance of those amino acid residues to the protein structure and function could then 
be investigated.  
 
Hence, the aims of this project were as follows: 
1. Construction of His-to-Ala (HA) mutants by site directed mutagenesis on hsp47 gene 
previously cloned into an expression vector. 
2. Assessment of the effects of HA mutations on the structure and function of HSP47.  
3. Investigation of the dynamics of certain regions of HSP47 during pH-transition using 
intrinsic Trp fluorescence on a series of Trp-to-Phe (WF) mutants. 
4. Proposing a molecular model for HSP47 pH-induced structural change based on own 
data and those already reported in the literature.  
  
23
1.2 Collagen 
Collagen is the most abundant protein component of ECM that gives tissues their specific 
mechanical and biochemical properties in multicellular animals (Gelse et al., 2003). To date 
27 different types of collagen encoded by more than 40 different genes are identified (Koide 
and Nagata, 2005). All collagens can be characterised by the (Gly-X-Y)n triplets repeats in 
which position 1 is always occupied by glycyl- residue and positions 2(X) and 3(Y) are 
usually prolyl- and hydroxyprolyl- residues. Hydroxyproline (Hyp, O) is an amino acid 
residue formed upon hydroxylation of proline (Pro, P) residue in a reaction catalysed by 
prolyl hydroxylase (Myllylä et al., 1977; Tuderman et al., 1977). It is based on these 
molecular characteristics (amino acid repeats) and supramolecular arrangements that give rise 
to the different types of collagen (I to XXVIII) (Kadler et al., 2007), consisting of specific α-
chains encoded by more than 40 different genes (Koide and Nagata, 2005). 
Polypeptide chains of collagen molecules are called α-chains while the polypeptides 
of procollagen are called proα-chains since they contain the additional propeptides at both N- 
and C-termini as depicted in Figure 1.1 (Prockop et al., 1979). These α-chains subsequently 
assemble to form a collagen triple helix which is a right-handed supercoil with three 
polyproline II-like left-handed helices (Figure 1.2A-C). All peptide bonds in the helix are in 
trans- configuration and the triple helix can exist both as homotrimers or heterotrimers with 
different α-chains (Beck and Brodsky, 1998). The structure of collagen was first proposed by 
Ramachandran and co-workers in 1955 (Ramachandran and Kartha, 1955). They suggested 
that collagen basically consists of three polypeptide chains, winding around each other to 
form a coiled coil. Each chain was said to be held to its neighbouring chains by two hydrogen 
bonds (H-bonds). Their proposal was rejected by Rich and Crick for not being 
stereochemically correct and the impossibility of having two sets of H-bonds to stabilise it 
(Rich and Crick, 1955). They then went further to suggest two new possible conformations of 
collagen triple helix based on the (GPO) amino acid repeats, and their own work on 
polyproline and polyglycine type II. Their new conformations suggested only one H-bond 
could form between neighbouring chains. Structure I has a glycyl- amino (-NH2) pairing with 
an adjacent glycyl- carbonyl (-CO) group which creates a bond pointing anticlockwise when 
observed from the C-terminal of the peptide chain, while structure II has the bond pointing 
clockwise as the pairing is between prolyl- carbonyl group. Analyses of X-ray images of 
(PGP)n peptide suggested that structure II was more viable (Yonath and Traub, 1969). A 
followed-up investigation using native collagen from kangaroo tail tendon corroborated this 
finding, and credited structure II of Rich-Crick model for being more accurate (Fraser et al., 
1979). 
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Figure 1.1: General structure of collagen.  
Adapted from (Gelse et al., 2003). The structure of procollagen molecule (type I) with the 
various subdomains and the cleavage sites for N- and C-proteases (or procollagenases). Also 
shown are the sugars attached to the helical domain and its non-helical termini. In the C-
terminal, the propeptide chains are held together by intrachain and interchain disulfide bonds, 
and have about 10 residues of mannose. These sugar moieties are probably important for 
secretion. Whereas in the N-terminal, only intrachain peptide bonds exist, with a small 
amount of sugar (Gelse et al., 2003; Guzman et al., 1978; Prockop et al., 1979).  
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Figure 1.2: The structure of (Pro-Hyp-Gly)10 in which the fifth Gly is replaced by Ala.   
A. Full length triple helical peptide, showing the interchain H-bond (yellow dashed line) 
between Pro carbonyl- and Gly amido- groups. The structure is rendered in ball-and-stick 
view, PDB ID: 1CAG. It can also be seen from the structure that there is ‘local unwinding’ in 
the middle of the triple helix at the Gly replacement site. Visualisation was done with 
Deepview SwissPDB Viewer v4.0.1. Adapted from (Bella et al., 1994; Voet and Voet, 2005). 
B. The peptide viewed along the helix axis (white dashed lines represent the H-bonds). 
Adapted from (Bella et al., 1994; Voet and Voet, 2005). C. The structures of poly-L-proline 
type I (PPI, right-handed) and type II (PPII, left-handed) shown in sticks representation. PPI 
is formed when the backbone dihedral angles are (φ, ψ: -75°, 160°) and are less compact than 
PPII as the peptide bonds are in cis isomers; while PPII have (φ, ψ: -75°, 145°) and the 
peptide bonds are in trans configuration. There is no intrachain H-bond present in either 
types of helices (Cubellis et al., 2005). Structures adapted from 
(http://www.cryst.bbk.ac.uk/pps97/assignments/projects/szabo/pphelix.htm). 
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Because of the cyclic nature and the rigidity of Pro and Hyp, the rotation of the 
polypeptide backbone is limited and thus contributes to the stability of the triple helix. In 
addition, the hydroxyl group of Hyp has also been found to help stabilising the triple helix 
(Prockop et al., 1979). Extensive studies on how Hyp stabilises the triple helix shows that the 
residue at position-Y is crucial for collagen triple helical conformation. It was earlier 
proposed that stabilisation is attained through water-mediated hydrogen bonding as the 
hydroxyl group of Hyp is directed outside the helix (Ramachandran and Chandrasekharan, 
1968). Collagen with increased Hyp content also shows increased enthalpic stabilisation. 
Another mechanism that has been suggested is the inductive effect of the electron 
withdrawing group (-OH) which prefers trans- to cis- peptide bond (Brodsky and Persikov, 
2005; Eberhardt et al., 1996). Many of these observations were made on short peptides that 
mimic the sequence of naturally-occurring collagen rather than the full-length native 
molecule. The reason for this is that these peptides offer the advantages of being easily 
manageable over natural collagen in terms of the desired amino acid sequence, length and 
physicochemical properties.  
 
1.2.1 Collagen-mimetic Peptides: Synthesis and Applications 
Reseach on collagen-mimetic peptides (CMPs), also known as collagen-related peptides 
(CRPs) and collagen-like triple helical peptides (THPs) (Cejas et al., 2007; Fields et al., 
1996) has been expanding rapidly, ranging from the modelling of collagen structure, to the 
interaction study between collagen binding clients. The huge amount of information that 
could be obtained with CMPs has also been utilised in biomedical research, often involving 
manipulation of collagen-binding receptors acting at various cellular locations (Fields, 2010).   
Many CMPs were synthesised using the solid phase procedure, with the earliest 
peptides synthesised have the repeats of Pro and Gly amino acids (Sakakibara et al., 1972). 
After that, method to incorporate Hyp into the systematically synthesised peptide was 
devised, using benzyl- side chain protection of the 4-carbon hydroxyl. The (POG) peptide 
was found to have higher melting temperature compared to the analogous (PPG) peptide, 
leading to suggestion that Hyp might have a stabilising effect on the triple helix (Sakakibara 
et al., 1973). Currently, almost all CMPs are synthesised based on stepwise solid-phase 
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method using tert-butyloxycarbonyl (Boc) or 9-fluorenylmethoxycarbonyl (Fmoc) 
chemistries. Recent advancement in synthetic techniques enables the making of various 
CMPs with different chain constituents, not only limited to homotrimer triple helices (Fields, 
2010). 
The propensity of the peptides to form triple helix is usually monitored using optical 
rotatory dispersion (ORD) or circular dichroism (CD) spectroscopy. Triple helical peptide 
gives a distinctive positive molar ellipticity at around 225 nm and a negative ellipticity at 
around 200 nm. At appropriate wavelengths, these techniques are also used to obtain the 
temperature at which triple helical to coil structural transition occurs, also known as melting 
temperature (Fields and Prockop, 1996).  
 
Circular Dichroism Spectroscopy 
 CD spectroscopy is a very useful technique to study protein folding and as well as the 
structural elements in both native or unfolded conformation (Schmid, 1997). The CD 
phenomenon arises from the difference in the absorption of the left-handed (L) and right-
handed (R) circularly polarised light. A CD signal will be observed when the optically active 
molecule differentially absorbs the L and R components giving rise to light that possesses 
elliptical polarisation. Spectropolarimeters are used to measure the difference in absorbance 
between the L and R components (∆A = AL – AR) but it is usually reported in ellipticity unit (θ) 
in degrees. A simple numerical relationship between ∆A and ellipticity is given by Equation 
1.1 below.  
 
θ = 32.98 ∆A  (Eq. 1.1) 
 
Some of the CD data in this thesis are given in ∆A unit, but mostly in mean residue ellipticity 
(MRE, deg cm2 dmol-1) unit which normalises the effect of concentration in cases where 
different samples on different experiments are to be compared. The conversion between these 
units is given in Chapter 6 (Materials and Method).  
Information on the structural composition of proteins can be obtained from their CD 
spectra. In the far-UV region (170-250 nm), different types of regular secondary structures 
contribute to distinctive CD spectra (Figure 1.3). Mainly α-helical proteins have negative 
bands at 222 and 208 nm and a positive band at 193 nm. Proteins with anti-parallel β-sheets 
have a negative band at 218 nm and a positive band at 195 nm while disordered proteins with 
irregular structure have a very low ellipticity above 210 nm but have a negative band at 
around 195 nm. For collagen triple helix, each strand has the conformation that resembles the 
poly-L-proline in which all of the bonds are trans to each other. The CD spectrum of this 
polypeptide gives a positive band at 218 nm and a negative band at around 195 nm (Figure 
1.3). Another type of structure observable with CD is the β-turn (Greenfield, 2007; Kelly et 
al., 2005). As proteins usually have different types of secondary structures, comparison of a 
spectrum with those of known three-dimensional structures is usually needed to estimate its 
structural content. There are several databases that can provide the information on known 
protein spectra (such as DICHROWEB), and their corresponding structural information based 
on the experimentally-determined structure (Whitmore and Wallace, 2008).   
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Figure 1.3: Far-UV CD spectra showing the different bands originating from different 
types of protein secondary structure.  
Adapted from (Kelly et al., 2005).   
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Applications of Collagen Mimetic Peptides 
One of the first purposes that led to the synthesis of CMPs is the interest in solving 
collagen’s structure. Many CMPs have been synthesised and characterised for that purpose in 
the past half a century. A major breakthrough in this path was when Ramachandran and 
Kartha introduced their model of collagen structure in 1955, quickly followed by Rich-Crick 
model in the same year and then Yonath-Traub model in 1969. The use of peptides for 
structural elucidation was initiated by Okuyama and co-workers in 1981. In their study, 
peptide (PPG)10 was crystallised and analysed. Its structure suggested that a hydrogen 
bonding between the individual peptide strands is contributed by the amino group of Gly to 
oxygen group of the first Pro residue of the (PPG) repeat in the neighbouring chain. The other 
specific H-bonds involve water molecules (Okuyama et al., 1981). This was not much 
different from the Rich-Crick structure II making it the generally acceptable model to date. 
The first high resolution crystal structure of a collagen triple helix was eventually solved in 
1994 using a CMP containing 10 repeats of (POG) amino acids with one replacement of Gly 
to Ala in the middle of the peptide chains (Bella et al., 1994). The structure allowed the 
assessment of the effects of Gly substitution, which causes local ‘twist relaxation’ of the 
triple helix to accommodate the additional methyl- group from Ala side chain. The high 
resolution X-ray structure also revealed the specific interaction of the peptide with water 
molecules in the stabilisation of the disrupted triple helix. This stabilisation is attained by the 
formation of H-bonds between glycyl- and hydroxyprolyl- residues, with interstitial water 
molecules, other than the predicted H-bonds between carbonyl- and amide- groups of Pro and 
Gly respectively (Figure 1.2B) (Bella et al., 1994). The structure of unsubstituted (POG) 
peptide was eventually solved to explain the implications of proline ring puckering on the 
triple helix stability (Okuyama et al., 2004). 
Recently, focus of CMP synthesis has been towards obtaining new collagen mimetic 
materials for use in medical applications. The reason for this is to avoid potential rejection of 
natural collagen by the host (immunogenic responses), especially if it is sourced from a 
different species, and also on religious basis. There is also the risk of transferring harmful 
agents, such as prions to humans. The ultimate goal is to design synthetic peptides that are 
fairly stable in vitro, able to form higher order collagenous fibril at certain conditions, non-
toxic endogenously, and should also possess properties that can easily be manipulated. The 
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fact that the field of peptide chemistry is reaching deeper into realm of possibilities makes 
this aim seemingly within reach. The development of technologies that can covalently link 
the three strands of triple-helical peptides together, such as solid-phase branching, solution-
phase cross-linking, chemoselective and native chemical ligation, disulfide (cystine) knots 
and various modifications could pave the way for more advanced techniques in peptide 
design (Fields and Prockop, 1996; Przybyla and Chmielewski, 2010).  
One of the most preferred modifications is the linking of the three peptide chains with 
cystine knots at the C-terminal region, arranged in such a way to mimic the staggered 
arrangement of collagen fibril. This arrangement occurs when collagen triple helices are 
arranged end-to-end in a tight conformation to minimise surface area by volume ratio (see 
section 2.7) (Kadler et al., 1996). The ‘templated’ approach with cystine knots usually 
enhances the thermal stability of the resulting triple helix (Fields, 2010), but obtaining a 
much bigger structure proved to be challenging, though possible. Using both (POG)n and 
(PPG)n peptides held together by cystine knots, Kotch and Raines were able to achieve what 
they called ‘self-assembly’ of the triple helix via intra- and intermolecular triple helix 
formations (Kotch and Raines, 2006). (POG)n peptides have a much higher stability than 
(PPG)n, as apparent from the stabilisation effect of Hyp. They also showed that the peptides 
self-assembled to form bigger fibrils more than 400 nm. This is longer than that of natural 
type I collagen (about 300 nm), even though the fibrils formed still contain short-length 
chains (Kotch and Raines, 2006). An approach giving a gel-like material was also reported by 
Yamazaki and co-workers using (POG) repeat peptides (Yamazaki et al., 2008). Cystine 
knots were introduced at different positions along the peptide length with the intention to 
create a staggered arrangement during self-assembly. The peptides form hydrogel upon 
incubation at 4°C with varying stability, depending on the knot location (Yamazaki et al., 
2008). In all reports, the synthesis routes described to obtain the starting molecules are still 
considerably long, especially for commercialisation. Hence, research is currently undergoing 
to find a much shorter route to achieve the highly desirable staggered arrangement in vitro for 
the purpose of gel formation. 
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1.2.2 Procollagen Assembly in the Endoplasmic Reticulum (ER)    
Procollagen biosynthesis occurs in the endoplasmic reticulum (ER) initially as 
‘preprocollagen’ molecule with a signal sequence attached at the N-terminus. The presence of 
this sequence causes the proα- polypeptide to be translocated into the lumen of rough ER. 
This signal sequence is removed as the chain enters the cisternae of rough ER. Post-
translational modifications including hydroxylations of the amino acids at the X- and Y-
positions, and glycosylations  by the action of hydroxylases and transferases also occur in the 
ER (Koide and Nagata, 2005). The most extensively characterised of these enzymes is prolyl 
4-hydroxylase (P4H) which is responsible for converting prolyl- residues to 4-hydroxyproline 
(4-Hyp). These hydroxylases act in a specific manner, where the position of the residue 
hydroxylated in the amino acid sequence is very important. The peptide must also be non-
helical, and for P4H and lysyl hydroxylase (LH), only proline or lysine at -Y position is 
recognised. On the other hand, prolyl 3-hydroxylase (P3H) acts on prolyl residue at position -
X. Upon folding to triple helix, these polypeptide chains must possess about 90 4-Hyp 
residues per chain to be stable at body temperature (out of a total of about 1000 amino acids 
for fibril forming collagens type I, II and III (Gelse et al., 2003)). The triple helical 
conformation then prevents further hydroxylation. Glycosylations of the hydroxylysyl 
residues then follows (Prockop et al., 1979).             
 Following association of the three pro-α chains at the C-propeptide, formation of 
interchain disulfide bridges initiates the formation of triple helix in the ER. There is a strict 
requirement for Gly at the third residue as these residues are small enough to allow them to 
be buried in the core of the helix. The helix then propagates towards the N-terminus, with 
several chaperones reported to help accelerating this process. The triple helix is actually still 
unstable at body temperature, leading to suggestion that molecular chaperones in the ER, 
such as HSP47, act to help to stabilise it in vivo (Koide and Nagata, 2005; Leikina et al., 
2002).      
 Similar to other proteins, after being assembled in the ER, procollagen molecules are 
transported to the Golgi before leaving the cell (Prockop et al., 1979). Beforehand, the 
globular propeptides at the amino- and carboxy- termini are cleaved by aminoprotease and 
carboxyprotease respectively. This then triggers fibrillogenesis process, which then prevents 
further unfolding (Leikina et al., 2002). Eventually, the collagen molecules assemble into 
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fibrils, either in the plasma membrane or in the transport compartment between Golgi and 
plasma membrane (Canty and Kadler, 2005). These so-called ‘immature fibrils’ do not 
possess the necessary tensile strength and require covalent cross-linking to strengthen them. 
This process is catalysed by lysyl oxidase (LO), which oxidises certain terminal lysyl- and 
hydroxylysyl- residues. As a result, two types of cross-links are generated. Firstly, 
intramolecular cross-links whereby two α-chains of the same molecule are joined together by 
aldol condensation of two aldehydes generated during the oxidation process. Secondly, cross-
links between the collagen triple helices which involve bond formations between aldehyde 
generated from lysine and hydroxylysine and amino group of a second lysine or 
hydroxylysine. These are then followed by several more stable cross-links (Prockop et al., 
1979). These processes are summarised in Figure 1.4. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
proline
lysine
galactose
glucose
covalent cross linking
Extracellular space
rER/Golgi
Nucleus
(alternative) –
splicing
gene
transcription
mRNA
secretion vacuoles
N-propeptide
C-propeptide
Cellular space
sugar molecules 
C 
HSP47
N 
Figure 1.4: Schematic diagram of procollagen assembly showing roughly the enzymes 
involved during various stages of the biosynthesis.  
(SP: signal peptidase; GT: hydroxylysyl galactosyltransferase and galactosylhydroxylysyl 
glucosyltransferase; LH: lysyl hydroxylase; PH: prolyl hydroxylase; OTC: oligosaccharyl 
transferase complex; PDI: protein disulfide isomerase; PPI: peptidyl-prolyl cis-trans-
isomerase; NP: procollagen N-protease; CP: procollagen C-protease; LO: lysyl oxidase; 
HSP47: heat shock protein 47). Adapted from (Gelse et al., 2003). 
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1.2.3 Molecular Chaperones in Collagen Biosynthesis 
The process of collagen biosynthesis from procollagen production in the ER to transport to 
Golgi apparatus, and then finally to ECM involves actions by several general and specific 
molecular chaperones. Molecular chaperones are a group of proteins that assist the correct 
folding of other polypeptides or proteins but are not components of the final folded structures 
(Ellis and van der Vies, 1991). The term ‘molecular chaperone’ describing proteins that 
ensure the correct folding of other proteins into functional oligomeric structures was 
proposed by John Ellis (Ellis, 1987) when describing the chaperoning action of a chloroplast 
protein in the assembly of a photosynthetic CO2-fixing enzyme, ribulose bisphosphate 
carboxylase-oxygenase (Rubisco) from its subunits.  
 Earlier, the information required for correct folding of protein was said to be specified 
by the amino acid sequence, as proposed by Anfinsen from the observation made with 
ribonuclease molecules (Anfinsen, 1973; Anfinsen et al., 1961). Due to this, earlier protein 
folding studies were based on the knowledge that proteins fold in the cell by the self-
assembly process. Until it was found that during some studies, at certain temperatures and 
polypeptide concentrations, a fraction of the peptide chains failed to fold correctly, and 
formed aggregates instead (Ellis and Minton, 2006). This is even more significant in cells 
where the concentration of proteins and others macromolecules are very high (up to 400 g/L) 
(Hartl and Hayer-Hartl, 2009). The discovery of molecular chaperones then prompted 
scientists to re-evaluate their initial theory on protein folding, taking into account the crucial 
function of chaperones in assisting the folding of polypeptide in vivo and preventing the 
undesirable misfolding steps that could lead to aggregations. The chaperones are also 
reported to assist protein assembly in vitro by decreasing the aggregated chain fractions (Ellis 
and Minton, 2006). 
 It is not surprising that the assembly and transport of collagen molecules are assisted 
by a succession of molecular chaperones. The ER alone has many chaperones that are 
involved in the biosynthesis of various other types of proteins. A review by Koide and Nagata 
(2005) provides an extensive overview on most chaperones involved in the synthesis of 
collagen, as early as the production of nascent procollagen chain to the formation of complete 
collagen triple helical molecule. The chaperones can be divided into ‘general’ and ‘specific’ 
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chaperones. Among the general chaperones are the immunoglobulin heavy-chain binding 
protein (BiP) or also known as 78 kDa glucose-regulated protein (GRP78), GRP94, calnexin 
and calreticulin, peptidyl-prolyl cis-trans isomerase (PPIase) and protein disulfide isomerase 
(PDI), while HSP47 is classified as a specific chaperone due to its single substrate 
recognition. Figure 1.5 lists these general and specific chaperones and their suggested binding 
sites on collagen molecule during biosynthesis. 
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Figure 1.5: Collagen chaperones binding regions (reported and predicted) at various 
stages of collagen biosynthesis in the ER.  
These include general ER chaperones like BiP, PDI, Grp94, CNX, CRT and PPIase, while 
P4H and HSP47 are classified as specific collagen chaperones. Adapted from (Koide and 
Nagata, 2005). 
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BiP/GRP78 and GRP9 
The immunoglobulin heavy-chain binding protein (BiP), also known as 78-kDa glucose-
regulated protein (GRP78), is the only member of heat shock protein 70 (Hsp70) family that 
resides in the ER. The chaperone is required for translocation of newly synthesised 
polypeptides across the ER membrane and subsequently for their folding and assembly in the 
ER lumen. BiP recognises a wide variety of nascent polypeptides that have no sequence 
similarity but can accurately discriminate between properly folded and unfolded structures 
(Blond-Elguindi et al., 1993). In collagen biosynthesis, BiP is proposed to promote protein 
assembly especially at the early stage of triple helical formation. It has been shown to bind to 
abnormal type I procollagen, specifically the pro-α chains that possess C-terminal propeptide 
mutation that interferes chain association and interchain disulfide bond formation (Lamandé 
et al., 1995). BiP binding to secretory proteins is transient before they have folded correctly, 
but it remains bound to misfolded and aberrant proteins (Lamandé et al., 1995). Hence, it is 
also possible that BiP is involved in the quality control of the terminal propeptide of the 
newly-synthesised procollagen molecules. GRP94 has been shown to form a complex with 
BiP in the stabilisation of nascent collagen chains (Ferreira et al., 1994; Ferreira et al., 1996).   
 
Calnexin and calreticulin 
Calnexin (CNX) was discovered in 1991 in several forms but was mainly related to 
multimeric T-cell antigen receptor (TCR), a chaperone that interacts with partially folded 
protein complex in the ER and is absent from the fully folded one (Degen and Williams, 
1991; Hochstenbach et al., 1992). CNX was found to share sequence motifs with calreticulin 
(CRT), a major calcium-binding intraluminal resident ER protein. The name CNX was 
proposed as it represents a membrane-bound homologue of CRT (Wada et al., 1991). CNX 
and CRT have been shown to interact transiently with a wide array of nascent proteins in the 
ER, especially the folding or assembly intermediates but not with fully folded structures (Ou 
et al., 1993). Hence, these chaperones are associated with the quality control by prolonging 
the retention of unfolded protein in the ER. Specifically, CNX and CRT interact with the 
glycan moieties of substrate glycoproteins after they have been trimmed by glucosidases I 
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and II to the monoglucosylated form (Helenius and Aebi, 2001). The critical function of these 
chaperones in collagen biosynthesis is yet to be demonstrated, but they have been postulated 
to bind to the C-terminal propeptide region that has been glycosylated with N-oligosaccharide 
right at the early stage of procollagen synthesis (Harwood et al., 1975). In type II collagen for 
example, glycosylations have been suggested to mediate the interaction with proteoglycans 
(Gelse et al., 2003). 
 
PPIase and PDI 
Peptidyl-prolyl cis-trans isomerase (PPIase) catalyses the cis-trans isomerisation of proline 
peptide bonds, which can be a rate-limiting reaction in many slow molecular conversions 
(Lang et al., 1987). Unfolded type I procollagen was shown to have 16% of X-Pro peptide 
bonds (where X is any amino acid) in cis conformation, and 8% in X-Hyp bonds (Sarkar et 
al., 1984) while the rest are in trans. Hence the newly-folded procollagen molecules require a 
chaperone to assist the formation of trans peptide bond for increased stability. This chaperone 
is important in the synthesis of correctly-folded collagen molecules as inhibition of its action 
in the presence of cyclosporin A results in the collagen produced by fibroblasts are over-
modified (especially lysine hydroxylation) with raised intracellular degradation (Steinmann et 
al., 1991).  
 Protein disulfide isomerase (PDI) is a chaperone that catalyses the correct pairing of 
disulfide bonds during folding processes assisted by disulfide bridges. It involves a redox 
reaction to form reduced/oxidised forms of PDI and the protein substrate (Creighton et al., 
1980; Darby and Creighton, 1995). In procollagen molecules, PDI is involved in the 
formation of disulfide bonds within the α-chains (intra-chain) and among the chains (inter-
chains) (Wilson et al., 1998). Another collagen chaperone in the ER, which is normally 
associated with PDI, is prolyl 4-hydroxylase (P4H). P4H catalyses the formation of 4-
hydroxyprolines by the hydroxylation of proline residues. The formation of hydroxyproline 
helps to stabilise the triple helical conformation of collagen, through water-mediated 
hydrogen bonding (Ramachandran and Chandrasekharan, 1968) or inductive effect of the 
hydroxyl group attached to the proline residues (Eberhardt et al., 1996). PDI also exists as a 
subunit of the active oligomeric complex of P4H (Koivu et al., 1987). As a subunit of P4H, 
the chaperone complex prevents the formation of insoluble aggregates of procollagen 
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molecules by binding to the unhydroxylated chains in the ER. Additionally, the complex also 
binds the incompletely folded parts of the collagen triple helices, increasing their solubility 
and preventing immature secretion by longer ER retention (Wilson et al., 1998). 
1.3 Heat Shock Protein 47 (HSP47) 
HSP47 has been identified by several names including colligin (Kurkinen et al., 1984), CB48 
(Yannariello-Brown and Madri, 1990), J6 (Wang and Gudas, 1990) and gp46 (Clarke et al., 
1991) based on the cell type by which it was discovered. All other nomenclatures have rarely 
been used to identify this chaperone, and hence for standardisation the name HSP47 is used 
throughout this study. Historically, HSP47 was first found in 1986 in heat-inducible chick 
embryo fibroblasts and was shown to be able to bind type I collagen (Nagata et al., 1986). 
HSP47 synthesis is increased upon cell incubation at 42°C, hence the name. The isoelectric 
point (pI) of HSP47 is around 9.0 and it is an unusually basic protein. The localisation of 
HSP47 in the ER was demonstrated using immunocytochemical studies with monoclonal and 
polyclonal antibodies against HSP47 in vitro (Satoh et al., 1996). The presence of an ER 
retention sequence, Arg-Asp-Glu-Leu (RDEL) can also signify that HSP47 is recycled back 
to the ER upon dissociation in the Golgi via the action of receptors to maintain the 
concentration of HSP47 inside the ER (Satoh et al., 1996).  
HSP47 is a cell-specific protein, and only expressed in collagen-synthesising cells 
(Saga et al., 1987), such as in fibroblasts. The complementary DNA (cDNA) has been cloned 
independently from F9 mouse carcinoma cells (Wang and Gudas, 1990) and from a cDNA 
library of heat-shocked chick embryo fibroblasts (Hirayoshi et al., 1991).  
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1.3.2 pH-dependent Conformational Change of Proteins 
pH is a critical factor in determining a correct folding and optimum function of proteins. 
Enzymes for example, have certain narrow pH ranges at which they become active. pH 
affects the binding affinity of the substrate to the enzyme, either due to the ionisation of 
amino acid residues of the enzyme; or due to the  ionisation of the substrate itself. A classic 
example is haemoglobin, where its affinity to oxygen depends on pH and carbon dioxide 
concentration.   
 Haemoglobin is a well-characterised protein made up of four subunits (tetramer). In 
vertebrates, the subunits are called α and β subunits. Each subunit also has a heme group and 
hence one oxygen binding site. Upon binding to oxygen, haemoglobin undergoes changes in 
the quarternary structure that brings the β subunits closer and narrows its central cavity. pH 
plays a crucial role in haemoglobin action as an increase in proton concentration enhances its 
tendency to release oxygen, a phenomenon known as the Bohr effect. This process reportedly 
involves the protonation of a His residue (H146) located at the C-terminus of each β subunit. 
In the non oxygen-binding form, this residue forms a salt bridge with an Asp residue (D94) 
thus stabilises the protonated form against dissociation and increases its pKa. The salt bridge 
is not observed in the binding form. This means that at low pH (high proton concentration), 
the non binding form is preferable and this increases the tendency of haemoglobin to release 
oxygen. This is important in the event of high metabolic activity when tissues produce more  
lactic acid, hence higher proton concentration. This in turn causes haemoglobin to release 
more oxygen molecules to cope with the higher metabolic requirement (Mathews et al., 1999; 
Stryer, 1995). 
Like haemoglobin, many proteins change their conformations at different pH values 
and most of which are critical for their functions. It is also well known that pH can greatly 
affect the tendency of proteins to precipitate, causing collapse in their structural integrity. 
Notwithstanding, milder pH variation can trigger measureable changes, that can either be 
localised to certain regions of the protein (particularly the ligand binding site), or the whole 
protein itself. In most cases, the changes are triggered by the ionisation of amino acid side 
chains strategically located in the protein interior that are accessible to solvent. In the cellular 
pH range, several amino acid side chains are ionised (Figure 1.6).  
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Figure 1.6: Major ionisation zones of several amino acid side chains.  
The side chains can be divided into acidic (Asp has a side chain pKa of about 3.9, Glu 4.2) 
and basic (Lys pKa of 10.0, Arg 12.5). His has a pKa of around 6.0 and is loosely classified as 
basic. Cys and Tyr are omitted as the side chains are mostly neutral at physiological pH range 
(Chan and Warwicker, 2009; Mathews et al., 1999). The ionisation regions for the  
–amino and –carboxyl groups are also shown for comparison. 
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An example of a side chain-triggered local conformational change is in the case of a 
protein that forms part of viral infection machinery. A His residue (H263) located in a fusion 
loop (called FL2) of glycoprotein B of herpes simplex virus type 1 (HSV-1) has been 
reported to trigger a local conformational change upon exposure to low pH. This 
rearrangement is suggested to play a role during endosomal entry of HSV probably via 
enhanced interaction with other glycoproteins of the acidic state (Stampfer et al., 2010). The 
local conformational changes of FL2 are illustrated in Figure 1.7. In this case, H263 is 
suggested to be a ‘trigger’ residue that controls the change in conformation that largely 
affects the function of the virus.   
A more profound pH-triggered conformation change was observed in monomer-to-
dimer transition of dynein light chain protein (DLC8). DLC8 is the smallest subunit of the 
microtubule-associated cytoplasmic dynein motor assembly, usually involves in intracellular 
transport of materials within cell cytoplasm (King, 2000). Very much like in glycoprotein B 
of HSV, the dimer dissociation of DLC8 is also controlled by the protonation of His residues. 
Instead of just a single residue, this process is suggested to involve the ionisation of several 
residues, which gradually increases the flexibility of the β-sheet loops at the dimer interface. 
Three His residues which are predicted to have slightly different pKa by NMR assignments, 
are ionised at different pH values and subsequently trigger strand repulsions. The repulsions 
finally cause the abolition of salt bridges before the dimer fully dissociate into monomer at 
pH as low as 3.0 (Mohan et al., 2006).  
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Figure 1.7: Proposed pH-induced conformational changes of loop FL2 of glycoprotein B 
of HSV. 
Firstly in (A), as illustrated by step 1, His 263 (H263) becomes protonated and tends to repel 
the uncharged region formed by Trp 174 (W174) and Tyr 265 (Y265). Then in (B) the loop is 
pulled into more hydrophilic environment, as a result the hydrogen bond between H177 and 
Glu 260 (E260) is abolished (step 2). Finally in (C) H263 forms a new salt bridge with Asp 
226 (D226) keeping the new conformation stable and in place (step 3) (Stampfer et al., 2010). 
Neutral WT protein is shown as white surface representation, residues 258-264 shown as 
sticks representation in cyan and the acidic conformation is shown in green stick 
representation.    
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1.3.3  HSP47 Binding and Releasing Properties  
The expression of HSP47 correlates with collagen expression indicating that HSP47 plays an 
important role in the processing, secretion and higher order assembly of collagen (Dafforn et 
al., 2001; Ishida et al., 2006; Satoh et al., 1996). Binding is also observed with gelatin, which 
is a denatured form of type I and III collagen. Unlike some proteins, glycosylation and 
phosphorylation of HSP47 are not essential for the binding event (Jain et al., 1994b; 
Kurkinen et al., 1984). HSP47 was earlier shown to be able to bind both single-stranded 
procollagen chains and triple helical collagen (Satoh et al., 1996). A more recent studies 
demonstrated that it is more likely to bind triple helical collagen instead of the single-
stranded ones (Koide et al., 2006a). Dafforn and co-workers (Dafforn et al., 2001) has 
established that under normal folding conditions, HSP47 is likely to exist as a native, five-
stranded β-sheet A (similar to the structure of α1-AT shown in Figure 1.8A, B) and is 
metastable. Metastability in serpins exists because the native state of serpins is not the most 
thermodynamically stable, and this increases the tendency of the protein to form more stable 
conformations (Im and Yu, 2000). This is achieved either after cleavage of the centre loop 
(RCL) upon binding with protease (Engh et al., 1989), or through conformational 
rearrangement at suitable conditions (Mottonen et al., 1992). 
Certain chaperones, such as heat shock protein 70 (Hsp70), DnaJ, GroEL and GroES 
complex, requires ATP for energy supply during chaperoning action. Hsp70 family members 
have the basic function of binding and releasing hydrophobic segments of unfolded 
polypeptide chain in a reaction cycle involving the hydrolysis of ATP. This class of 
chaperone can be found in the ER, cytosol, mitochondria and chloroplast (Georgopoulos and 
Welch, 1993). Hsp70 homologue in bacteria is called DnaK. Another chaperone, DnaJ is 
found to interact closely with DnaK by stimulating its ATP hydrolysis activity, which is 
significantly higher in the presence of another chaperone GrpE. It was suggested that DnaJ 
binds DnaK, causing the rate of ATP hydrolysis to accelerate. GrpE then binds and 
subsequently accelerates the rate of release of the bound ADP (Liberek et al., 1991). These 
chaperones are involved in bacterial protein assemblies during stress conditions and also 
some other normal cellular functions. Likewise, GroEL/ES are chaperone complex originally 
the products of groE gene locus of E. coli. GroEL, which is the large sub-unit possesses a 
cylindrical-shaped molecular arrangement with a central hole about 6 nm in diameter, 
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constituted of 14 identical subunits that are arranged in two stacked rings of seven sub-units 
each. Electron micrograph revealed that GroEL has a ‘double-doughnut’ shape. At one end of 
the double-doughnut is GroES, which is a smaller subunit, heptameric ring-like molecule and 
known to bind only to GroEL (Lodish et al., 1995). In short, the complex assists protein 
folding when ATP and GroES bind the same GroEL ring (called cis ring) as misfolded 
polypeptide. The polypeptide is allowed to fold correctly in the ring cavity until dissociation 
from the ring is triggered by ATP hydrolysis in the other ring (trans ring) that allows ATP 
entry and another polypeptide. This process then continues back and forth (Horwich et al., 
1999). So these chaperone complexes utilises ATP as energy source while assisting the 
folding of polypeptides. HSP47, unlike these chaperone systems, does not require the 
presence of ATP for association with and dissociation from collagen, prompting a number of 
studies to investigate its mechanism of action (Nakai et al., 1992).  
Binding of HSP47 to collagen in vitro was reported to be in a pH-sensitive manner. 
The binding was observed at pH 8.0 and abolished at pH 6.3 (Saga et al., 1987). The 
structural aspects of this pH-change property studied using circular dichroism (CD) and 
fluorescence spectroscopy suggested that HSP47 undergoes a two-step conversion from high 
to low pH state via an intermediate structure. The β-sheet content is estimated to increase 
during the transition by up to 10-20%, based on CD spectra curve-fitting procedure 
(Thomson and Ananthanarayanan, 2000). This property is attributed to the protonation and 
deprotonation of histidine (His) imidazole side chain due to the transition midpoint around 
pH 6.2, which resembles that of the pKa of His side chain (El-Thaher et al., 1996). In the 
presence of HSP47, fibril formation of collagen is prevented at neutral but not at low pH 
(Thomson and Ananthanarayanan, 2000). Further research reported on the pH-dependent 
binding of HSP47, including to a synthetic collagen-like peptide (PPG)10,  showed HSP47 
undergoes conformational change as pH is reduced from 7 to 6 causing dissociation from the 
peptide (Dafforn et al., 2001).          
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Figure 1.8: Typical structure of serpin family members. 
A. The ‘front’ view of α1-AT (PDB ID: 1QLP) showing the positions of central β-sheet A 
(sA), sheet B (sB) and sheet C (sC) above sB. B. ‘Back’ view of α1-AT showing that all the 
helices (A to I, labelled hA to hI) except hF lie on the relative back side of the protein. The 
serpin reactive centre loop (RCL) is exposed at the top of the molecule. C. The cleaved 
(single chain) structure of α1-AT (PDB ID: 7API). The RCL is shown in blue and the rest of 
A-sheet is in red. D. The latent structure of PAI-1 (PDB ID: 1C5G). Figures adapted from 
(Elliott et al., 2000; Engh et al., 1989; Gettins, 2002; Tucker et al., 1995).  
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More detailed binding studies suggested that the dissociation of HSP47 from 
procollagen occurs as the HSP47/procollagen complex enters cis-Golgi compartment when 
the concentration of free HSP47 decreases as the ER-retention receptors retrieve HSP47 
(Natsume et al., 1994). Using surface plasmon resonance, it was shown that this rapid 
decrease of free HSP47 causes dissociation because of its high dissociation rate constant 
(kdiss) from collagen of more than 10-2 s-1 (Natsume et al., 1994; Satoh et al., 1996). Despite 
this, the occurrence of pH-dissociation in vivo could not yet be confirmed. The 
conformational requirements of collagen/collagenous peptide for HSP47 recognition has been 
studied extensively by Koide and co-coworkers (Koide et al., 2000). Using a library of 
collagenous peptides, they demonstrated that the hydroxylation of the second Pro residue in 
the sequence (Pro-Pro-Gly)n reduced the interaction between HSP47 and the peptide. As 
tested in yeast two-hybrid systems, Pro residues in the X and Y positions do not contribute 
equally to the interactions with HSP47 as single Pro to Ala substitution at the X position 
abolishes the binding but this does not occur at the Y position. Peptide library screening 
showed that Arg at position Y is preferred for HSP47 binding, followed by Pro, up to 5-6 
times more. This is related to the triple helix stability of the former peptides compared to the 
other amino acids (Koide et al., 2000).  
The tendency of HSP47 to bind the triple helical part of collagen molecules was also 
reported by other studies (Thomson and Ananthanarayanan, 2000). Using CNBr fragments of 
collagen type I and II, the region in collagen molecule which has got the highest affinity for 
HSP47 binding was determined to lie towards the N-terminus (Thomson et al., 2003). 
Synthetic peptides, like (PPG)10 were also used to study the interaction with HSP47 leading 
to the finding that the binding of HSP47 to (PPG)10 is less tight when compared to full-length 
collagen, given that (PPG)10  is monomeric. The binding event also promotes the 
conformational ordering of the peptide bonds in Pro residues leading to PII  helix formation 
(Dafforn et al., 2001). An investigation has also revealed that HSP47 recognises triple-helical 
collagen clients, and is unlikely to bind to the molecules before the triple helix is formed 
(Koide et al., 2006a). By using short (POG) heterotrimeric collagen peptides, it was 
demonstrated that at least one Arg residue per triple helix at Y position is sufficient for 
HSP47 recognition. Enhanced interaction was also observed when the amino acids at -3 
position (Y-3) from Arg at the Y position is Thr, with the highest affinity observed when both 
Arg and Thr are located at the same polypeptide in the triple helix. These suggest that HSP47 
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helps stabilising the triple helix when the cell is under stressed condition, by increasing 
binding to the lower affinity sites under stressed environment, other than the usual high 
affinity ones during normal chaperoning function (Koide et al., 2006b).         
As in the case of other pH-dependent proteins, pH changes are suggested to be 
particularly important for HSP47 as it is a collagen-specific chaperone and its release from 
collagen is triggered by protonation. This means that the only mechanism of action for 
HSP47 is via pH-induced conformational change and thus justifies the needs to fully 
understand the general and specific structural rearrangement during the process.  
1.3.4  Functions in Collagen Biosynthesis 
As a unique chaperone that only binds to collagen, various functions have been proposed for 
HSP47. Although the actual mechanism of the chaperone is still being debated, among the 
suggested functions include: 
a) Protecting the newly-synthesised pro-collagen chains from being folded or aggregated 
until translation is complete (Satoh et al., 1996).  
b) Stabilising newly-synthesised pro-collagen in the event of metabolic stress (Ferreira et 
al., 1994). 
c) Inhibiting the degradation of pro-collagen in the ER (Jain et al., 1994a). 
d) Helping the formation of three-dimensional assemblies of collagen molecules 
(Dafforn et al., 2001; Kurkinen et al., 1984; Nakai et al., 1992) by inducing the 
formation of a polyproline type II conformation (Dafforn et al., 2001). 
e) Assisting the formation of correct trimers among different α-chains in heterotrimeric 
collagens, probably with other collagen chaperones, and preventing the secretion of 
incorrectly-folded heterotrimers (Kobayashi and Uchiyama, 2010). 
f) Stabilising the correctly-folded triple helix against external stress, such as elevated 
temperature (Koide et al., 2006b; Makareeva and Leikin, 2007). 
g) Stabilising partially folded triple helical intermediates that would be unstable at body 
temperature (Koide et al., 2000; Koide et al., 2006b). 
h) Binding to misfolded areas within fully formed collagen to reduce aggregation 
(Dafforn et al., 2001). 
i) Preventing the secretion of immature or misfolded procollagen molecules (Nakai et 
al., 1992). 
j) Retaining the underhydroxylated procollagen in the ER longer (Satoh et al., 1996). 
The advent of many sophisticated techniques in biological research has enabled HSP47 
researchers to further support or refutes all the suggested functions listed above. For example, 
the function of HSP47 to help stabilise the collagen chain in the event of cellular stress has 
 
 
49
  
50
been receiving more attention as recent study on HSP47 binding motives on collagen 
molecules suggests the presence of high-affinity and low affinity binding sites. These low 
affinity binding sites are thought to be the sites where HSP47 molecules bind to in stress 
conditions, apart of the normal binding site during regular cellular events (Koide et al., 
2006a; Koide et al., 2006b). Furthermore, HSP47 involvement as early as pro-collagen 
synthesis is now heavily debated as it is recently found to bind to single stranded collagen 
peptide significantly less than the triple helical molecules (Koide et al., 2006a; Koide et al., 
2002). These then suggest that other collagen chaperones are involved in stabilising the single 
stranded nascent pro-collagen molecules, like BiP, CNX and CRT. The ability of HSP47 to 
retain underhydroxylated collagen triple helices is also supported by further research on the 
importance of hydroxylation for HSP47 binding and collagen transport to the Golgi (Koide et 
al., 1999; Koide and Nagata, 2005; Walmsley et al., 1999). Despite these, there are many 
other functions that are still being investigated, especially involving the molecular changes 
induced upon HSP47 binding to collagen molecules. 
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1.3.5 HSP47 and Diseases 
Wound Healing 
HSP47 is a chaperone that is expressed constitutively in collagen-synthesising cells and 
tissues. Its expression has been shown to increase during induced skin and gastrointestinal 
wound. In neonatal rat for example, a few days after wound introduction, increased collagen 
expression and thus an increase of HSP47 expression could be observed in dermis and 
subcutaneous tissues (Wang et al., 2002). Detection of HSP47 expression was performed 
using immunoblotting while collagen expression was probed using RT-PCR of collagen type 
I mRNA. Similarly, in rat model induced with gastric ulcer, an increase in HSP47 expression 
was recorded, especially from the third day to twelfth day after ulcer induction. Most of the 
increased expression was observed in fibroblast cells around the ulcer wound, probably 
involved in ulcer healing. Healthy gastric tissues also showed HSP47 expression, but at a 
much lower level (Guo et al., 2002). Other than just in skin and gastric ulcers, HSP47 
expression was also detected in induced oral ulcer. In normal tissues, HSP47 is usually found 
in the suprabasal layer of the oral epithelium and the lamina propria, which is a layer of 
connective tissue under the epithelium. Upon ulcer induction, HSP47 expression increases 
significantly especially at the stage of wound healing, before decreasing to the initial level 
after complete regeneration. Hence, like in the case of gastric ulcer healing, this suggests that 
HSP47 also assists collagen deposition during remodelling phase of the induced oral 
ulcerative wound (Vasques et al., 2010). 
 
Fibrosis 
HSP47 has been known to be involved in many types of fibrotic diseases, characterised by 
the extensive depositions of collagens. A large number of studies have reported the up-
regulation of HSP47 in the event of fibrosis. A recent observation suggested that the increase 
in HSP47 expression promotes excessive collagen assembly in patients with chronic graft-
versus-host disease (cGVHD), which involves uncontrolled fibrosis in the lacrimal glands 
(Ogawa et al., 2007). Furthermore, HSP47’s abnormal expression has also been associated 
with oral submucosal fibrosis, which is a pre-cancerous condition (Yang et al., 2008).  
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 Another type of fibrosis that would be a potential target for treatment is liver fibrosis. 
It is a result of the chronic damage to the liver due to the accumulation of extracellular matrix 
(ECM) proteins. Cirrhosis mortality, which is the end stage of fibrosis, has been rising in 
numbers in the UK lately (Henderson and Iredale, 2007) suggesting an urgent need for 
treatment. It is worthy to note that in industrialised nations, the main reasons for this fibrosis 
are hepatitis C infection, alcohol abuse and non-alcoholic steatohepatitis (NASH). The 
relationship of HSP47 expression and the progression of fibrosis have been well researched 
(Masuda et al., 1994; Razzaque et al., 1998), and in cirrhotic liver, HSP47 is shown to be 
expressed intensely (Brown et al., 2005; Sato et al., 2008). Nonetheless, HSP47 is also 
present in control liver tissue suggesting that the chaperone might serve as an important 
function in normal healthy liver. This poses a real challenge to knock-down therapy 
approaches (Brown et al., 2005). 
 
Osteogenesis imperfecta (OI) 
As has been anticipated by HSP47 researchers and collagen biologists in general, the first 
direct connection between HSP47 and osteogenesis imperfecta (OI) was reported in 2009, 
based on the study on OI Dachshunds dogs (Drögemüller et al., 2009). A mutation at Leu 
position 326 to Pro (L326P) in HSP47 was found in OI individuals. The amino acid is highly 
conserved across all vertebrates carrying HSP47 protein. Later on, a similar mutation was 
also found in human individuals suffering from OI (Christiansen et al., 2010). The abnormal 
HSP47 is degraded via proteasome pathway and the absence of normal HSP47 appears to 
have several effects on type I procollagen production. Firstly, procollagen trimers are rapidly 
transported from the ER to the Golgi. Then the overall transit time from the ER to the 
extracellular space is also increased. The trimers were also found to be hypersensitive to 
protease degradation suggesting that they are immaturely expressed. These in the end affect 
the collagen fibril assembly in the ECM and lead to irregular bone mineralisation pertinent to 
OI (Christiansen et al., 2010). 
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Connection with Cancer Progression 
HSP47 gene expression (also called SERPINH1), has been detected in many types and stages 
of cancer. Recently, a comparative study of public gene expression data of seven types of 
cancer found that SERPINH1 is one of the top marker genes for stomach cancer, particularly 
at the early stage. Collagen type XII gene (COL12A1), is also one of the possible markers in 
the aforementioned cancer type (Xu et al., 2010). Similarly, HSP47 antigen has been detected 
in sera of breast cancer patients, among 27 other biomarkers (Anderson et al., 2011). The 
gene has also been shown to be highly upregulated in neuroblastoma tumour cells after 
treatment with demethylating agent 5'-aza-2'-deoxycytidine (5-aza-dC). This is because 
hypermethylation of various genes has been reported to be closely-related to NB. In the 
presence of 5-aza-dC, SERPINH1 gene expression is induced more than 80-fold thus the 
growth of neuroblastoma is impaired. It was also found that, in the NB cell lines, the higher 
the level of collagen expression, the higher the tumorigenicity (Yang et al., 2004). In some 
cases of carcinomas, HSP47 is highly expressed. For example in the epithelial cells of 
ulcerative colitis associated carcinoma, that relates to the increase in collagen type I 
production. The function of collagen from epithelial cells is somewhat unclear (Araki et al., 
2009). Overexpression is also observed in oral squamous cell carcinoma induced by areca nut 
chewing, which is a famous pastime among East, South, and South East Asian communities. 
This habit has been declared as unhealthy due to the carcinogenicity of the compounds 
present in the nut. The high expression of HSP47 was found to accompany collagen 
expression in the tissues surrounding the tumour, probably to prevent metastasis (Lee et al., 
2011). Similar overexpression has also reported in head and neck squamous cell carcinoma 
(Li et al., 2008), and pancreatic carcinoma (Maitra et al., 2002). These findings suggest the 
growing significance of HSP47 as biomarker and potential target for therapy for various 
types of cancerous cells.  
 
Potential HSP47-related Treatments 
Treatments of various fibrotic diseases by targeting HSP47 mechanism are actively being 
developed due to its binding specificity to collagen. Among these include small molecule 
inhibitors and RNA interference (RNAi), using viral and non-viral gene delivery system (Li 
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et al., 2008; Sato et al., 2008; Thomson et al., 2005). But there has been another treatment 
method reported to be able to suppress HSP47 expression thus suppressing collagen 
deposition in fibrotic diseases, namely employing the antisense oligonucleotides. 
Oligonucleotides are short (13-25 nucleotides) unmodified or chemically modified single 
stranded DNA molecules that hybridises to a unique sequence in the total pool of targets in 
cells. Generally, the mechanism of inhibition of gene expression by oligonucleotides can be 
divided into two: 1. Via the RNase H-dependent oligonucleotides, which induces mRNA 
degradation. 2. The steric-blocker oligonucleotides which prevents or inhibit splicing or 
translational machinery progression. The majority of drugs employing oligonucleotides are 
based on the first mechanism (Dias and Stein, 2002). Antisense oligonucleotides has been 
shown to abrogate the expression of HSP47 in peritoneal fibrosis in rats, thus suppressing the 
expression of collagen types I and III (Nishino et al., 2003). Later on, the oligonucleotides 
have been shown to suppress pulmonary fibrosis induced by paraquat (a herbicide) ingestion. 
The level of HSP47 expression was halved and fibrotic lesions was inhibited based on the 
difference in connective tissue deposition (Hagiwara et al., 2007c). Furthermore, experiments 
on a rat model suffering from pulmonary fibrosis induced with bleomycin and 
lipopolysaccharide was also found to inhibit or decrease HSP47 expression (Hagiwara et al., 
2007a; Hagiwara et al., 2007b). Bleomycin is a cytostatic drug commonly used in the 
treatment of cancer, with an undesirable side effect of inducing chronic pulmonary 
inflammation that may progress to fibrosis in some cases. Compared to other techniques, 
oligonucleotides administration does not require gene transfection. 
Vector systems on the other hand, also have their own potential. Adenoviral vector 
targeting HSP47 as tumour-specific biomarker has been developed, and used to target the 
head and neck squamous cell carcinoma (HNSCC) (Li et al., 2008). Liposomes, as an 
alternative to viral delivery system, have also been applied to deliver small interference RNA 
(siRNA) against gp46 (the rat homolog of HSP47). The vitamin A-coupled liposome system 
carrying the siRNA has been shown to resolve collagen deposition in cirrhotic rat liver  by 
suppressing HSP47 expression (Sato et al., 2008). Hepatic stellate cells, which are the 
principal cell type responsible for liver fibrosis, were particularly selected as the cells take up 
vitamin A from circulation before storing it. For this reason, vitamin A was coupled to the 
surface of liposome to achieve a more specific targeting to the cells, before the siRNA targets 
gp46 and suppresses its expression. Finally, the use of small molecules is also appealing for 
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pharmacological targeting of HSP47. Four small molecules have been identified to inhibit 
HSP47 function in vitro, but the efficacy of these compounds in cells and in vivo is yet to be 
tested (Thomson et al., 2005).    
Inhibiting excessive collagen synthesis in various fibrotic diseases by blocking HSP47 
function is a promising mechanism for the treatment of such diseases. Therefore, it is 
essential to understand the mechanism by which HSP47 binds to collagen. This will facilitate 
the development of drug design strategies so that the best treatment method can be devised.    
 
1.4 Serpins 
HSP47 is a slightly unusual member of the heat shock proteins as it belongs to the serine 
protease inhibitor (serpin) family as well. Serpins generally have a highly conserved 
secondary structure that is usually made up of a core of three β-sheets surrounded by nine α-
helices (Huber and Carrell, 1989). They can be found widely across eukaryotes, in their 
related viruses and also in higher plants (Gettins, 2002). As a member of the serpin 
superfamily, HSP47 has been shown to possess several of the archetypal serpin 
characteristics. Hence, it is helpful to consider the structure and behaviour of the members of 
this family to assist in studying HSP47 functions.  
Serpins are single chain proteins with conserved domains of around 370-390 amino 
acid residues. Members of this group of proteins have a highly conserved secondary 
structure. Serpins are characterised by the presence of three groups of β-sheets (A to C) and 
eight to nine α-helices (hA to hI) (Figure 1.8A, B) named according to the Huber and Carrell 
nomenclature of α1-antitrypsin (α1-AT) (Huber and Carrell, 1989). Many members of this 
group are serine protease inhibitors, but some are non-inhibitors such as ovalbumin, pigment 
epithelium derived factor (PEDF), thyroid- and corticosteroid binding globulins (T- and 
CBG) and angiotensinogen (AGT) (Silverman et al., 2001). In inhibitory serpins (native 
form), the interaction with their target proteases is at a reactive site within a loop structure 
(reactive centre loop or reactive serpin loop, RCL or RSL) of about 30-40 amino acids from 
the C-terminus (Figure 1.8A, B). The loop is exposed on the surface making it susceptible to 
proteolysis by non-target proteases (Potempa et al., 1994). The bond cleaved during 
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proteolysis is known as the ‘scissile bond’ which linked residues called P1 and P΄1 on the 
RCL. Upon binding to target proteases, the residues N-terminal to the scissile bond then 
insert into β-sheet A forming the ‘cleaved’ form of serpin (Engh et al., 1989). The protein is 
said to undergo a ‘stressed’ to ‘relaxed’ (S to R) transition which gives rise to an increase in 
thermostability and loss of inhibitory activity (Figure 1.8C). In the case of α1- AT, the 
binding of trypsin protease at the active site causes the protease to be translocated to the distal 
end from the point of initial docking, the distance of which was suggested to be more than 70 
Å (Stratikos and Gettins, 1999).      
The native conformation of serpins required for their inhibitory activity consists of a 
five stranded β-sheet A with the RCL exposed to the environment. A more stable but non-
inhibitory conformation, called the ‘latent’ form can also be achieved via the insertion of 
RCL into the β-sheet A giving a fully antiparallel β-sheet (Figure 1.8D). This conformation 
explains the inactivity of the latent form as the RCL is inaccessible to the cognate proteases. 
The structural rearrangement also involves the extraction of the first strand of β-sheet C 
(s1C). The latent form can be observed in plasminogen activator inhibitor-1 (PAI-1) and 
antithrombin. In PAI-1, the newly-inserted β-strand forms hydrogen bonds and hydrophobic 
interactions with the third (s3A) and the fourth strand of β-sheet A (s5A) leading to the 
hyperthemostability of the latent form (melting temperature of up to 70°C). The native 
metastable form usually melts around 60°C (Mottonen et al., 1992; Munch et al., 1991). 
As more serpins are discovered, their functions are also moving away from the 
classical serpin function of protease inhibition. In fact the first structure of uncleaved serpin 
was the structure of a noninhibitory serpin ovalbumin (Stein et al., 1990). Ovalbumin in the 
most abundant protein found in egg white. In the ovalbumin structure, the peptide loop 
analogous to the RCL of inhibitory serpin forms a protruding α-helix (Stein et al., 1990). This 
is particularly important as structures of serpins before that were only available are in cleaved 
form, especially that of cleaved α1-AT (Loebermann et al., 1984). The structure of thyroxine-
binding globulin (TBG) has also been solved (Zhou et al., 2006). Thyroxine is the major 
hormone controlling cellular development as well as the rate of body metabolism. It is carried 
in the blood by TBG, which has a high binding affinity to it. The structure of thyroxine-
bound TBG revealed that the binding pocket of thyroxine molecule is formed by strands 3-5 
of β-sheet B and helices H and A (Zhou et al., 2006) (Figure 1.9A, B). The pocket provides 
an enclosed hydrophobic environment, and allows formation of H-bond between thyroxine 
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and the adjacent residues in the pocket. The reversible release of thyroxine from the pocket is 
governed by the partial insertion of the side chain of P14, a residue situated 14 residues 
before the ‘scissile’ residue P1 of the RCL, into β-sheet A. The release is triggered by the 
insertion of the RCL up to P12, which causes contraction of the binding pocket, hence the 
release of thyroxine. What triggers this insertion is still unclear; heat is among the factors 
proposed. Using the model of δ-ACT as model for TBG with unbound thyroxine, TBG is 
shown to be in equilibrium between the high-affinity binding and the low affinity forms, 
distinguished by the partial RCL insertion into β-sheet A (Figure 1.9C) (Zhou et al., 2006). 
In another case, the crystal structure of another noninhibitory serpin PEDF shows that 
at the RCL region, there are Pro residues adjacent to the scissile bond which probably do not 
facilitate loop insertion. The RCL region of PEDF was also predicted to project outward of 
the protein body. Another possible explanation of the loss of inhibitory activity of PEDF is 
the inability of the main β-sheet A to open up and accept the RCL insertion. PEDF is found 
as a component of the retinal inter-photoreceptor matrix as well as in the vitreous and 
aqueous liquid in the adult eye (Simonovic et al., 2001).   
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Figure 1.9: The structure of thyroxine-binding globulin (TBG) shown here with bound 
thyroxine. 
A. The structure of TBG, with the main β-sheet A is shown in blue, the β-sheet B that forms 
the pocket of thyroxine binding site (green) and helix A (hA, brown). The RCL is shown in 
red, with residues 350-357 of the loop not shown due to the unordered nature of the region. 
Thyroxine is shown in stick representation. B.  The binding pocket, enclosed by strands 3-5 
of β-sheet B as the base, and helices A and H. C. TBG equilibrium between the high-affinity 
form (right) and the low-affinity form (left). The location for threonine P14 is shown in 
space-filling representation. All adapted from (Zhou et al., 2006). 
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1.4.1 HSP47 as a Serpin 
HSP47 found in chick embryo fibroblast (CEF) was shown to have the highest homology to 
the serpin human protein C inhibitor (hPCI, 30% identity) and also a slightly lower sequence 
identity to the other serpin members (10-30% identity) (Hirayoshi et al., 1991). This is 
significant as serpins are well known to have a common scaffold of secondary structures. 
CEF HSP47 is homologous to the serpin family members especially the highly conserved 
serpin secondary structure, such as part of the serpin RCL region. The serpin characteristics 
are, some of which are observed in HSP47: (1) small glycoprotein with a single polypeptide 
chain and several oligosaccharide side chains (though the sugar group was later found not to 
be crucial for HSP47 function), (2) homologous amino acid sequences, (3) having a common 
secondary and probably tertiary structure, (4) possessing a conserved reactive centre loop 
(RCL) and (5) containing conserved flanking sequences around the RCL. The amino acids 
around the region homologous to serpin RCL of HSP47 resemble more to the sequence found 
in ovalbumin (a non-inhibitory serpin) and CEF HSP47 also lacks the reactive P1 bond. This 
prompted the suggestion that HSP47 is another noninhibitory member of serpin superfamily 
(Hirayoshi et al., 1991). 
In the same year, a HSP47 homologue found in rat skeletal myoblasts (known as gp46 
at that time) shows sequence similarities to human α1-AT and hPCI precursors with about 
30% of identical amino acid residues, unsurprisingly similar to that found in CEF. The even 
distribution of conserved residues suggests similar secondary structure which is syncronous 
with that observed with CEF HSP47. Rat gp46 shows sequence similarity to α1-AT and hPCI 
especially at the residues near the putative RCL cleavage site P1-P΄1. But unlike the inhibitory 
serpins, in gp46 residues upstream to the site possess larger side chains, another finding 
leading to suggestion of HSP47 noninhibitory function as large side chains makes loop 
insertion into β-sheet A less preferable (Clarke et al., 1991).   
It is now well established that HSP47 is a noninhibitory member of the serpin 
superfamily with a substantial amount of secondary and tertiary structural similarities. This is 
very helpful due to the lack of HSP47 crystal structure to date. As more serpin crystal 
structures are obtained, the information could be used to assist the homology modelling of 
HSP47.   
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1.4.2 HSP47 Homology Modelling 
Three dimensional structures of proteins provide the best information in order to investigate 
the mechanism and chemistry at atomic resolution. Two methods have been extensively 
utilised for protein structural determination; X-ray crystallography for crystallisable proteins, 
and nuclear magnetic resonance (NMR) spectroscopy for non crystallisable proteins and for 
determination of protein conformation in solution. X-ray is suitable for structure 
determination of proteins too large to be analysed by NMR. NMR, on the other hand, allows 
investigation at a condition closer to the native environment of proteins (Mathews et al., 
1999). Originally used for structure determination of proteins in aqueous environment, NMR 
has been actively developed for use for membrane proteins that dissolve in detergent micelles 
or lipid bilayers (Marassi and Opella, 1998). The use of both techniques to analyse one 
protein rarely gives conflicting outcome.  
Homology modelling has also been used as routine structure ‘determination’ as the 
speed at which gene sequences are discovered is too rapid for structural biologists to cope in 
solving the three dimensional coordinate of the coded proteins (Rodriguez et al., 1998). 
Additionally, for proteins that do not meet the criteria for, or resist X-ray crystallography and 
NMR spectroscopy, homology modelling is the best (or only) option available to guide 
biological experiments. These include site-directed mutagenesis and development of protein 
inhibitor based on structural information. To get a homology model of a considerable 
accuracy, templates of known protein structures closely-related to the protein of unknown 
structure must be present. These structures are usually obtained from online databases, 
namely the RCSB Protein Data Bank governed by the Research Collaboratory for Structural 
Bioinformatics (http://www.pdb.org) (Berman et al., 2000). As of December 2010, the 
database holds more than 70,000 of biomolecular structures determined using X-ray 
crystallography, NMR spectroscopy and cryo-electron microscopy. Then together with the 
sequence data of the protein to be determined, many programs can be used to construct the 
model, be it stand-alone or web-based. Among the stand-alone modelling programs are 
MODELLER (http://www.salilab.org/modeller/), DeepView (Swiss Pdb-Viewer) 
(http://spdbv.vital-it.ch/) and YASARA (http://www.yasara.org/) while web-based programs 
are like 3D-JIGSAW (http://bmm.cancerresearchuk.org/~3djigsaw/), SWISS-MODEL 
(http://swissmodel.expasy.org/) and ESyPred3D 
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(http://www.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred/). DeepView and SWISS-
MODEL both use the same server at Expert Protein Analysis System (ExPASy) of the Swiss 
Institute of Bioinformatics (http://expasy.org/). 3D-JIGSAW has recently been used to model 
mutant HSP47 protein that has contributed to osteogenesis imperfecta (OI) in Dachshunds 
(Drögemüller et al., 2009). The mutation was found to be at Leu326 and from nucleotide 
sequence of the affected individuals, it is substituted with Pro. This could significantly affect 
the wild-type peptide backbone, thus leading to disruption in the local secondary structural 
conformation (Drögemüller et al., 2009). The effect of the mutation on the collagen binding 
and release function of HSP47 however was not discussed in the report.        
Due to the nature of HSP47, from our observations, crystallisation has been found to 
be difficult as it tends to aggregate in the concentration range usually required for 
crystallisation. Generally, in order to obtain a reliable homology model, an identity between 
the target protein and the template must first be determined. If the percentage identity falls 
below 30%, model quality estimation on the basis of sequence identity becomes unreliable 
(Bordoli et al., 2009). But as HSP47 belongs to the serpin superfamily that have highly 
conserved secondary structures, this makes molecular modelling an acceptable approach with 
about 30% identity with its closest serpin relatives. The first attempt to model HSP47 was 
made in 1995 using mature recombinant mouse (mrm) protein (Davids et al., 1995) using the 
known structure of hPCI. It was initially predicted to exist in the latent state at physiological 
pH, as HSP47 failed to inhibit a series of proteases.  It is unlikely that latent conformation is 
adopted as latency is known to increase the thermostability of serpins (Munch et al., 1991), 
and HSP47 is later shown to be metastable (Dafforn et al., 2001). The work paved the way 
towards finding a better model to suit HSP47 behaviour. Later, HSP47 was modelled as 
RCL-exposed, five-stranded β-sheet A, similar to that of α1-AT (Dafforn et al., 2001) despite 
the exact position of RCL region relative to overall structure is still being debated. A similar 
model was also presented to explain the effect of mutation on HSP47 structure found in OI 
individuals (Drögemüller et al., 2009).  
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CHAPTER 2: INVESTIGATION ON THE IMPORTANT HISTIDINE RESIDUES 
FOR HSP47 pH-SWITCH FUNCTION 
2.1 Introduction 
This chapter presents thorough investigation on a series of His-to-Ala (HA) mutants. This 
first involved computational prediction of all surface residues in order to examine the 
contributions of histidine residues to HSP47 pH-change behaviour in vitro. The prediction of 
surface His residues was performed on a mouse HSP47 homology model using PropKa 
program, and the positions were mapped to predict their locations. Each of the residues was 
subjected to site-directed mutagenesis. A few adjacent residues were mutated simultaneously. 
Expression and solubility of the mutants were first assessed and the general binding 
behaviour to gelatin was assayed. Gelatin is the denatured form of collagen, containing both 
triple helical and single stranded molecules. Soluble and gelatin-binding mutants were then 
subjected to gelatin column purification in order to investigate their pH release behaviour. It 
was necessary that the properties of HSP47 WT were established first so comparison with 
those of HA mutants can be made in order to probe for possible perturbations. Using circular 
dichroism (CD), the secondary structural content of HSP47 was investigated prior to studying 
the effects of pH on HSP47 secondary structure. Furthermore, collagen mimetic peptides 
(CMP) were employed to demonstrate how changes in pH affect the change in HSP47 
structure, which in turn triggers the release from collagen.  
 Similarly, the effects of mutation on HSP47 structure were also investigated by CD. 
Then the ability of the mutants to arrest collagen fibrillisation was examined. This provided 
information on the effects of mutation on HSP47-collagen binding interface. Finally, the 
effects on HSP47 structural transition from alkali to acid state were probed by comparing the 
change in structure of the constructed mutants to that of WT. Data obtained from these 
experiments would provide the insights of how His residues participate actively in HSP47 
pH-switch mechanism, how mutations perturbs normal pH transition as well as information 
on collagen binding and release behaviour.   
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2.2 Homology Model Construction of Mouse HSP47 
Section 1.4.2 has described the advantages of homology modelling for proteins in cases 
where X-ray or NMR structures are absent, mostly due to the protein itself resisting 
crystallisation. Although there are certain limitations to when working with homology 
models, templates of known protein structures closely-related to the protein being studied can 
be used to get a homology model of a considerable accuracy. The main depository is the 
RCSB Protein Data Bank, where more than 70,000 protein structures have been deposited. A 
30% sequence similarity is generally taken as a bench mark in getting a good homology 
model (Schwede et al., 2008). 
Molecular modelling of mouse HSP47 has been reported previously (Davids et al., 
1995). It involves alignment of the HSP47 sequence with the one of a known crystal structure 
of a serpin family member, human protein C inhibitor (hPCI). The study also confirmed the 
non-protease inhibitory activity of HSP47 despite having high homology to serpin members 
(around 30% identity). The model also seems slightly inaccurate due to the fact that HSP47 
was predicted to exist in latent state at physiological pH values, while a latent serpin is 
hyperthermostable (with a melting temperature of around 70°C). This behaviour is not 
observed in mouse HSP47 (Dafforn et al., 2001; Dafforn et al., 2004). HSP47 is then 
proposed to adopt a conformation similar to the native structure of serpins. 
 Hence, construction of a more reliable model is needed to guide the mutagenesis 
experiments. As with most homology modelling, a native serpin scaffold is needed. There 
have been quite a number of serpin crystal structures reported, such as the inhibitory serpins 
α1-antitrypsin (Elliott et al., 1998), antithrombin (Schreuder et al., 1994) and a variant of 
antichymotrypsin (Wei et al., 1994); as well as the non-inhibitory serpins such as ovalbumin,  
the first serpin structure found in the native form (Stein et al., 1990) and pigment epithelium-
derived factor (PEDF) (Simonovic et al., 2001). Figure 2.1 presents the alignment of the 
sequence of a mature recombinant mouse HSP47 with some closely-related serpins. The 
alignment scores are all in the small range of 23-27%.  
The first serpin structure to be solved was that of a cleaved α1-AT (Loebermann et al., 
1984). The cleaved structure was reported before the native structure was solved. Research 
interest on this serpin has been growing dramatically since. It was even selected as a 
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structural archetype from which other serpins can be modelled. The nomenclature of serpin 
secondary structures now follows that of α1-AT (Huber and Carrell, 1989) making this serpin 
a suitable template for HSP47 homology model construction, with a good sequence similarity 
(25% pairwise alignment score with mrmHSP47) compared to the other serpins aligned. 
 The mouse HSP47 homology model was provided by the Nagata group at Kyoto 
University on a collaboratory basis (Figure 2.1), constructed using Deepview v4.0.1 
modelling software (Guex and Peitsch, 1997). α1-AT was selected as template structure. The 
model was then used to guide the mutagenesis experiments and all HSP47 figures shown in 
this chapter and the following chapters are made using this model.    
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1BY7            ----------------------MEDLCVANTLFALNLFKHLAKASPTQNLFLSPWSISST 38 
1OVA            ----------------------XGSIGAASMEFCFDVFKELKVHHANENIFYCPIAIMSA 38 
1QLP            MDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATA 60 
2CEO            --------------------GSLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAA 40 
mrmHSP47        MAEVKKPLEAAAPGTAEKLSSKATTLAERSTGLAFSLYQAMAKDQAVENILLSPLVVASS 60 
                                         :      :.:.::: :       *:: .*  : :: 
 
1BY7            MAMVYMGSRGSTEDQMAKVLQFNEVGAAAD----------KIHSSFRSLSSAINASTG-N 87 
1OVA            LAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSSLRDILNQITKPND-V 97 
1QLP            FAMLSLGTKADTHDEILEGLNFNLTEIPEA----------QIHEGFQELLRTLNQPDS-Q 109 
2CEO            LVMLSFGACCSTQTEIVETLGFNLTDTPMV----------EIQHGFQHLICSLNFPKK-E 89 
mrmHSP47        LGLVSLGGKATTASQAKAVLSAEKLRDEEV------------HTGLGELLRSLSNSTARN 108 
                : :: :*    *  :    :  :                   : .:  :   :. .     
 
1BY7            YLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGK 147 
1OVA            YSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGI 157 
1QLP            LQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGK 168 
2CEO            LELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN-ISAAKQEINSHVEMQTKGK 148 
mrmHSP47        VTWKLGSRLYGPSSVSFADDFVRSSKQHYNCEHSKINFRD-KRSALQSINEWASQTTDGK 167 
                      . *:  .      .::.  :  *       :*      * : **. ..  *.*  
 
1BY7            IPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLYP-FRVNSAQRTPVQMMYLRE 206 
1OVA            IRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMP-FRVTEQESKPVQMMYQIG 216 
1QLP            IVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEED-FHVDQVTTVKVPMMKRLG 225 
2CEO            VVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQME 206 
mrmHSP47        LPEVTK--DVERTDGALLVNAMFFKPHWDEKFHHKMVDNRG-FMVTRSYTVGVTMMHRTG 224 
                :  :    .:.      *** : **  *   *. .       * :       * **     
 
1BY7            KLNIGYIEDLKAQILELPYA-GDVSMFLLLPDEIADVSTGLELLESEITYDKLNKWTSKD 265 
1OVA            LFRVASMASEKMKILELPFASGTMSMLVLLPDEVS----GLEQLESIINFEKLTEWTSSN 272 
1QLP            MFNIQHCKKLSSWVLLMKYL-GNATAIFFLPDEGK-----LQHLENELTHDIITKFLE-- 277 
2CEO            QYYHLVDMELNCTVLQMDYS-KNALALFVLPKEGQ-----MESVEAAMSSKTLKKWNR-- 258 
mrmHSP47        LYNYYDDEKEKLQMVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKAWMG-- 278 
                        . .  :: :         :..:*..       :: :*  :. . :. :     
 
1BY7            KMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQA 325 
1OVA            VMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSSS-ANLSGISSAESLKISQAVHAA 331 
1QLP            NEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNG-ADLSGVTEEAPLKLSKAVHKA 336 
2CEO            LLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSEN-ADFSGLTEDNGLKLSNAAHKA 317 
mrmHSP47        KMQKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHAT 338 
                   .    : :*:  :   ::*   *  :*: .. ... *::* ::    * ::.. * : 
 
1BY7            MVDVNEEGTEAAAGTGGVMTGRTGH--GGPQFVADHPFLFLIMHKITNCILFFGRFSSP- 382 
1OVA            HAEINEAGREVVGSAEAGVDAAS----VSEEFRADHPFLFCIKHIATNAVLFFGRCVSP- 386 
1QLP            VLTIDEKGTEAAGAMFLEAIPMS----IPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPT 392 
2CEO            VLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPT 377 
mrmHSP47        AFEWDTEGNPFDQDIYGREELRS-----PKLFYADHPFIFLVRDNQSGSLLFIGRLVRPK 393 
                    .  *              .        .  ::.*:: : .  : . **:*:   *  
 
1BY7            -------- 
1OVA            -------- 
1QLP            QK------ 394 
2CEO            EA------ 379 
mrmHSP47        GDKMRDEL 401 
 
Figure 2.1: Multiple sequence alignment of mature recombinant mouse HSP47 
(mrmHSP47) with several closely-related serpins. 
Among the serpins selected for alignment is human PAI-1 (PDB ID: 1BY7), ovalbumin 
(1OVA), α1-AT (1QLP) and a non-inhibitory serpin thyroxine-binding globulin (2CEO). All 
amino acid sequences are obtained from Protein Data Bank (http://www.rcsb.org/pdb). "*" 
means that the residues are identical in all sequences in the alignment; ":" means that 
conserved substitutions are observed; "." means that semi-conserved substitutions are 
observed, according to common amino acid side chain grouping (Thompson et al., 1994). The 
alignment score between mrmHSP47 and PAI-1 is 27%, 26% (ovalbumin), 25% (α1-AT) and 
23% (TBG). 
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Figure 2.2: Ribbon structure representations of a homology model of HSP47, using α1-
antitrypin structure (see Figure 1.7) as reference.  
A. The three main β-sheets are labelled sheet A-C and the α-helices are labelled hA-hI. B. 
‘Back’ view of the homology model. These figures and all subsequent molecular figures were 
produced using PyMol v0.99 (DeLano, 2004) (unless stated otherwise).  
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2.3 Predicting the Solvent Accessibility and Locations of all Histidine (His, H) 
Residues 
Mouse HSP47 has fourteen His residues altogether (Figure 2.3). Mutating all these fourteen 
could possibly affect the conformational integrity in case of buried residues. Hence we 
searched for a good criterion for mutagenesis by covering as much important sites as 
possible. For this purpose, the location and solvent accessibility of the residues were mapped 
on the homology model that was constructed earlier. Figure 2.4 shows their predicted 
locations on the model. To obtain a better prediction on accessibility and ionisation pH values 
of the residues, we used PropKa software available at http://propka.ki.ku.dk (Li et al., 2005). 
It is a FORTRAN-based tool that allows calculation of the pKa values of ionisable groups in 
proteins based on specific empirical rules.  
It has been reported that the predicted pKa generally falls within 1 pH value to 
experimentally-determined pKa in 44 proteins (Li et al., 2005). The values for His residues 
however must be used with caution, as based on calculations, the relative mean standard 
deviation (RMSD) of experimental/predicted pKa for His residues are relatively high 
compared to other residues (Li et al., 2005). 
  
AEVKKPLEAAAPGTAEKLSSKATTLAERSTGLAFSLYQAMAKDQ 
1 
AVENILLSPLVVASSLGLVSLGGKATTASQAKAVLSAEKLRDEE 
VHTGLGELLRSLSNSTARNVTWKLGSRLYGPSSVSFADDFVRSS 90 110 
KQHYNCEHSKINFRDKRSALQSINEWASQTTDGKLPEVTKDVER 158 135 140 
TDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMH 220 191 192 197 198 
RTGLYNYYDDEKEKLQMVEMPLAHKLSSLIILMPHHVEPLERLE 244 255 256 
KLLTKEQLKAWMGKMQKKAVAISLPKGVVEVTHDLQKHLAGLGL 275 297 302 
TEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTEGNPFDQDI 335 341 
YGREELRSPKLFYADHPFIFLVRDNQSGSLLFIGRLVRPKGDKM 368 
RDEL 400 
 
Figure 2.3: Mature mouse HSP47 amino acid sequence (Ala1 to Leu400), shown using 
one-letter amino acid codes.  
The RDEL ER-retention sequence is shown in bold. The His residues are highlighted in blue, 
and the five Trp residues are highlighted in red.   
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Figure 2.4: The predicted locations of all the His residues (blue) shown here against the 
overall structure of mouse HSP47 (grey).  
A. The ‘front’ representation of the homology model. B. The ‘back’ representation. One letter 
amino acid name is used, and the numbers that follow the residue names indicate the amino 
acid position in HSP47 primary sequence. C & D. Surface representation to show the solvent 
accessibility of all His residues in their respective environments.  
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Table 2.1 shows the predicted pKa values for all His residues, along with the modelled 
solvent accessibility and the degree of conservation in HSP47 across all reported species 
(Figure 2.4). There are eight residues altogether that are predicted to be ionised around the 
HSP47-collagen dissociation pH of 6.3 (Saga et al., 1987). The residues are H135, 191, 197, 
198, 244, 255, 256 and 302. They are also highly conserved (more than 90% identity) across 
all 12 species, excluding H255 which is only 46% identical (Figure 2.4). More detailed 
observation on the locations of these residues revealed that they can generally be grouped 
into three clusters. The first cluster, on top of β-sheet A is called the ‘breach’ cluster as it is 
close to the breach region of serpin. This region is very critical for serpin function as it is an 
insertion point for reactive centre loop (RCL) into sheet A following binding to protease 
substrate (Whisstock et al., 2000). The second cluster is called the ‘shutter’ cluster, which is 
found near the centre of sheet A centred at the start of helix B (Stein and Carrell, 1995). This 
domain is important in facilitating the opening of strands 3 of β-sheet A (s3A) and s5A to 
accept RCL insertion. The last cluster is the ‘gate’ cluster, borrowing from the nomenclature 
of a flexible loop connecting s3C and s4C, which is critical in the conversion of PAI-1 from 
native to latent structure (Stein and Carrell, 1995). His residues grouped into these clusters 
are shown in Table 2.2. The locations of these clusters in HSP47 homology model are shown 
in Figure 2.6.     
All eight surface residues were chosen as mutagenesis candidates to investigate the 
effects of mutation on HSP47 pH-switch function.     
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Table 2.1: The solvent accessibility of fourteen His residues in mouse HSP47, their 
predicted pKas and the degree of conservation across 12 species analysed. 
Solvent accessibility and pKa values were predicted using PropKa* program. His residues 
with predicted pKa values close to HSP47-collagen dissociation pH are italicised.  
 
 
Residue 
 
Solvent accessibility Predicted pKa* Degree of conservation (%)
H90 buried 4.45 100 
H135 surface 6.35 100 
H140 buried 3.28 100 
H191 surface 6.36 100 
H197 surface 6.36 100 
H198 surface 7.23 92 
H220 buried 4.76 100 
H244 surface 6.15 92 
H255 surface 6.50 46 
H256 surface 6.44 100 
H297 buried 0.23 100 
H302 surface 6.51 92 
H335 buried 3.41 100 
H368 buried 1.08 100 
*error of about 1 pH unit to experimentally-determined proteins (Li et al., 2005).  
 
 Gallus_gallus                   --------MQIFLVLALCG------LAAAVPSEDRK-LSDKATTLADRST 35 
Taeniopygia_guttata             --------MWIIMGLALLG------LAAAVPSEDRK-LSDKATTLAERST 35 
Alligator_mississippiensis      --------MWAIQLLAMGV------LVAAVPSEDKK-LSDKANALADRSA 35 
First amino acid in mrm 
nomenclature 
Mus_musculus                    -MSLLLG-TLCLLAVALAAEVK-KPLEAAAPGTAEK-LSSKATTLAERST 46 
Rattus_norvegicus               MRSLLLG-TLCLLAVALAAEVK-KPVEAAAPGTAEK-LSSKATTLAERST 47 
Cricetulus_griseus              MRSLLLG-SFCLLAVALAAEVK-KPVEAAAPGTAEK-LSSKATTLAERST 47 
Homo_sapiens                    MRSLLLLSAFCLLEAALAAEVK-KPAAAAAPGTAEK-LSPKAATLAERSA 48 
Macaca_mulatta                  MHSLLLLSAFCLLAVALTAEVK-KPAAAAAPGTAEK-LSPKAATLAERSA 48 
Xenopus_laevis                  MWMIKLLALSILLVVDAAVNKKPIAEKKVEPPLEQK-MSQHANVLADKSA 49 
Danio_rerio                     --------MWVSSLIALCL------LAVAVSGEDKK-LSTHATSMADTSA 35 
Oncorhynchus_mykiss             --------MWVTNVVVLCL------LAVAAPGEDKKKLSSHATTMADKSA 36 
Carassius_auratus               --------MLVSSVVLLCL------LATVS---GDKALSSHASILADNSA 33 
                                                            .      * :* :*  :*: *: 
 
Gallus_gallus                   TLAFNLYHAMAKDKNMENILLSPVVVASSLGLVSLGGKATTASQAKAVLS 85 
Taeniopygia_guttata             TLAFNLYHAMAKDKDMENILLSPVVVASSLGLVSLGGKATTASQAKAVLS 85 
Alligator_mississippiensis      TLAFNLYHAMAKDKNMENILVSPVVVASSLGLVSLGGKAATASQAKAVLS 85 
Mus_musculus                    GLAFSLYQAMAKDQAVENILLSPLVVASSLGLVSLGGKATTASQAKAVLS 96 
Rattus_norvegicus               GLAFSLYQAMAKDQAVENILLSPLVVASSLGLVSLGGKATTASQAKAVLS 97 
Cricetulus_griseus              GLAFSLYQAMAKDQAVENILLSPLVVASSLGLVSLGGKATTASQAKAVLS 97 
Homo_sapiens                    GLAFSLYQAMAKDQAVENILVSPVVVASSLGLVSLGGKATTASQAKAVLS 98 
Macaca_mulatta                  GLAFSLYQAMAKDQAVENILVSPVVVASSLGLVSLGGKATTASQAKAVLS 98 
Xenopus_laevis                  GLAFNLYQIMAKDKKVENILLSPVVVASSLGLVSMGGQASTAAQAKTVLN 99 
Danio_rerio                     NLAFNLYHNVAKEKGLENILISPVVVASSLGMVAMGSKSSTASQVKSILK 85 
Oncorhynchus_mykiss             NLAFSLYHTVAKEKGLDNILISPVVVASSLGMVALGGKASTASQVKSVLS 86 
Carassius_auratus               NFAFNLYHNLAKEKDIENIVISPVVVASSLGLVALGGKSNTASQVKTVLS 83 
                                 :**.**: :**:: ::**::**:*******:*::*.:: **:*.*::*. 
 
Gallus_gallus                   ADKLNDDYVHSGLSELLNEVSNSTARNVTWKIGNRLYGPASINFADDFVK 135 
Taeniopygia_guttata             ADKLNDDYVHSGLSELLSEVSNSTARNVTWKIGNRLYGPASITFAEDFVK 135 
Alligator_mississippiensis      ADKLNDDYVHSGLSELLNEVSNSTARNVTWKIGNRLYGPSSISFADDFVK 135 
Mus_musculus                    AEKLRDEEVHTGLGELLRSLSNSTARNVTWKLGSRLYGPSSVSFADDFVR 146 
Rattus_norvegicus               AEKLRDEEVHTGLGELVRSLSNSTARNVTWKLGSRLYGPSSVSFADDFVR 147 
Cricetulus_griseus              AEKLRDEEVHKGLGELLRSLSNSTARNVTWKLGSRLYGPSSVNFVEDFVH 147 
Homo_sapiens                    AEQLRDEEVHAGLGELLRSLSNSTARNVTWKLGSRLYGPSSVSFADDFVR 148 
Macaca_mulatta                  AEQLRDEEVHTGLGELLRSLSNSTARNVTWKLGSRLYGPSSVSFADDFVR 148 
Xenopus_laevis                  AEKLSDEHIHSGLAELLNEVSNSTARNVTWKMGNRLYGPSSISFSDNFVK 149 
Danio_rerio                     ADALKDEHLHTGLSELLTEVSDPQTRNVTWKISNRLYGPSSVSFAEDFVK 135 
Oncorhynchus_mykiss             ADALNDEHLHTGLSELLTEVSDPKTRNVTWKISNRLYGPSSVTFADNFVK 136 
Carassius_auratus               ATTVKDEQLHSGLSELLTEVSNSTARNVTWKISNRLYGPSSVSFVDNFLK 133 
                                *  : *: :* **.**: .:*:. :******:..*****:*:.* ::*:: 
 
Gallus_gallus                   NSKKHYNYEHSKINFRDKRSALKSINEWAAQTTDGKLPEVTKDVEKTDGA 185 
Taeniopygia_guttata             NSKKHYNYEHSKINFRDKRSALKSINEWAAQTTDGKLPEVTKDVEKTDGA 185 
Alligator_mississippiensis      NSKKHYNYEHSKINFRDKRSALKSINEWASQTTNGKLPEVTKDVEKTDGA 185 
Mus_musculus                    SSKQHYNCEHSKINFRDKRSALQSINEWASQTTDGKLPEVTKDVERTDGA 196 
Rattus_norvegicus               SSKQHYNCEHSKINFRDKRSALQSINEWASQTTDGKLPEVTKDVERTDGA 197 
Cricetulus_griseus              SSKQHYNCEHSKINFRDKRSALQSINEWASQTTDGKLPEVTKDVERTDGA 197 
Homo_sapiens                    SSKQHYNCEHSKINFRDKRSALQSINEWAAQTTDGKLPEVTKDVERTDGA 198 
Macaca_mulatta                  SSKQHYNCEHSKINFRDKRSALQSINEWAAQTTDGKLPEVTKDVERTDGA 198 
Xenopus_laevis                  DSKKHYNYEHSKINFRDKRSTLRSINEWAAQTTDGKLPEVTSDVEKTDGA 199 
Danio_rerio                     NSKKHYNYEHSKINFRDKRSAINSINEWAAKTTDGKLPEITKDVKNTDGA 185 
Oncorhynchus_mykiss             SSKKHYNYDHSKINLRDKRSAVNSINEWAAKSTDGKLPEITKDVQNADGA 186 
Carassius_auratus               SSKKHYNCEHSKINFRDKRSAVKAINDWASKSTDGKLPEVTKDVEKTDGA 183 
                                .**:*** :*****:*****::.:**:**:::*:*****:*.**:.:*** 
 
Gallus_gallus                   LIVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVPMMHRTGLYNYYDD 235 
Taeniopygia_guttata             LIVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVPMMHRTGLYNYYDD 235 
Alligator_mississippiensis      LIVNAMFFKPHWDEKFHHTMVDNRGFMVTRSFTVGVPMMHRTGLYNYFDD 235 
Mus_musculus                    LLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDD 246 
Rattus_norvegicus               LLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDD 247 
Cricetulus_griseus              LLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDD 247 
Homo_sapiens                    LLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVMMMHRTGLYNYYDD 248 
Macaca_mulatta                  LLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVMMMHRTGLYNYYDD 248 
Xenopus_laevis                  LIVNAMFFKPHWDERFHHQMVDNRGFMVTRSFTVSVPMMHRTGLYKYTDD 249 
Danio_rerio                     MIVNAMFFKPHWDEKSHHKMVDNRGFLVTRSHTVSVPMMHRTGIYGFYED 235 
Oncorhynchus_mykiss             TIANAMFFKPHWDEKFHEKMVDNRGFLVTRSFTVSVPMMHRTGLYKFHDD 236 
Carassius_auratus               MIINAMFYKPHWDEQFHHKMVDNRGFLVHRSYTVSVPMMHRTGIYGLFDD 233 
                                 : ****:******: *. *******:* **.**.* ******:*   :* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73
  
74
Gallus_gallus                   EAEKLQVVEMPLAHKLSSMIFIMPNHVEPLERVEKLLNREQLKTWASKMK 285 
Taeniopygia_guttata             EAEKLQVVEMPLAHKLSSMIFIMPNHVEPLERVEKLLNKEQLKTWTGKMK 285 
Alligator_mississippiensis      ETEKLQIVEMPLAHKLSSMIFIMPNHVEPLERVEKLLTREQLKTWISKLK 285 
Mus_musculus                    EKEKLQMVEMPLAHKLSSLIILMPHHVEPLERLEKLLTKEQLKAWMGKMQ 296 
Rattus_norvegicus               EKEKLQLVEMPLAHKLSSLIILMPHHVEPLERLEKLLTKEQLKTWMGKMQ 297 
Cricetulus_griseus              EKEKLQILEMPLAHKLSSLIILMPHHVEPLERLEKLLTKEQLKAWMGKMQ 297 
Homo_sapiens                    EKEKLQIVEMPLAHKLSSLIILMPHHVEPLERLEKLLTKEQLKIWMGKMQ 298 
Macaca_mulatta                  EKEKLQIVEMPLAHKLSSLIILMPHHVEPLERLEKLLTKEQLKIWMGKMQ 298 
Xenopus_laevis                  ETNNLQILEMPLAHKLSSMIIIMPYHVEPLERLEKLLTREQVNAWDGKMK 299 
Danio_rerio                     TENRFLIVSMPLAHKKSSMIFIMPYHVEPLDRLENLLTRQQLDTWISKLE 285 
Oncorhynchus_mykiss             TENKVFVLDMPLGQKQSSLVFIMPYHLEPLDRLEKLLTRKQLETWMGKME 286 
Carassius_auratus               TTNNLLVLDMALAHKMSSIVFIMPYHVESLERVEKLLTRQQLNTWISKME 283 
                                  :.. ::.*.*.:* **::::** *:*.*:*:*:**.::*:. * .*:: 
 
Gallus_gallus                   KRSVAISLPKVVLEVSHDLQKHLADLGLTEAIDKTKADLSKISGKKDLYL 335 
Taeniopygia_guttata             KRSVAISLPKVVLEVSHDLQKHLGGLGLTEAIDKTKADLSKISGKKDLYL 335 
Alligator_mississippiensis      KRSVAISLPKVSLEVSHDLQKHLADLGLTEAIDKNKADLSKISGKKDLYL 335 
Mus_musculus                    KKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYL 346 
Rattus_norvegicus               KKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYL 347 
Cricetulus_griseus              KKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYL 347 
Homo_sapiens                    KKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYL 348 
Macaca_mulatta                  KKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYL 348 
Xenopus_laevis                  KRAVAVSLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISGKKDLYL 349 
Danio_rerio                     ERAVAISLPKVSMEVSHDLQKHLGELGLTEAVDKPKADLSNISGKKDLYL 335 
Oncorhynchus_mykiss             ERAVAISLPKVSMEVSHNLQKTLGELGLTDAVDKTKADLSNISGKKDLYL 336 
Carassius_auratus               QRAVAVSLPKVSVEVSHDLQKHLTELGLTEAVDKAKADLSNISGKKDLYL 333 
                                :::**:****  :**:*:*** *  ****:*:** *****.:******** 
 
Gallus_gallus                   SNVFHAAALEWDTDGNPYDADIYGREEMRNPKLFYADHPFIFMIKDSKTN 385 
Taeniopygia_guttata             SNVFHAAALEWDTEGNPYDADIYGREEMRNPKLFYADHPFIFMIKDTKTN 385 
Alligator_mississippiensis      SNVFHAAALEWDTEGNPFDADIYGREEIRNPRLFYADHPFIFLIKDNKTN 385 
Mus_musculus                    ASVFHATAFEWDTEGNPFDQDIYGREELRSPKLFYADHPFIFLVRDNQSG 396 
Rattus_norvegicus               ASVFHATAFEWDTEGNPFDQDIYGREELRSPKLFYADHPFIFLVRDNQSG 397 
Cricetulus_griseus              ASVFHATAFEWDTDGNPFDQDIYGREELRSPKLFYADHPFIFLVRDNQSG 397 
Homo_sapiens                    ASVFHATAFELDTDGNPFDQDIYGREELRSPKLFYADHPFIFLVRDTQSG 398 
Macaca_mulatta                  ASVFHATAFELDTDGNPFDQDIYGREELRSPKLFYADHPFIFLVRDTQSG 398 
Xenopus_laevis                  ASMFHAAALEWDTEGNPFDSDLYSREELRSPKLFYADHPFVFLIKDNKTD 399 
Danio_rerio                     SNVFHASSLEWDTEGNPFDPSIFGSEKMRNPKLFYADHPFIFLVKDNKTN 385 
Oncorhynchus_mykiss             SNVFHASSMEWDIEGNPFDTSIFGSEKLRNPKLFYADHPFIFLVKDNKTN 386 
Carassius_auratus               SNVFHASAMEWDTEGNPPDTSIYGTDKLKTPKLFYADHPFIFLVKDKKTN 383 
                                :.:***:::* * :*** * .::. ::::.*:********:*:::*.::. 
 
Gallus_gallus                   SILFIGRLVRPKGDKMRDEL 405 
Taeniopygia_guttata             SILFIGRLVRPKGDKMRDEL 405 
Alligator_mississippiensis      SILFIGRLVRPKGDKMRDEL 405 
Mus_musculus                    SLLFIGRLVRPKGDKMRDEL 416 
Rattus_norvegicus               SLLFIGRLVRPKGDKMRDEL 417 
Cricetulus_griseus              SLLFIGRLVRPKGDKMRDEL 417 
Homo_sapiens                    SLLFIGRLVRPKGDKMRDEL 418 
Macaca_mulatta                  SLLFIGRLVRPKGDKMRDEL 418 
Xenopus_laevis                  SILFIGRLVRPKGDKMRDEL 419 
Danio_rerio                     SILFIGRLVRPKGDKMRDEL 405 
Oncorhynchus_mykiss             SILFIGRMVRPKGDKMRDEL 406 
Carassius_auratus               SILFMGRLVQPKGDKMRDEL 403 
                                *:**:**:*:********** 
 
Figure 2.5: Sequence conservation of His residues (highlighted in blue) across 12 species 
known to carry hsp47 gene.  
All amino acid sequences are obtained from Protein database on NCBI 
(http://www.ncbi.nlm.nih.gov/protein). "*" means that the residues are identical in all 
sequences in the alignment; ":" means that conserved substitutions are observed; "." means 
that semi-conserved substitutions are observed, according to common amino acid side chain 
grouping (Thompson et al., 1994). The species investigated are Alligator Mississippiensis 
(American alligator), Carassius auratus (goldfish), Cricetulus griseus (Chinese hamster), 
Danio rerio (zebrafish), Gallus gallus (chicken), Homo sapiens (human), Macaca mulatta 
(rhesus monkey), Mus musculus (mouse), Oncorhynchus mykiss (rainbow trout), Rattus 
norvegicus (Norway rat), Taeniopygia guttata (zebra finch), and Xenopus laevis (African 
clawed frog). 
Table 2.2: HSP47 surface histidine residues grouped into three main clusters. 
 
Clusters Residues 
Breach H191, H197, H198, H244 
Gate H255, H256 
Shutter H302 
 
  
 
 
 
75
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: The locations of ‘breach’, ‘gate’ and ‘shutter’ cluster in HSP47 homology 
model.  
SHUTTER 
GATE 
BREACH 
s3A 
s5A 
s3C 
s4C 
H197 
H198 
H191 
H244 
H135 
H255 
H256 
H302 
His residues predicted to be on the surface of the molecule is highlighted in blue and shown 
in ‘spheres’ representation. Figure produced with PyMol v0.99. 
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2.4 Construction of HSP47 Wild-type (WT) Plasmid DNA 
A mature recombinant mouse hsp47 gene was amplified by PCR using a 5´ primer with an 
NdeI restriction site and a 3´ primer with a HindIII restriction site and cloned into the 
equivalent restriction sites in the expression vector pET-24b(+). This work was done 
previously in our laboratory at the Imperial College Genetic Therapies Centre by Dr Dee 
Olerenshaw and Dr Takayuki Homma. Further details of the recombinant plasmid are given 
in Chapter 6 Materials and Methods. 
 
2.5 Mutation, Expression and Collagen Binding Ability of HSP47 WT and His 
Mutants 
All His residues of interest, selected based on computational prediction, were mutated to 
alanine (Ala, A). This allows assessing the effects of mutation on pH-switch mechanism 
simultaneously with the possible structural contribution of a replaced His residue to the 
overall structure. His-to-Ala (HA) mutations were introduced by modified site-directed 
mutagenesis (Sawano and Miyawaki, 2000). Each construct was sequenced to screen the 
correct mutation and full sequencing was performed to confirm that there are no other 
mutations in the region between the T7 promoter and terminator. Most of the mutants were 
found to be equally soluble compared to HSP47 WT when expressed in E. coli host strain 
BL21(DE3)pLysS (Figure 2.6A). HSP47 is known for being a highly insoluble protein when 
expressed in high concentration under normal E. coli growth and expression conditions, from 
our experience. In order to overcome this, temperature of the main growth period was 
decreased to 20-25°C (from 37°C which was only used for pre-culture) while IPTG 
concentration was also lowered to 0.1 mM from the normal 1 mM. This succesfully ensured 
higher solubility of the expressed proteins and reduced the presence of inclusion bodies, as 
can be seen in Figure 2.7A.  
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Batch binding experiment showed that the binding behaviour of the mutants to gelatin 
beads is not significantly impaired (Figure 2.7B). This then allows the use of gelatin column 
to observe the collagen release behaviour and subsequent purification of the mutants for 
further biophysical experiments. 
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Figure 2.7: Expression, solubility and binding ability of all HA mutants constructed, 
relative to WT.  
A. Expression level of HSP47 WT and HA mutants. Separation was done on 12% Tris-
glycine SDS-PAGE. L: Cell lysate, S: Centrifuged lysate (supernatant). B. Binding ability of 
the mutants, relative to WT (100%, n=3) determined using gelatin pull down assay. 
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2.6 Purification of HSP47 WT and HA Mutants 
Gelatin-agarose was used as column packing matrix since mouse HSP47 WT and HA 
mutants were shown to be able to bind to gelatin from the batch gelatin binding assay (Figure 
2.7B). The column was connected to an FPLC system for quick, single step purification. 
Collagen/gelatin affinity techniques have been widely used for HSP47 purification (Dafforn 
et al., 2001; El-Thaher et al., 1996; Nishikawa et al., 2010) due to the aforementioned 
advantage. Purification of HSP47 WT gave a distinctive peak during pH gradient elution with 
sodium phosphate buffer from pH 8.0 to 4.1 in about 15 column volumes (Figure 2.8). 
Fractions were collected in the presence of 1 M of sodium phosphate pH 8.0 to immediately 
recover the alkaline pH at which HSP47 is in its native form. SDS-PAGE analysis with CBB 
detection indicates that the eluted protein is more than 95% pure and suitable for direct 
biophysical analysis without further purification (Figure 2.9). Typical yields are between 0.3-
0.5 mg/mL. 
Mutants H135A, H191A, H244A, H255A:H256A and H302A also had a similar peak 
to WT during elution (Figure 2.10). Although the concentration of peak fractions varies due 
to the slight difference in expression level and solubility, all the mutants are above 95% in 
purity after purification as estimated from SDS-PAGE analysis. A more thorough 
investigation also revealed that the location of H191A elution peak is shifted to slightly 
higher pH value. The measured pH value of the peak fraction is also slightly higher than that 
of WT and the other mutants (i.e. pH 5.9-6.1), instead of around 5.7. This suggests that the 
release mechanism of HSP47 from gelatin is affected when His residue at position 191 is 
replaced with Ala, even though the column binding ability seems unchanged.  
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Figure 2.8: FPLC purification trace (reproduction) of HSP47 WT using a gelatin-
agarose affinity column.  
Dotted line represents pH gradient from pH 8.0 to 4.1. Fractions at different stages of 
purification (black bars) were analysed with Coomassie Brilliant Blue (CBB) staining after 
separation on 12% Tris-glycine SDS-PAGE.  
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Figure 2.9: 12% Tris-glycine SDS-PAGE analysis of HSP47 WT.  
Lane M: Precision Plus Protein Standard (Bio-rad). L: Cell lysate, S: Soluble fraction 
(supernatant). 
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Figure 2.10: Reproduction of the FPLC traces of all HA mutants in comparison to 
HSP47 WT.  
Mutants of interest are highlighted in bold. Dotted line represents buffer pH gradient from 8.0 
to 4.1. 
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On the other hand, mutants H197A and H198A showed an interesting behaviour. A 
significantly reduced elution peak was recorded during gelatin-agarose purification (Figure 
2.11), despite good expression and solubility. In addition, during washing and elution, the 
mutants seem to be slowly eluted off the column. Replacing both residues (H197A:H198A 
double mutant) amplifies this effect. SDS-PAGE analysis of the eluted fractions (tail 
fractions) of the double mutant shows the presence of high concentration of HSP47 (Figure 
2.12), at high purity. Unlike H191A mutation that perturbs HSP47 release behaviour, 
mutations of His at positions 197 and/or 198 instead alter the column binding behaviour, 
weakening the ability of the mutants to withstand extensive washing. Further downstream, 
complete elution occurs when the elution pH value reaches the region of normal dissociation 
value. These suggest that there are other His residues that are ionised and triggers the 
complete release from gelatin column. 
These observations suggest that replacement of His residues at these positions 
perturbs the gelatin binding behaviour in such a way that the HSP47-collagen interactions 
(investigated here using gelatin) are no longer strong and specific, especially in the column 
experiment. It is possible that minor structural alteration causes disruption in the strong 
binding affinity. The effect of His to Ala mutation on other proteins has been reported before, 
for example on the receptor-associated protein (RAP) to probe its pH-sensitive binding 
behaviour toward the low density lipoprotein receptor (LDLR) family (Lee et al., 2006). RAP 
is an ER-resident protein, with a mode of action similar to that of HSP47 chaperone during 
collagen synthesis and transport to the Golgi. Another example is the substitution of His 369 
with Ala in bleomycin hydrolase (BH), which changes the hydrogen bonding network and 
causes a complete loss in catalytic activity (O'Farrell and Joshua-tor, 2007). This 
demonstrates that HA mutation could affect the binding specificity between a protein and its 
ligand. In HSP47, this is possible especially if H197 and H198 are located at the HSP47-
collagen binding interface.  
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Figure 2.11: Reproduction of the FPLC trace of H197A:H198A through gelatin-agarose 
column.  
Black bar indicates interval where fractions were collected for SDS-PAGE analysis. Dotted 
line indicates buffer B gradient. Fractions numbers given are approximate. 
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Figure 2.12: 12% Tris-glycine SDS-PAGE analysis of H197A:H198A through gelatin-
agarose column.  
Approximate fraction numbers are also given for comparison with the FPLC trace. 
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2.7 Investigation of the Biophysical Properties of HSP47 WT   
In this section, the biophysical properties of HSP47 WT are first established. 
Characterisations of HSP47 have been reported previously using biophysical techniques such 
as circular dichroism and fluorescence spectroscopy. So to enable comparison with the 
constructed mutants, the properties of the recombinant mouse HSP47 expressed in pET-
24b(+) vector were analysed and are initially presented. Then the results for HSP47 HA 
mutants are discussed, by comparing with the properties of that of WT.  
 
Circular Dichroism Structural Analysis  
CD was utilised to assess the conformation of the mutants expressed in comparison to that of 
WT (presented in Section 2.10). It would highlight any potential distortion in the protein 
structure due to the abolition of salt bridge between the respective residues and their 
neighbours. In human prolactin (hPRL), three His residues held together by aromatic stacking 
have been previously suggested to contribute to the biological function (Tettamanzi et al., 
2008). hPRL is a 23 kDa endocrine hormone and a member of cytokine family. It was found 
that mutation of one His residue seems to perturb the pKa of the other, as observed with 
nuclear magnetic resonance (NMR) spectroscopy (Tettamanzi et al., 2008). After NMR, CD 
is the next best option to obtain indirect information about possible interactions between the 
residues. 
CD spectrum of HSP47 WT revealed that it is a typical α/β-protein (Figure 2.13). The 
stability of the purified protein was then assessed using temperature titration by monitoring 
the change in CD signal at 222 nm (∆∆A222) as a function of temperature. That particular 
wavelength was chosen as it provides information on the status of the α-helical portions of 
the protein during the melt and also a longer wavelength that would eliminate the effect 
caused by changes in light scatter that can occur during thermal denaturation. As the 
temperature increases, there will be a loss in secondary structure of the protein (Dafforn et al., 
2004). Other than detecting stability, the melt profile can also be used in serpin studies to 
suggest potential transition from native to latent structure. Although this has never been 
reported before for HSP47, as a member of serpin family with highly conserved secondary 
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structure, this behaviour could not be ruled out completely. HSP47 WT shows a transitional 
midpoint (Tm) of around 59°C (± 0.5), estimated using the ‘tangent method’ and using the 
equation described in Section 6.15 (Persikov et al., 2004). In ‘tangent method’, the point at 
which transition starts to occur and the end-point are traced and estimated from the fully 
folded and fully unfolded state. In cases where these are difficult to trace (especially the end-
point due to poorer readings at high temperature), an assumption has to be made where an 
end-point is reached when the changes in CD signal is not more than 500 MRE unit. There is 
a possibility of introducing large errors into the midpoint determination as this is not a 
standard method, but this could be minimised with many repeat experiments, or by 
overlaying several curves together for direct comparison.  
 The presence of such transition at lower temperature are attributed to the melting of a 
typical native form of serpin family members, of which the β-sheet A is composed of only 
five strands with the sixth strand exposed, forming the serpin loop (Dafforn et al., 2001). 
Latent form melts at a much higher temperature (Dafforn et al., 2004). 
  
 
 
 
 
 
 
 
 
 
A B
Figure 2.13: Far-UV CD spectrum (A) and thermal denaturation profile (B) of HSP47 
WT.  
Concentration was fixed to 3 μM and measured in 50 mM sodium phosphate buffer pH 8.0 
with 100 mM NaCl. Dashed arrow in (B) represents the predicted melting point. Thermal 
denaturation is a non-reversible process as aggregation could be observed in the CD cuvette 
after titration. Dotted lines represent the estimated start and end of transition, used in the 
‘tangent’ method of melting point estimation. 
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Collagen Anti-fibrillisation Property  
Collagen triple helices are known to self-interact at optimum condition (neutral pH, 
temperature of around 30°C) to form a higher order structure called the collagen fibril. This 
process, like the self-assembly in proteins, is an entropy-driven process which involves the 
loss of solvent molecules from the surface of protein molecules (Kadler et al., 1996). It is 
regarded as involving two processes, the first of which is fibril nucleation, whereby soluble 
collagen molecules aggregate forming nuclei. Then it is followed by the growth of the nuclei 
into fibrils by accumulation of further soluble collagen particles (Wood, 1960). As a result, 
the molecules form fibrils with circular cross-section, which has minimum surface area by 
volume ratio. In vivo, cleavage of the globular propeptides at the amino- and carboxy- termini 
by aminoprotease and carboxyprotease triggers the fibrillogenesis process before being 
stabilised by intra- and intermolecular chemical cross-linking (Section 1.1.2). The most 
abundant collagen types in vertebrates (type I, II, III, V and XI) form fibrils with D-period 
(the distance between cross striations of collagen triple helical molecule in staggered 
arrangement) between 65-67 nm, which gives collagen fibrils their quintessential axial 
periodicity (Kadler et al., 1996) defined by the ‘hole’ and ‘overlap’ zones as illustrated in 
Figure 2.14.   
In vitro fibrillisation experiment is usually condicted using acid soluble collagen, as 
mild acid solution typically yields more collagen during preparation via extraction from 
collagenous tissues. The fibrillisation process involves a lag phase followed by a propagation 
phase and finally an equilibrium phase where the fibrils are in equilibrium with the 
monomers (Kadler et al., 1988; Thomson and Ananthanarayanan, 2000). Collagen type I 
fibrillisation is typically studied at 34°C because the rate of fibril propagation decreases 
above 37°C in the presence of micro-unfolding monomers. These monomers undergo 
reversible unfolding and become a larger fraction of the monomer and fibril system (Kadler 
et al., 1988). Fibril formation is observed by monitoring turbidity spectrophotometrically at 
313 nm, which is proportional to the fibrillar material formed (Williams et al., 1978).  
The turbidity plotted as a function of time for type I collagen solution shows an 
expected fibrillisation curve with three apparent phases (Figure 2.15). Fibrillisation was 
initiated by bringing the pH of the solution from acidic (pH 3) to near neutral (pH 7.4), at 
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which fibrillisation occurred immediately and monitoring was recorded at 10-minute intervals 
until equilibrium phase was reached. The lag phase observed was about 10 to 20 minutes, 
double from that reported previously (Thomson and Ananthanarayanan, 2000). This may be 
due to the collagen used in this case; pepsin treated collagen type I is known to form shorter 
fibrils over a longer period of time than untreated collagen (Gelman et al., 1979). Pepsin is 
usually used in the manufacturing process to increase collagen solubility. 
HSP47 is known to have the ability to arrest collagen fibril formation in vitro at 
neutral pH. This activity is abolished at HSP47-collagen dissociation pH, reportedly around 
pH 6.2-6.3 (Thomson and Ananthanarayanan, 2000). As the efficiency of HSP47 to arrest 
fibrillisation relates to the functional integrity of HSP47 collagen binding interface, the 
ability of HSP47 WT to arrest fibrillisation was first investigated. The finding could then be 
used to observe the effect of HA mutation of HSP47 ability to prevent fibril formation. 
When HSP47 WT was included at an equal molar ratio to collagen, fibrillisation was 
completely inhibited with no turbidity observed over the duration of the assay (Figure 2.15). 
Inhibition at 1:2 (HSP47:collagen) molar ratio was incomplete owing to insufficient capture 
of collagen by HSP47 WT and fibrillisation was observed to proceed at a slower rate, and 
hence slight turbidity was recorded near minute 110. This inhibition is specifically due to the 
prevention of the interaction between collagen triple helix molecules by HSP47. A similar 
experiment conducted using heat-inactivated HSP47 did not show complete inhibition of 
fibril formation, unlike with active chaperone molecules (data not shown).  
  
Fibril 
Microfibril 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: Schematic representation of the staggered structure of a collagen fibril, to 
illustrate the D-spacing.  
The D-spacing is the distance between cross striations (‘hole’ and ‘overlap’), with each 
collagen molecule is about 300 nm long (4.4 D-units). The ‘hole’ is formed at the end of one 
triple helix and the beginning of the next (Prockop et al., 1979). Figure adapted from (Voet 
and Voet, 1995). 
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Figure 2.15: The fibrillisation curve of collagen solution upon incubation at 34°C, pH 
7.3-7.4 at 2 µM concentration (■).  
Between 0-20 mins, the solution is said to be in lag phase, 20-100 mins (propagation phase) 
and 100- mins (equilibrium phase). Upon addition of HSP47 at the same molar ratio, fibril 
formation is completely inhibited (□) at 1:1 (HSP47:collagen). Incomplete inhibition is 
observed in the presence of lower HSP47 concentration ( ), at 1:2 (HSP47:collagen).   
 
 
 
90
  
91
Investigation of Secondary Structural Changes during pH Titration 
CD spectroscopy has been used previously to demonstrate that HSP47 structurally undergoes 
a two-step conversion from high to low pH states via an intermediate state (El-Thaher et al., 
1996). This transition was suggested to involve His protonation but which His residue or His 
residue cluster responsible for this change is unclear. Substituting a particular His residue 
with Ala would eliminate the imidazole side chain ionisation. If the residues are critical for 
the structural change, the mutant constructed would exhibit aberrant collagen binding/release 
behaviour and so may follow a different structural transitional pathway from its binding to 
non-binding states. This can be obtained indirectly by examining the spectral transition upon 
gradual change in pH of the protein solution. pH was sequentially decreased by the addition 
of 1-2 µL aliquots of phosphoric acid. Phosphoric acid was used instead of hydrochloric acid 
to avoid the presence of chloride (Cl-) ions, which is known to interfere with CD signal 
(Dafforn et al., 2004).  
Figure 2.16 shows the effect of pH on the ellipticity of HSP47 WT in the far-UV 
region. It is apparent that there is a significant change in the overall structure of the protein 
during the process. Curve fitting procedure with k2D deconvolution program 
(http://dichroweb.cryst.bbk.ac.uk/html/home.shtml) (Whitmore and Wallace, 2004; 
Whitmore and Wallace, 2008) suggests that decrease in pH induces the decrease in α-helical 
character and increase in β-sheet structure of the protein (Table 2.3). Even though the use of 
curve fitting for CD spectra is debatable when discussing the dynamics of protein structural 
change, a similar observation has been reported previously (Thomson and Ananthanarayanan, 
2000) where the β-structure was shown to increase to nearly 40% at acidic pH. Hence this 
can be used to estimate of the extent of HSP47 conformational change with pH. 
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Figure 2.16: Effect of pH on the ellipticity of HSP47 WT.  
Protein concentration is 3 μM, in 50 mM sodium phosphate buffer pH 8.0 with 100 mM 
NaCl, at 25°C. 
 
 
 
Table 2.3: pH-induced changes in the secondary structural content of HSP47 WT.  
Structural contents were estimated with k2D software on Dichroweb server 
(http://dichroweb.cryst.bbk.ac.uk/html/home.shtml).  
 
 pH α-helix β-sheet Random coil Error 
7.1 0.32 0.17 0.51 0.085 
6.7 0.31 0.13 0.56 0.087 
6.3 0.31 0.13 0.57 0.087 
6.0 0.21 0.26 0.52 > 0.22 
5.7 0.25 0.20 0.55 > 0.22 
5.3 0.14 0.33 0.53 > 0.22 
5.0 0.15 0.30 0.55 0.182 
4.7 0.18 0.28 0.55 0.182 
4.3 0.14 0.36 0.51 > 0.22 
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By plotting the change in CD signal at 222 nm (∆∆A222) as a function of pH, the 
resulting curve would show the secondary structural rearrangement, particularly α-helical 
content, upon change in the pH of the environment. Reduction in ellipticity at 222 nm is 
generally considered as a loss in α-helical content of proteins (Hirst and Brooks, 1994). For 
HSP47 WT, the observation was done independent of the spectra recording and titration was 
automated as pH was progressively monitored using an ultraslim electrode. For HSP47 WT, 
an abrupt change in structure is seen between pH 6.7 and 5.7 in the downward titration 
(Figure 2.17). This fits well with the results reported previously in a study that used 
transformed data from individual spectral scans at different pH values (El-Thaher et al., 
1996). Analysis of the data obtained in this set of measurements revealed that the middle 
point for this transition (inflection point) is at pH 5.70 (± 0.10) (the procedure and 
assumptions are as described in the determination of melting temperature section). This value 
deviates slightly from the reported HSP47/collagen dissociation value of 6.3 (Saga et al., 
1987), that can be attributed to the different environment in which the protein is studied 
(Chen et al., 2002; Garrett et al., 1998) such as the composition of the collagen type used in 
the study and buffer components. This is still in the typical pKa range for surface histidine 
residues, as in human prolactin (hPRL) the range is reported to be between 5.8 to 6.6 
(Tettamanzi et al., 2008).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17: Change in CD signal upon titration of HSP47 WT, monitored at 222 nm.  
Data can be obtained either by plotting ellipticity at 222 nm from individual spectral scans at 
different pH values or automated titration measurement module at fixed wavelength available 
with the instrument. Both techniques gave comparable results. Broken arrow shows the 
transitional midpoint, calculated using the formula explained in Chapter 6 (Materials and 
Method). Dotted lines represent the start and end values of transition, estimated based on the 
‘tangent’ method. 
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2.8 Characterisation of CMPs 
In order to investigate the significance of the structural change to HSP47/collagen binding, a 
synthetic collagen mimetic peptide (CMP) was utilised as collagen substitute. CMPs have 
extensively been used in the study of HSP47-collagen interaction (Asada et al., 1999; Dafforn 
et al., 2001; Koide et al., 1999; Koide et al., 2006a; Nishikawa et al., 2010; Okano-Kosugi et 
al., 2009).  
Among the mostly-used CMPs in HSP47-related binding experiments are the 30-
amino acid long (Pro-Pro-Gly)10 (Dafforn et al., 2001) and (Pro-Hyp-Gly)10. The (POG)10 
peptide mimics collagen well as the basic collagen amino acid repeat is (X-Y-Gly)10 where X 
is usually Pro and Y is either Pro or Hyp. Hyp has been known to stabilise triple helical 
peptide via hydration effect (Bella et al., 1995) or direct intermolecular hydrogen bonding 
interactions (Kramer et al., 2001). Therefore, it creates a stable triple helical peptide, which is 
suitable for various physicochemical studies (X-ray crystallography, NMR) and has been 
shown to assemble into higher order structures under defined conditions (neutral pH, 
temperature higher than 35°C, 1 mM) (Kar et al., 2006). (POG)10 would be the control 
peptide in the identification of HSP47 binding partner candidate. Additionally, incorporation 
of Arg at Y position is known to enhance HSP47 binding affinity, compared to other amino 
acids. This is probably due the formation of a hydrophobic interface by the Arg side chain 
that directly interacts with HSP47 hydrophobic cleft (Koide et al., 2002; Nishikawa et al., 
2010). For this reason, a CMP with one Arg residue was also included. The sequences of the 
two peptides are shown below: 
 
(POG)10, POG  : POG POG POG POG POG POG POG POG POG POG 
(POG)4PRG(POG)5, PRG : POG POG POG POG PRG POG POG POG POG POG 
  
 
The ability of the peptides to form triple helices was investigated by CD. CMPs tend 
to form polyproline type II (PII) conformation upon folding due to the rigidity of the imino 
acid backbone. This conformation gives rise to a distinctive positive peak at around 215-220 
nm and a negative peak at around 195-197 nm (Goodman and Kwak, 1999; Tifany and 
Krimm, 1972). This was observed here with POG and PRG peptides after incubation at 4°C 
overnight (Figure 2.18). The extent of triple helical formation can be estimated from the ratio 
of positive over negative peak, Rpn. The calculated Rpn values for POG and PRG are 0.09 and 
0.07, respectively, compared to a previously reported Rpn value for the native collagen of 
approximately 0.13 (Feng et al., 1996). The Rpn value shows that POG and PRG peptides 
have the propensity to form triple helical molecules.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.18: CD spectra of POG and PRG peptides.   
Measurements were done at 20 µM in sodium phosphate buffer pH 8.0 with 100 mM NaCl, 
at 25°C. Ellipticity is expressed in ΔA instead of MRE. The appearance of maximum at 225 
nm and minimum at 200 nm indicates that the peptides adopt triple helical conformation. 
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To investigate the binding affinity of HSP47 to the peptides, a pull-down assay was 
designed with the peptides immobilised onto cyanogen bromide (CNBr)-activated Sepharose 
beads. CNBr reacts with hydroxyl (–OH) groups on Sepharose to form reactive cyanate ester 
groups. The peptides can be coupled to CNBr-activated Sepharose, under mild conditions, via 
primary amino (–NH2) groups. The activated groups on the beads react with primary –NH2 
groups on the peptide to form isourea linkages as shown in Figure 2.19 (Kohn and Wilchek, 
1982). Monitoring of the coupling efficiency was performed using HPLC system coupled to 
particle detector unit. Figure 2.20 shows the chromatogram of the peptides before and after 
coupling, in which more than 99% of the peptides were successfully coupled to the Sepharose 
beads. The unreacted active groups were also blocked with ethanolamine to prevent 
unspecific binding in the next experiments. 
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Figure 2.19: Sepharose beads activation by CNBr and peptide coupling to the activated 
matrix.  
Figure adapted from Affinity Chromatography Handbook (GE Healthcare). 
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Figure 2.20: Chromatograms of POG and PRG peptide (0.75 mg/mL) before and after 
coupling.  
Peptide samples were in 50 mM sodium phosphate pH 8.0 with 100 mM NaCl.  
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HSP47 binding assays were then performed on the beads with the immobilised 
peptides, using the same protocol as in the pull down assay with gelatin agarose beads. The 
obtained gel image revealed that PRG beads retain much more HSP47 than POG (Figure 
2.21) suggesting a significantly stronger binding of HSP47 to PRG than to POG. Though 
understandably HSP47 shows lower binding affinity than it does to the much larger 
molecules of gelatin (lane labelled ‘GA’), HSP47 binding to PRG beads is evidence of 
successful coupling and confirm previous observations (Koide et al., 2002). This suggests 
that PRG peptide synthesised could be a suitable HSP47 binding partner. 
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Figure 2.21: Affinity of HSP47 to immobilised peptides, visualised with CBB staining 
after separation on 12% SDS-PAGE under reducing condition.  
M: Precision Plus Protein Standard (Bio-rad). S: cell supernatant (total soluble protein 
content). GA: Gelatin-agarose beads. Mock: uncoupled Sepharose beads.  
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2.9 Binding Affinity of HSP47 WT to PRG Peptide 
CD was used to probe the binding of HSP47 to PRG peptide in response to pH change. The 
binding was investigated by monitoring the changes in CD signal upon addition of the 
peptide, with a blank titration for background subtraction. The change in signal at 216 nm 
(ΔA216) was then plotted as a function of PRG concentration giving a saturation binding 
isotherm that can be fitted to a single site binding model (Figure 2.22). The wavelength at 
216 nm was chosen instead of at 225 nm due to the change in CD signal is larger at that 
wavelength, giving a higher quality titration data (Dafforn et al., 2001).  
 It was found that HSP47 still binds PRG peptide at pH 6.5. Then as the pH reaches 
5.5, complete dissociation occurs based on the non-converging curve fit. This suggest that 
structural transition that occurs at around that pH is accompanied by the release of HSP47 
binding to peptide, which can be related to full length collagen as well. An attempt to narrow 
down the pH range of HSP47-peptide dissociation by observing CD spectral patterns of 
smaller pH intervals was unsuccessful due to the detection limit of the CD spectropolarimeter 
and the noise that accompanies every titration. Despite this, the information obtained is useful 
in explaining the nature of HSP47 pH-triggerable release. Combined with HSP47 WT gelatin 
column release behaviour, it is now established that the dissociation from collagen is 
accompanied (or triggered) by a large change in its secondary structure. As Arg residue forms 
an important part of the binding interface, it is possible that the structural change triggers the 
change in the hydrophobic interface of HSP47, which in turn results in dissociation.    
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Figure 2.22: Binding isotherms showing the effect of pH on the binding of HSP47 WT 
(0.8 µM) to PRG peptide. 
Isotherms were determined at pH 7.4, 6.8, 6.5, and 5.5. All isotherms were plotted as 
percentage of saturation for comparison, except for at pH 5.5 where data was fitted to linear 
function for easier visualisation. Curve fitting and dissociation constant (kd) determination 
was performed using OriginPro v8.5.  
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To discuss this process further, it is important to gather all the information from 
previous studies that involve HSP47-collagen binding interface. To date, there has been no 
specific collagen binding site proposed for HSP47 at atomic resolution due to the absence of 
the three-dimensional structure of the chaperone. An interesting suggestion was made based 
on work with synthetic peptides on the orientation of HSP47 binding interface (Koide et al., 
2006a), that revolves around the crucial Arg residue. Using peptides that incorporate 
photoreactive p-benzoyl-L-phenylalanine (Bpa) residue at various positions along the peptide 
chain, a binding pattern of HSP47 to peptide upon UV-cross linking was obtained. It was 
found that Bpa residues located at positions from -10 to 8 to the central Pro-Arg-Gly (known 
as the HSP47 recognition sequence, with Arg at position 0) are recognised by HSP47 (Koide 
et al., 2002). The length of this recognition region is about 5.3 nm, leading to suggestion that 
HSP47 binds collagen in such a way that the longer axis is parallel to the common axis of the 
collagen triple helix (Figure 2.23A).       
Alternatively, the hydrophobic region outlined by sheet B, helix A (hA), helix G (hG) 
and helix H (hH) in the HSP47 homology model has also been speculated to be a collagen 
binding site (Dafforn et al., 2001; Davids et al., 1995) (Figure 2.23B). This was suggested 
based on the possibility of the modelled groove to accommodate a collagen triple helical 
peptide via hydrophobic interactions. Deletion of hA and strands 4 of sheet B (s4B) and s5B 
has been shown to abolish the binding (Davids et al., 1995), which suggests an affected 
structural conformation. Upon detailed observation of the homology model that we 
constructed in this study, it was found that many residues located in sheet B, hA, hG and hH 
may contribute to the hydrophobicity of the groove (e.g. Lys, Pro, Ile). This makes the 
proposal worthy of further investigation.   
In both proposals, hydrophobic interaction seems to play a major part. For this reason, 
it is very possible that release of HSP47 from collagen is triggered by structural 
rearrangement that abolishes hydrophobic interface in contact with a collagen chain. This 
rearrangement could be a consequence of the ionisation of His imidazole side chain. 
Subsequent study with HA mutants should elucidate this even further. 
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Figure 2.23: Two proposals for HSP47-collagen binding interface.   
A. HSP47-collagen complex based on UV cross-linking of photoreactive residues to HSP47, 
with the critical Arg residue as position ‘0’. Residue highlighted in red could not be replaced 
with Bpa due to the detrimental effect of substitution to HSP47 binding. In the model HSP47 
is proposed to bind collagen parallel to the common axis of the triple helix. From (Koide et 
al., 2006a). B. Hydrophobic collagen binding groove suggested from earlier HSP47 
homology modelling work. β-sheet B serves as the ‘base’ of the groove, with helices A, H 
and G help to create a closed hydrophobic environment. From (Dafforn et al., 2001; Davids et 
al., 1995) shown on current homology model of HSP47. C. ‘Surface’ representation of B to 
show the hydrophobic regions, especially near the proposed collagen binding groove. 
Hydrophobicity classifications of amino acid residues are adapted from 
http://www.sigmaaldrich.com/life-science/metabolomics/learning-center/amino-acid-
reference-chart.html based on (Monera et al., 1995).   
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2.10 Characterisations of HSP47 HA Mutants 
CD Structural Analysis 
CD spectra of the mutants were first examined to assess conformational changes of the 
expressed proteins and probe any distortion in the protein structure due to the substitution of 
hydrophobic environment of the respective residues and the neighbouring residues. 
Overlaying spectra of WT, H135A, H191A, H244A, H255A:H256A and H302A 
(H197A:H198A could not be analysed as this mutant does not bind well to gelatin-agarose 
column) suggests that the mutants have secondary structural content similar to that of WT as 
all of the mutants give almost identical spectra (Figure 2.24A). This means that the content of 
β-sheets and α-helices and consequently the secondary structure are not significantly altered 
upon mutation of these His residues, at alkaline pH. 
As shown in Figure 2.24B, the melting temperatures (Tm) of these mutants narrowly 
varies between 57-58°C (WT 59.0 ± 0.5; H135A 57.0 ± 0.5; H191A 57.0 ± 0.5; H244A 57.5 
± 0.5; H255A:H256A 58.0 ± 0.5; H302A 58.0 ± 0.5°C) which is not markedly different to 
WT (59°C). Again, this suggests that the respective mutations do not induce HSP47 to adopt 
a different conformation, e.g. the typical hyperthermostable latent form of serpins, as the 
latent form normally has a very high melting temperature, more than 70°C (Dafforn et al., 
2004). 
Combination of spectral and melting data presented here suggests that mutations of 
His residues at positions 135, 191, 244, 255, 256 and 302 present no noticeable alterations in 
the secondary structure of HSP47. This is also consistent with their predicted locations at the 
surface of the protein. 
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Figure 2.24: Far-UV CD spectra (A) and thermal denaturation profiles (B) of HSP47 
WT and HA mutants.  
Concentrations were between 2.8-3.0 μM and measured in 50 mM sodium phosphate buffer 
pH 8.0 with 100 mM NaCl. 
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Collagen Anti-fibrillisation Property  
It has been demonstrated that mouse HSP47 WT has the ability to prevent collagen 
fibrillisation at equal molar ratio of HSP47 to collagen and so do all of these HA mutants as 
shown in Figure 2.25. This means that the collagen fibrillisation property is not lost upon 
mutations suggesting the HA mutations do not substantially alter the collagen binding region 
nor the binding interface. This is also in agreement with the CD data that the native folding of 
HSP47 is not altered upon introduction of the mutation. Consequently all HA mutants in the 
‘gate’ and ‘shutter’ cluster are able to prevent fibrillisation effectively in the same way and to 
the same extent as HSP47 WT.  In addition, the mutant carrying ‘breach’ cluster mutation 
(using H191A as model), is also able to fully arrest fibrillisation. This confirms our 
observations from gelatin-agarose pull-down binding assay (Figure 2.7B).  It also underlines 
that the differences between ‘breach’ HA mutants (His residues at positions 197 and 198) and 
HSP47 WT in terms of gelatin column elution behaviour (Figure 2.10), are probably not 
associated with concomitant functional defects in the initial collagen recognition of the 
mutants. Whether or not there is another mechanism involves after the initial docking is 
unknown, but it is now getting clearer that the His residues actively participating in the pH-
switch behaviour localises in the ‘breach’ cluster of the chaperone. It is also tempting to 
investigate further the effect of mutations on the structural transitions of HSP47 induced by 
pH-change. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.25: The fibrillisation curve of collagen solution in the presence of HSP47 WT 
and HA mutants upon incubation at 34°C.  
pH of the reaction mix is between 7.3-7.4, with 2 µM concentration of collagen and HSP47. 
Assays were performed in triplicate. 
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Secondary Structural Changes during pH Titration 
Towards Predicting the Structural States of Mutants HSP47 during Titration 
As the HA mutants were constructed to probe the critical residues participating in the HSP47 
pH-switch mechanism that triggers its release to collagen, pH titration would be a useful 
approach to probe the structural changes occurring during this transition. The overall 
structural change is first investigated by observing CD spectra at certain pH values. As seen 
in Figure 2.26, the transitions of the mutants showed similar behaviour to WT. From the 
spectra (representing the secondary structures possessed), it can be concluded that all mutants 
(apart of those at positions 197 and 198, in which the effect is unknown as they could not be 
purified using gelatin-agarose column) undergo a similar secondary structural transitional 
pathway from alkaline to acid states. It can also be concluded that the initial and final states 
are not significantly changed from the common shape of the CD spectra. These suggest 
similar secondary structural content. This information is useful in determining that the 
introduced mutations alter the pH transition of the mutants but not their initial alkali and final 
acid states. 
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Figure 2.26: Effect of pH on the ellipticity of HSP47 HA mutants.  
Protein concentrations were between 2.8-3.0 μM measured in 50 mM sodium phosphate 
buffer pH 8.0 with 100 mM NaCl, at 25°C. 
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Towards Finding the Collagen-release pH of the HSP47 Mutants 
A more specific structural transition can be observed by looking at the change in ellipticity at 
222 nm (ΔΔA222), which mostly corresponds to the change in α-helical character of the 
protein. As shown in Figure 2.27, mutants H135A, H244A, H255A:H256A and H302A have 
similar transitional midpoints to that of WT (WT at pH 5.70 ± 0.10 (mean ± SEM); H135A at 
pH 5.75 ± 0.05; H244A at pH 5.65 ± 0.05; H255:H256A at pH 5.75 ± 0.10; H302 at pH 5.75 
± 0.05). These values correspond to the dissociation pH of the mutants from the gelatin 
column (as demonstrated for WT), and thus can aptly be regarded as the collagen dissociation 
pH for each mutant. On the other hand, H191A was found to have a significantly higher 
midpoint compared to WT, i.e. pH 5.90 (± 0.05) against pH 5.70 for WT. These agree well 
with earlier FPLC chromatogram showing that this particular mutant elutes at a slightly 
higher pH value, and therefore at higher collagen dissociation pH. It can be concluded that 
the absence of H191 residue from HSP47 causes the chaperone to release its binding from 
collagen prematurely. It is very likely that this residue acts as key residue, locking the 
binding of HSP47 to collagen and only allows its release once the correct pH is reached. Data 
obtained from HA mutant experiments are summarised in Table 2.4.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.27: Change in CD signal upon titration of HSP47 WT and HA mutants, 
monitored at 222 nm.  
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Table 2.4: Summary of data on biophysical properties of HSP47 WT and mutants.  
Data shown includes thermal stability, inflection points observed under pH titration study, 
degree of conservation in HSP47 family and the secondary structural locations of the 
mutations introduced based on HSP47 homology model.  
 
Mutations 
Locations 
(Huber & 
Carrell 
nomenclature) 
(Huber and 
Carrell, 1989) 
Conserved 
in HSP47 
family? 
Tm (oC) ± 
0.5 
Collagen 
anti-
fibrillisation 
property 
pH titration 
inflection 
points 
WT - - 59.0 - 5.70 ± 0.10 
H135A hE 100% 57.0 Yes 5.75 ± 0.05 
H191A 
s3A-s4C, 
breach 
100% 57.0 Yes 5.90 ± 0.05 
H197A: 
H198A 
s3A-s4C, 
breach 
100% 
92% 
* * * 
H244A 
s2B-s3B, 
breach 
92% 57.5 Yes 5.65 ± 0.05 
H255A: 
H256A 
s3B-hG, 
gate 
 
46% 
100% 
58.0 Yes 5.75 ± 0.10 
H302A hI, shutter 92% 58.0 Yes 5.75 ± 0.05 
*The properties of H197A:H198A could not be determined as it could not be eluted normally from gelatin-
agarose column.  
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Determination of H191A Collagen-release pH using Fluorescence Anisotropy 
Results presented in this chapter suggest that one mutant, H191A, exhibits notable behaviour 
especially its release from gelatin/collagen. This is based on several observations: First, the 
pH of the peak fraction of H191A in gelatin column elution experiment was found to be 
slightly higher than that of HSP47 WT; second, using CD, its pH induced trans-
conformational change from alkali to acid state was also found have a midpoint at higher pH 
value compared to WT. This section is aimed at further investigating the active participation 
of H191A in the ‘breach’ cluster in triggering HSP47 release from collagen. Other than 
native collagen and gelatin, HSP47 is known to be able to bind CMP, as described in Section 
2.9. Gelatin was used in the column elution experiment (Section 2.6), while collagen was 
used in the fibrillisation assay (Section 2.10). Native collagen has been used to demonstrate 
the different release of HSP47 WT and H191A mutant via fibrillisation assays at different pH 
conditions. Unfortunately, collagen fibril formation does not occur at acidic condition, even 
just below pH 7 (data not shown). For the same purpose, gelatin-agarose beads have also 
been used via modified pull down assay by washing the bound HSP47 with buffers at 
different pH values. This was also unsuccessful probably due to aggregation of gelatin-bound 
HSP47 when washed with low pH buffer, as observed on Western blot membrane probed 
with HSP47-specific antibody (data not shown). Hence, CMP is the next best candidate, used 
as substrate in fluorescence anisotropy experiment.  Compared to the other two techniques 
described above, anisotropy spectroscopy measurement does not require high concentration 
of HSP47 and substrate due to its high sensitivity. This should eliminate aggregation problem 
at low pH. Data obtained from this technique should also come only from HSP47/CMP direct 
binding and release effect.   
Anisotropy (r) is defined as the extent of polarisation of fluorescence emission when a 
sample is excited with polarised light. Anisotropy arises from the presence of transition 
moments for absorption and emission that lie along specific directions within the fluorophore 
structure (Lakowicz, 2006). The instrumental setup is similar to the normal fluorescence 
spectroscopy measurement, except that excitation and emission polarisers are positioned in 
the light-path for polarisation (Figure 2.28).   
 
  
 
 
 
 
 
 
Figure 2.28: Measurement of fluorescence anisotropies shown in schematic diagram.  
Adapted from (Lakowicz, 2006).  
 
 
The sample is usually excited with vertically polarised light, with the electric vector 
parallel to the z-axis. The emission intensity is then measured through a polariser, where 
when the emission polariser is oriented parallel to excitation polarisation the intensity is 
named I║. And when the polariser is perpendicular to the excitation polarisation the 
fluorescence intensity is called I┴. Anisotropy is then calculated according to the following 
equation: 
⊥
⊥
+
−=
II
IIr
2ll
 ll  (Eq. 2.1)  
Anisotropy does not have a unit and it is independent of the total intensity of the 
sample and concentration of fluorophore. Rather, it is an intensity ratiometric measurement. 
Sometimes, the term polarisation is also used to describe this phenomenon though the use of 
anisotropy is more preferable. Polarisation is defined by: 
⊥
⊥
+
−=
II
IIP
ll
 ll   (Eq. 2.2) 
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These two terms are related by these equations (Lakowicz, 2006): 
r
rP += 2
3   (Eq. 2.3) 
P
Pr −= 3
2   (Eq. 2.4)  
 
When small fluorophores, such as fluorescent dyes, are excited with polarised light, 
the emitted light is largely depolarised because free molecules tumble rapidly in solution 
during its fluorescence lifetime. The fluorescent lifetime (τ) is the time between excitation 
and emission. But if the fluorophore binds to a larger molecule, its effective molecular 
volume increases. The rotation is slowed so that the emitted light is in the same plane as the 
excitation light. Because of this, bound fluorophore will have high intrinsic polarisation 
value, therefore high anisotropy, while free molecules have low value (Invitrogen, 2006) 
(Figure 2.29). 
 
 
 
 
 
 
 
 
 
Figure 2.29: The origin of anisotropy difference between small, free molecule and large 
complexes.  
Adapted from (Invitrogen, 2006). 
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A pH-stable fluorophore, with relatively high fluorescence lifetime is required to be 
coupled to CMP, as it does not possess intrinsic fluorescence. Among many amine reactive 
dyes, BODIPY (4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid) 
(Figure 2.30) was found to be suitable, particularly due to its stability across a wide pH range 
due to the absence of ionic charge, and relatively high fluorescence lifetime, τ~6 ns. This dye 
also has a high extinction coefficient and a very high quantum yield, approaching 1. Even 
though it has a small Stokes shift (10-20 nm), excitation at suboptimal wavelength can be 
used to avoid interference from light scattering during fluorescence detection (Hermanson, 
1996). As an amine-reactive dye, BODIPY was coupled to PRG peptide (Figure 2.31) and 
conjugation was found to increase the hydrophobicity of PRG peptide due to the presence of 
BODIPY molecule at the N-terminus, as observed in the HPLC chromatogram of the purified 
conjugate in Figure 2.32. Thus it can be estimated that the conjugation reaction is almost 
100% efficient due to absence of unconjugated PRG peptide.  
 
 
 
 
 
Figure 2.30: Molecular structure of BODIPY. 
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Figure 2.31: Coupling strategy for the conjugation of BODIPY to PRG peptide, adapted 
from (Hermanson, 1996).  
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Figure 2.32: Reversed-phase HPLC analysis of conjugation reaction of PRG peptide to 
BODIPY dye, detected at 214 nm (blue) for peptide backbone absorption.   
 
 
119
The conjugate was then used for anisotropy measurement. It was found that the 
anisotropy of the conjugate (0.0112 ± 0.0012) does not vary significantly from that of free 
BODIPY in water (0.0123 ± 0.0005), even though conjugation was predicted to increase the 
anisotropy of BODIPY due to decrease in molecular tumbling. Titration of the conjugate with 
increasing concentration of HSP47 (up to three-fold molar excess) also does not show any 
significant change in anisotropy (Figure 2.33).  
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Figure 2.33: The plot of anisotropy change of PRG-BODIPY conjugate upon titration 
with increasing concentration of HSP47. 
The concentration of conjugate was fixed at 0.5 μM. Titration did proceed beyond 3-fold 
molar excess of HSP47 to conjugate as HSP47 at high concentration tends to form insoluble 
aggregates. The experiment was performed in 50 mM sodium phosphate pH 8.0 with 100 
mM NaCl, at 25°C.    
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To investigate this, Perrin equation and Stokes-Einstein-Debye equation were 
employed to calculate the molecular volume of the fluorescence species, so the 
hydrodynamic radius (Stokes radius, Rh) can be predicted for comparison with the values 
reported in the literatures. Perrin equation states that anisotropy depends on rotational 
diffusion of the molecule, expressed as rotational correlation time, Φ, based on Eq. 2.5 
below. Φ depends on the size and shape of the molecule (González Flecha and Levi, 2003).     
φτ /1+=
orr   (Eq. 2.5) 
Where ro is the anisotropy in the absence of diffusion, τ is the fluorescence lifetime of the 
probe.  
 Most anisotropy experiments with macromolecules assume that it is a spherical 
particle rotating with small angular velocities. With this assumption, the rotational correlation 
time can be expressed by the Stokes-Einstein-Debye equation below: 
Tk
V
.
.ηφ =                (Eq. 2.6) 
Where η is the solvent viscosity coefficient, V is the molecular volume of the particle, k is the 
Boltzmann constant and T is temperature. Equations 2.5 and 2.6 can then be combined to give 
Eq. 2.8: 
c
r
V
Tk
rr oo +=+
= η
η
η
τ
.
.
..1
  (Eq. 2.7) 
From this relationship, the coefficient c and ro can be obtained by plotting the change in 
anisotropy against different solvent viscosity (η). Figure 2.34 shows the plot constructed 
using the conjugate in the presence of increasing concentration of glycerol. From the plot, ro 
was predicted as 0.0413 ± 0.0047 and c was 2.7756 ± 0.5234 mPa.s. Then using the average 
BODIPY fluorescence lifetime (τ) of 6 ns based on previous reports on BODIPY and its 
derivatives (Karolin et al., 1994; Mikhalyov et al., 2002) , k as 1.38 × 10-23 J/K, T = 293.15 
K, the molecular volume of the conjugate was then calculated as 8.74 ± 1.64 nm3. This gives 
a Stokes radius (hydrodynamic radius, Rh) of 1.27 ± 0.46 nm. The value obtained is slightly 
smaller than those reported for triple helical structure for collagen mimetic peptide which is 
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in the range of 1.6-2.5 nm (Kar et al., 2006; Kotch and Raines, 2006; Pires and Chmielewski, 
2009) for 8-10 repeats of (POG) peptide. This computed value of Rh is also prone to error due 
to the assumption that the particle being considered is spherical, which is acceptable for 
proteins but should be exercised with care for non-spherical peptide (Edward, 1970).  
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Figure 2.34: Dependence of conjugate anisotropy on the viscosity of solution. 
The line represents the best fit of the date based on Eq. 2.7.   
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Furthermore, in order to determine the presence of any helical character after 
conjugation of BODIPY to PRG peptide, CD spectra of the coupled and uncoupled peptides 
were collected at equal concentration. From Figure 2.35, it can be concluded from the spectra 
that no triple helical character is present in the conjugate solution, unlike those observed with 
free peptide. Thus these suggest that conjugation prevents the formation of triple helical 
conformation of the collagen mimetic peptide PRG, although the mechanism is still unclear. 
It is possible that the steric effect at the N-terminus of the peptide chain increases after 
conjugation with BODIPY. This could then lead to the unchanged anisotropy of PRG-
BODIPY conjugate upon titration with HSP47, as previous report suggests that HSP47 binds 
well to triple helical peptide but significantly lower to single stranded ones (Koide et al., 
2006a). Despite this, fluorescence anisotropy is a very useful technique to study the 
interaction of HSP47 with its substrate, provided that the barrier to triple helical formation 
after conjugation could be overcome.      
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Figure 2.35: CD spectra of free PRG peptide and PRG conjugated with BODIPY. 
Measurements were performed at a concentration of 20 μM in water, at 25°C. 
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2.11 Conclusion 
The investigation on HA mutants proved to be useful as the location of His residues that play 
the most important roles can now be narrowed down to the ‘breach’ cluster. Mutating H197 
and/or 198 to Ala affects the typical collagen binding specificity while mutant H191A shows 
an affected release characteristic. It is therefore very likely that ‘breach’ cluster is the most 
important cluster in the HSP47 pH-change, allowing HSP47 to bind collagen at high pH and 
triggering the release at lower pH. Hence, study on the dynamics of these structural 
transitions was recommended and in the next chapter this was tackled by employing intrinsic 
tryptophan fluorescence spectroscopy.  Overall, data presented in this chapter account for 
more than half of the His residues of HSP47. It is not at all implausible to propose that the 
residues actively involved in the pH-switch mechanism is highly localised to a certain region 
of the chaperone. It should also be highlighted that these suggestions are made based on the 
homology model of HSP47, depending on the accurate location of the residues mentioned. 
Otherwise, the high secondary structure similarity between serpin family members may 
support these proposals. The findings reported in this chapter were used in proposing the 
model for HSP47 pH-switch mechanism which would be presented in Chapter 4. 
  
125
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
Results and Discussion: HSP47 pH-induced Dynamics Probed 
using Intrinsic Tryptophan Fluorescence Spectroscopy 
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CHAPTER 3: HSP47 pH-INDUCED DYNAMICS PROBED USING INTRINSIC 
TRYPTOPHAN FLUORESCENCE SPECTROSCOPY 
 
3.1 Introduction 
Fluorescence spectroscopy has been used extensively to study protein conformation and 
interaction. Aromatic amino acids, such as tyrosine (Tyr, Y) and tryptophan (Trp, W), are 
able to act as intrinsic chromophores and therefore able to produce fluorescence signals 
(Figure 3.1). The nature of this process depends on the micro-environment of these 
chromophores, making it useful in studying the behaviours of proteins. Thus, intrinsic protein 
fluorescence can be used to monitor proteins of interest in response to heat, pressure, pH 
change and denaturants. When coupled with other biophysical techniques such as CD and 
NMR, conformational changes during these processes can be monitored in even greater 
detail. As fluorescence spectroscopy is very sensitive to both chemical and physical 
interference, high purity compounds are desirable (Pain, 2004).   
The aim of this study is to locate any Trp residue(s) that may be in a 
hydrophobic/hydrophilic environment at HSP47 alkaline state and exposed to a different 
environment upon transition to acid state. Each Trp was mutated to phenylalanine (Phe, F) 
that has similar structural bulkiness compared to Trp, but do not contribute to fluorescence 
emission when excited at 295 nm. This could suggest an important dynamic region during pH 
transition if the fluorescence is quenched upon mutation. Direct monitoring of a single Trp 
residue is most desirable as this eliminates possible interference from other residues while 
multiple Trp-to-Phe (WF) mutations are not advisable as it has been shown in previous 
studies that such mutations pose additive instability effects on the protein (Hasselbacher et 
al., 1995; Meagher et al., 1998). This supports the approach to construct single WF mutant to 
observe if there is any deletion effect on WT fluorescence behaviour during pH titration. For 
this purpose, the fluorescence behaviour of HSP47 WT was initially established.  
  
Figure 3.1: The absorption (A) and emission (E) spectra of Phe, Tyr and Trp in aqueous 
solution pH 7 (Lakowicz, 2006). 
 
 
In the previous chapter, the ‘breach’ cluster of HSP47 has been established to contain 
the His residues participating actively in the pH-triggerable release of binding to collagen. 
There should also be a significant regional structural transition that takes place during the 
process. In the absence of a 3-dimensional structure, the extent of the structural 
rearrangement is unknown. Although it is likely that whole protein experiences this change, it 
is even more likely that there are certain regions that significantly undergo this process. This 
is in light of the localisation of the important His residues in the ‘breach’ cluster of HSP47. 
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Intrinsic fluorescence spectroscopy is among the first methods used to study the structural 
transition of HSP47 from alkaline to acidic pH (El-Thaher et al., 1996) and ever since has 
been one of the methods of choice among HSP47 molecular researchers. These include 
studies on its structure (Dafforn et al., 2001; Thomson and Ananthanarayanan, 2000) and 
interactions with collagen and collagen-related peptides (Dafforn et al., 2001; Koide et al., 
2006a; Koide et al., 2002; Macdonald and Bächinger, 2001). 
In serpins, intrinsic Trp fluorescence has extensively been used previously to study 
the interaction between serpins and their cognate proteases. In the same year as the discovery 
of the crystal structure of the RCL of α1-antitrypsin (α1-AT, α1-proteinase inhibitor) (Elliott et 
al., 1996), tryptophan fluorescence was used to distinguish between the various forms of the 
serpin (Koloczek et al., 1996). This includes the latent form, the A-sheet dimer (‘head to tail’ 
polymerisation), C-sheet dimer (‘head to head’ polymerisation) and the A-sheet dimer 
propagating from the C-sheet dimer. Wild-type α1-AT does not readily adopt these forms, but 
only after a cycle of denaturation and renaturation. α1-AT has two Trp residues, one in strand 
3 of β-sheet A (W194) and the other in strand 2 of β-sheet A (W238). In the latent form, 
which is characterised by RCL insertion into the A-sheet, W238 is more exposed to solvent 
than W194 based on the shifting of emission maximum (λem of W238 is red-shifted by 4 nm 
compared to W194). This was determined using fluorescence quenching with potassium 
iodide (KI) as the quencher. W238 is assumed as quenchable component as it is exposed to 
the environment and vice-versa for W194. With fluorescence quenched resolved spectra 
(FRQS) and red-edge excitation techniques, the two forms of polymers can be distinguished 
based on dipole relaxation of W238 and W194: A-sheet polymerisation and C-sheet 
polymerisation. The former is characterised by the insertion of RCL into β-sheet A, and the 
latter is formed by interactions in the C-sheet. W238 is at least 50% more exposed in A-sheet 
polymers compared to C-sheet polymers (Koloczek et al., 1996).  
The ‘breach’ residue W194 is then shown to be crucial in controlling the rate of 
polymerisation of antichymotrypsin (ACT) (Pearce et al., 2007). Again, the location of the 
residue at the N-terminus of RCL is probably the reason for the residue to adopt this role. In 
its native form, replacement of Trp with Phe (W194F) does not significantly alter the 
inhibitory property. The polymerisation process was found to be up to 14 times faster with 
the mutant than WT upon heating at 48°C, which induces polymerisation. Meanwhile, the 
rate of polymer intermediate species is accelerated 35 times when monitored using the 
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intensity of external reporter bis-8-anilinonaphthalene-1-sulfonate, also known as 4,4´-bis(1-
anilinonaphtalene-8-sulfonate) or bis-ANS (Pearce et al., 2007). This compound was first 
shown to bind tightly to the hydrophobic pocket of bovine serum albumin (BSA) 
accompanied by substantial enhancement in fluorescence of the reporter (Rosen and Weber, 
1969). Generally bis-ANS fluoresce brightly in hydrophobic environment and is virtually 
non-fluorescent in polar environment, i.e. water (Takashi et al., 1977). This particular 
property makes it suitable for probing hydrophobic patches on protein surfaces, protein 
unfolding process, and in the study using ACT, for monitoring of the progress of its 
polymerisation. Data obtained using WF mutant of ACT demonstrate that some Trp residues 
play an active role in structural integrity and stability in serpins. Bis-ANS has also been used 
in studying α1-AT polymerisation mechanism (James and Bottomley, 1998), which 
effectively is a continuation to another study using intrinsic Trp fluorescence reported two 
years earlier (Koloczek et al., 1996). As explained above, bis-ANS binds hydrophobic 
patches on the protein surface. The fluorescence of bis-ANS enhanced significantly upon 
binding to polymerised α1-AT, suggesting the formation of more hydrophobic regions 
compared to the native protein. The first step of polymerisation, which is the opening of β-
sheet A, is characterised by the increase in hydrophobicity in the area in vicinity to it. This 
then enhances the fluorescence of bis-ANS. In the second phase which is the addition of the 
monomer to the initiator, it is characterised by a gradual decrease in bis-ANS fluorescence 
signal. This phenomenon is related to the insertion of RCL of a donor molecule into the 
initiator, resulting in displacement of bis-ANS molecules bound to the ‘opened’ β-sheet A 
(James and Bottomley, 1998).   
In a separate study, interaction of antithrombin (AT) and its heparin substrate has also 
been probed using Trp-to-Phe mutants (Meagher et al., 1998). Compared to HSP47 which has 
five Trp residues, AT has four Trp residues instead (here called AT-W49, 189, 225 and 307). 
The locations of two of the residues are analogous to the Trp residues in HSP47 (called 
HSP47-W). They are AT-W189, located on helix F (similar to HSP47-W158), and AT-W225 
which corresponds to HSP47-W192 at the end of strand 3 of β-sheet A. The other Trp 
residues of AT are located at the beginning of helix-A (AT-W49) and finally AT-W307 is on 
helix H. The four WF mutants were used to monitor fluorescence changes upon binding to its 
substrate, heparin. The possibility of energy transfer between the residues is ruled out as one-
third of the sum of fluorescence spectra of the mutants resembles that of WT. This is 
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consistent with calculation as distances between the residues are known to be between 15-35 
Å.  There is no significant energy transfer can be observed between residues separated more 
than 2 × Ro (Moens et al., 2004). Ro refers to Förster distance which is the distance at which 
resonance energy transfer (RET) is 50% efficient. The critical distance between Trp-Trp for 
RET is generally reported to be between 5-12 Å (Steinberg, 1971; Zhong et al., 2002). The 
mutants are then used to explain the structural rearrangement undergone by AT upon heparin 
binding in terms of fluorescence enhancement of the Trp residues. Steady-state fluorescence 
was also used to show the effect of heparin binding, most of which are experienced by two 
residues only (W225 and W307) based on the enhancement of fluorescence emission. The 
environment around W189, which resides at the furthest distance from heparin binding site 
and RCL, on the other hand, is less sensitive to the binding. Overall, Trp residues located in 
close proximity to the RCL and nearby regions involved in the stressed to relaxed transition 
experience the largest change in intensity and wavelength shift of fluorescence emission 
(Meagher et al., 1998).    
 These extensive studies on members of serpin family demonstrate the potential of 
fluorescence spectroscopy in elucidating protein folding processes, especially with respect to 
their secondary structural transition induced by different factors.   
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3.2 Mapping the Locations of Trp Residues in HSP47 Homology Model 
HSP47 has five Trp residues at positions 110, 158, 192, 275 and 341 (Figure 3.2). In the 
model, W110 is located at the end of sheet 2 of β-sheet A (s2A) close to the loop between 
s2A and helix D (hD), W158 at the hF, W192 in the loop between s3A and sheet 4 of β-sheet 
C (s4C), W275 at the hH and finally W341 is located at the loop after s5A near the ‘hinge’ 
region, the region at which the RCL turns and joins β-sheets A to become s4A in latent or 
cleaved form of serpin (Hopkins et al., 1993). These Trp residues produce a strong intrinsic 
fluorescence emission when excited at 295 nm. All residues are predicted to be solvent 
accessible, and the accessibility ranges from almost 90% (W275) to 3% (W192). W110 and 
W341 are predicted to be about 30% exposed, while W158 is about 40%. Calculations were 
done using ASA-View program on the online server at 
http://gibk21.bse.kyutech.ac.jp/netasa/asaview/ (Ahmad et al., 2004). This is one of the 
structural classification and analysis tools that can be found on the RCSB Protein Data Bank 
http://nist.rcsb.org/pdb/home/home.do.  
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Figure 3.2: HSP47 homology model showing the locations of five Trp residues.  
Trp residues are shown in red in ‘spheres’ representation.  
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3.3 Construction, Expression and Purification of Trp-to-Phe (WF) Mutants  
WF mutations were introduced as in the HA mutant construction and expressed in E. coli 
BL21(DE3). Their expression and solubility was first assessed to investigate possible 
destabilising effect of the mutation to the protein. Expression of all mutants were found to be 
comparable to WT when analysed on 12% Tris-glycine SDS-PAGE gel stained with CBB 
(Figure 3.3A). Figure 3.3B shows solubility of the mutants compared to that of WT. 
Replacement of Trp residues with Phe seems to affect HSP47 solubility greatly, in contrast to 
HA mutants. The most dramatic effect is observed with W192 mutation, when the protein 
expressed has very low solubility and not detectable on the gel. W110F has an acceptable 
solubility for purification, while W158F also has a low solubility, but detectable in the 
soluble fraction of E. coli lysate. The variations in solubility upon mutation probably relates 
to the degree of solvent exposure. W192 is the least exposed, which explains the very low 
solubility of the Phe variant. W158 and W275 are probably less exposed than predicted, 
based on the adverse effect of mutations on their solubilities.  
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Figure 3.3: Expression and solubility of HSP47 WT and WF mutants.  
A. Total protein content (L) and soluble protein fraction (S) WT and mutants expressed in E. 
coli BL21(DE3) separated on 12% SDS-PAGE and stained with CBB. HSP47 bands are 
highlighted in black square. M: Precision Plus Protein Standards (Bio-rad). B. Solubility of 
mutants relative to WT (100%, n=3). W192F is hardly soluble in the same buffer conditions 
as used with the other mutants. Quantification was done using NIH ImageJ software after 
immunodetection with anti-HSP47 antibody. 
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Glycerol has widely been reported to increase protein solubility when added at a 
certain concentration, especially in protein crystallisation when a high concentration is often 
required as it reduces buffer polarity thus stabilises the hydrophobic regions (Gerlsma, 1968; 
Sedgwick et al., 2007; Simpson and Kauzmann, 1953; Tanford et al., 1962). It has been 
suggested that the presence of glycerol causes the alteration in the effective protein size 
because of a small expansion of its radius, or by the enhancement of a layer of solvent 
limiting the distance of closest approach between the protein molecules (Farnum and 
Zukoski, 1999). For this reason, glycerol was added during cell lysis to facilitate 
solubilisation of mutants W158F, W192F and W275F. Effect of glycerol addition to the 
solubility of the mutants is shown in Figure 3.4. Addition of glycerol at 15%(v/v) has 
different effects on the solubility of these mutants. W192F shows a two-fold increase to that 
of WT, while W158F only shows slight increment of its solubility.  A reverse effect is 
observed with W275F, where it was found to be less soluble. Hence, HSP47 WT, W110F, 
W275F, and W341F were purified without glycerol in the lysis buffer, while W158F and 
W192F were lysed with 15%(v/v) glycerol in the buffer. The mutants were purified using 
HisTrap Ni-NTA column as the mutation is not expected to perturb its binding and release 
property. This is supported by the gelatin-agarose binding assay (Figure 3.5) where all 
soluble mutants possess more than 50% binding ability compared to that of WT. Replacement 
of gelatin-agarose column with Ni-NTA column offers a much faster purification at higher 
flow rate with a higher protein binding capacity.  The yields of W275F and W158F after 
purifications were found to be very low, so these mutants were not investigated further. 
Otherwise, a typical yield was between 0.18 to 0.20 mg/mL after imidazole removal.  
050
100
150
200
250
W158F W192F W275F
R
el
at
iv
e 
S
ol
ub
ili
ty
 (W
T 
10
0%
)
No glycerol
15% glycerol
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Effect of 15%(v/v) glycerol on HSP47 WF mutants solubility.  
Solubility is relative to WT (100%, n=3). Quantification was done using NIH ImageJ 
software after immunodetection with anti-HSP47 antibody. Glycerol does not seem to change 
W158F solubility, increases significantly the solubility of W192F, but has an adverse effect 
on the solubility of W275F. 
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Figure 3.5: The binding ability of soluble WF mutants constructed to gelatin 
immobilised on agarose beads. 
Binding ability is relative to WT (100%, n=3). Binding assay was performed in lysis buffer 
containing 15% glycerol. Quantification was done using NIH ImageJ software after 
immunodetection with anti-HSP47 antibody. 
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3.4 Structural Analysis of Purified Mutants 
Effects of WF mutation on the secondary structure of HSP47 are first investigated using far-
UV circular dichroism (CD). Comparison of the spectra of all purified mutants with that of 
WT revealed that there is no significant difference or perturbation in the shape of the 
observed spectra (Figure 3.6A), except that of W110F. There is also a slight variation in 
signal intensity of the spectra that belong to mutants W192F and W341F, which suggests that 
Trp residues in HSP47, to some extent, contribute to the overall CD signal. This has also 
been noted elsewhere, for example in the mutational work performed on Trp residues in 
barnase. It reveals the significant difference in the far-UV CD spectra of the mutants 
compared to WT (Vuilleumier et al., 1993). Similar effects are also seen when other aromatic 
amino acids are mutated, i.e. Tyr and Phe. In the case of dihydrofolate reductase (DHFR), all 
but one of Trp-to-Phe mutants constructed also show slightly different far-UV CD spectra 
compared to WT (Ohmae et al., 2001). One reason proposed for decreased CD signal 
characteristic of mutant DHFR relates to the formation of exciton coupling between two 
adjacent Trp residues that contribute to CD signal. Exciton coupling is simply defined as 
interaction between two electronic transition in different groups, or also called μ-μ coupling 
(Strickland and Beychok, 1974). Mutation of either residue in the pair diminishes the signal. 
Aromatic side chains have also been suggested to contribute to CD signal via interactions 
with other side chains such as amides, carboxylate, guanidino and even with peptide bonds of 
the main protein chain. Among the factors that determine these interactions include the dipole 
strength and electronic transition moment of the functional groups, and also the distance 
between the groups (Strickland and Beychok, 1974). The distance referred to for such 
interactions in barnase is between 6-8 Å (Vuilleumier et al., 1993). How exactly the excitonic 
pair is formed by Trp residues in HSP47 is difficult to predict based on the homology model 
alone. Oservation of the model suggests that there are plenty of possible interactions between 
aromatic side chains of HSP47 which makes the theory plausible (Figure 3.7). In case of 
W110F, there is a possibility of slight structural perturbations, but it does not affect its overall 
activity as this mutant is still capable of binding to gelatin as good, as WT (Figure 3.5).  
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Figure 3.6: Far-UV CD spectra (A) and thermal denaturation profiles (B) of HSP47 WT 
and WF mutants.  
Concentration was fixed to 2 μM and measured in 50 mM sodium phosphate buffer pH 8.0 
with 100 mM NaCl. 
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Figure 3.7: ‘Front’ and ‘Side’ visualisations of HSP47 homology model showing all five 
Trp residues (red) and all Tyr and Phe residues (yellow).  
The predicted closest distance between the side chains of W110 and F187 is 8.5 Å. Aromatic 
residues are shown in ‘spheres’ representation. Atomic distance computed using Deepview 
Swiss-pdbViewer v4.0.1.  
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In order to investigate whether the slight spectral difference is accompanied by perturbed 
structure and hence HSP47 stability, CD temperature titration experiment was conducted. 
Based on the melting profile, the stability of WF mutants is not significantly perturbed by the 
mutations. Compared to HSP47 WT, which has a transitional midpoint (Tm) of 52 ± 0.5°C, 
the Tms for the mutants differ only in the range of 2°C (W110F 53 ± 0.5; W192F 52 ± 0.5; 
W341F 54 ± 0.5°C) as shown in Figure 3.6B. This indicates that there is no major 
perturbation in structure or destabilisation due to the mutation occurs.  
  
3.5 Intrinsic Fluorescence Titration of HSP47 WT 
Intrinsic protein fluorescence is observed when a chromophore-containing amino acid (such 
as Trp and Tyr) absorbs light and becomes excited from ground electronic state (S0) to higher 
electronic state vibrational level (S1). The molecules then relax rapidly to the lowest 
vibrational level of S1, a process called internal conversion (generally occurs at 10-12 s or less) 
with the energy is lost to the surroundings as thermal energy. From the lowest energy 
vibrational state of S1, the molecules then return to the higher excited vibrational ground state 
level before reaching thermal equilibrium. This process results in the emission of radiation or 
lower energy and longer wavelengths, called fluorescence. Some energy also dissipates in 
non-radiative ways (Lakowicz, 2006; Pain, 2004).  
 Tyr and Trp absorb light around 280 nm with quantum yields (Q) of 0.1 and 0.2 
respectively. Q is simply defined as the number of emitted photons relative to the number of 
absorbed photons. The Q value for Phe is very low at only 0.04, and it also has the shortest 
absorption and emission wavelengths. This is why protein fluorescence study usually 
involves only Tyr and Trp residues. Meanwhile, the fluorescence of Tyr occurs at around 303 
nm when excited at 280 nm, and it is relatively insensitive to solvent polarity. Trp, on the 
other hand, emits at around 350 nm (in water) and highly sensitive to solvent polarity and its 
local environment. Trp residues in protein can also be specifically excited at 295 nm to 
minimise absorption by Tyr residues (Lakowicz, 2006).  
Fluorescence spectra of mouse HSP47 WT at different pHs are shown in Figure 3.8. 
Spectra recorded at nearly neutral pH show an intensity maximum at 328 ± 1 nm (λem), 
indicating that the Trp residues are, on average, packed in a less polar environment, 
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compared to fully exposed residues (Pain, 2004). As pH decreases down to 6.5, the 
fluorescence intensity (If) is relatively unchanged. But as pH is lowered to 6.0 or further, a 
red-shift starts to occur accompanied by an increase in intensity. Hence, it is possible that at 
this pH, a structural rearrangement is triggered that changes the local environment around 
which the Trp residues are located. This exposes them to a more polar environment as can be 
seen from the shift of λem to higher wavelength. The trend in shifting continues as titration 
progresses to pH 5.7, when the intensity reaches its peak. At this pH the λem has shifted to 
near 335 nm. Further addition of acid decreases the intensity. As the fluorescence decay of 
tryptophan is known to be stable in the pH range of 8-4 (De Lauder and Wahl, 1970), the 
quenching is probably caused by neighbouring side chains. It is probable that the ionised His 
imidazole side chain quenches proximal Trp residues that come to close contact due to the 
structural rearrangement (Czabotar et al., 2004; Vos and Engelborghs, 1994; Willaert and 
Engelborghs, 1991). Aggregation was not observed in this case and the concentration before 
and after titration was not significantly changed. The changes in λem and If can then be plotted 
against pH to observe the behaviour more clearly (Figure 3.9).  
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3.8: Fluorescence emission spectra of HSP47 WT recorded with an excitation 
wavelength of 295 nm.  
Arrow indicates the shift in maximum wavelength during titration. Concentration was fixed 
at 1 µM in sodium phosphate buffer pH 8.0 with 100 mM NaCl, at 25°C.  
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Figure 3.9: The plot of the change in maximum emission wavelength (λem) and 
fluorescence intensity (If, at the initial λem) against change in pH of HSP47 WT.  
Values were taken from individual spectra recorded during pH titration. Initial λem was taken 
as it gives much better data for plotting and visualisation purposes. λem values include ±0.5 
nm instrumental errors. 
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The trend of the change in λem is comparable to HSP47 structural change during pH 
titration observed with CD as described in the previous chapter, though the actual mechanism 
that gives rise to this might not be similar. But the most significant change can be seen 
between pH 6.3 and 5.5, which is also in the His imidazole ionisation range. Based on the 
change in λem value, three apparent phases can be observed: (Phase 1) Minimal changes in 
maximum emission wavelength between pH 8.0 to approximately 6.3. (2) A sudden shift in 
maximum wavelength between pH 6.3 and 5.5 to longer wavelength indicating a more 
exposed environment of the intrinsic Trp residues. (3) A constant maximum emission 
wavelength as titration progresses further. Similarly while monitoring the maximum 
fluorescence emission intensity at the initial λem, three distinctive phases can also be 
identified: (Phase 1) The gradual decrease in intensity as the pH decreases from 8.0 to 6.3. (2) 
The sudden increase in intensity as pH reaches 6.3, until about pH 5.7. (3) The gradual 
decrease as titration continues below pH 5.7 probably due to quenching as explained above. 
The relationship between the change in λem and the change in secondary structure monitored 
using CD is difficult to predict due to the complex nature of Trp fluorescent emission. But 
overall it can be suggested that the main rearrangement of HSP47 during pH transition can be 
monitored using intrinsic Trp fluorescence spectroscopy. It is from the so called alkaline 
(non-protonated) state (>pH 6.3) to the acid (protonated) state (<pH 5.5), which occurs in the 
His imidazole pKa window. This rearrangement is accompanied by the release of binding to 
collagen (as demonstrated using collagen mimetic peptide in Chapter 2).  
Reverse titration was also performed on HSP47 WT from acidic to alkaline pH with 
the addition of NaOH in small aliquots to investigate the reversibility in the change of λem and 
intensity. The change in λem is totally reversible suggesting the reversibility of HSP47 pH 
transition (Figure 3.10A). In contrast, maximum emission intensity progressively decreases 
during reverse titration probably due to irreversible quenching effect by ionising side chains 
(Figure 3.10B). Based on these observations, the construction of Trp to Phe mutants seemed 
appropriate to indirectly probe a more specific locality at which this transition occurs based 
on the change in λem. It is concluded in Chapter 3 that from alanine mutagenesis of surface 
His residues, the important residues participating in pH-switch mechanism are probably 
localised at the top of β-sheet A, the so called ‘breach’ cluster. Given this finding, it is also 
possible that the change in structure only centred on that particular cluster without affecting 
the whole protein structure. For this reason, each of the Trp residues was mutated one by one 
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and the fluorescence behaviour was observed. This eliminates the need to introduce more 
than one mutation that may be detrimental to the protein stability. The mutation will replace 
the chromophore, with the least possible effect on the structural integrity at that mutation site.  
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Figure 3.10: Reversibility of the change in (A) maximum emission wavelength (λem) and 
(B) fluorescence intensity (If) at the initial λem of HSP47 WT.  
Titration was initially done from pH 8.0 to 4.0 (Descending plot) before bringing the pH back 
to 8.0 again (Reverse plot) with concentrated NaOH. pH was raised after acid titration with 
the addition of concentrated NaOH. Values were taken from individual spectra recorded 
during pH titration. All curves are comparable after several repeat titrations. 
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3.6 Fluorescence Characterisation of HSP47 WF Mutants  
 CD spectra of the mutants do not show any significant difference from WT, apart of 
those attributed to exciton coupling between aromatic side chains, as explained in Section 
3.4. This suggests that there is no perturbations in the secondary structure of mutants W110, 
192 and 341 (Figure 3.6A). Then by scanning the fluorescence spectra of the mutants at the 
same excitation wavelength and at the same concentration, variations in the If and λem are 
apparent (Figure 3.11). Removal of W110 causes a drop in fluorescent intensity by around 
10% to that of WT while W192 and W341 probably contribute to similar effect on 
fluorescence as removal of either chromophore decreases If by nearly 20% respectively. The 
emission spectrum of W110F shows a blue shift which suggests a slight decrease in polarity 
of the environment of the other four Trp residues or either one of them as a result of W110 
mutation. The opposite of this has been observed in the mutagenesis study of E. coli DHFR 
(Ohmae et al., 2001). This also explains the slight perturbation seen in the CD spectrum of 
W110F (Figure 3.6A).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Fluorescence emission spectra of HSP47 WT and WF mutants recorded 
with an excitation wavelength of 295 nm at alkaline pH.  
Concentrations were fixed at 1 µM in sodium phosphate buffer pH 8.0 with 100 mM NaCl, at 
25°C.  
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Fluorescence pH-titration of HSP47 WF Mutants  
Similar to the experiment carried out on HSP47 WT, the change in maximum emission 
wavelength (λem) of the mutants were plotted as a function of pH (Figure 3.12). As 
demonstrated earlier, this parameter was chosen to probe the conformational rearrangement 
of HSP47 during pH titration. Monitoring of λem against pH for WT shows a transition in the 
collagen-dissociation pH region, and unlike fluorescent intensity, is independent of 
collisional quenching. The changes in λem against pH for the mutants were then fitted to 
single pH ionisation model, with all fits converged well (Figure 3.12). The results of the 
fitting is summarised in Table 3.1. The pKa for W110F and W192F agrees well with the pKa 
of HSP47 WT, while W341F gives a slight pKa shift which suggests perturbations in the 
fluorescence-probed structural transition. The curve for W192F is also slightly deviates from 
that of WT, though this still could not be fully verified from our current data and tools for 
analysis. 
W341 along with W192 are predicted to be located in the ‘breach’ cluster from the 
homology model. It is probably due to their vicinity to the ‘breach’ His residues that 
participate actively in triggering pH-controlled release that causes these mutants, especially 
W341F to experience slight perturbations during pH titrations.  
In addition, the fact the λem data could be fitted to single ionisation model suggest that 
there is a possibility of single Trp residue mainly responsible for the change. W110, W192 
and W341 can be ruled out as mutation of these residues does not abolish this behaviour. 
W275 is probably the residue involved due to its predicted location at helix H (hH) opposite 
of the ‘breach’ cluster. One of the two proposals for HSP47-collagen binding interface also 
involves the hydrophobic region between β-sheet B, hA and hG/hH (Dafforn et al., 2001; 
Davids et al., 1995). This means that there is a possibility that W275 experiences the largest 
change in environment as HSP47 rearranges its structure during pH change. Unfortunately, 
this currently could not be determined due to the low solubility of this mutant construct. 
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Figure 3.12:  The changes in maximum emission wavelength of HSP47 WT and WF 
mutants during pH titration.  
Values were taken from averaged individual spectra recorded during pH titration. Curve 
fitting was performed with GraFit Pro v7.0.0. All curves are comparable after several repeat 
titrations. Arrows represents the progress of titration from high to low pH, while broken 
arrows indicate the inflection points. 
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Table 3.1: Summary of data for HSP47 WT and WF mutants.  
 
Mutation Melting 
temperature ± 
0.5°C 
Degree of residue 
solvent exposure1 
Fitting data 
Inflection point 
(pH)2 
WT 52.0 - 6.02±0.18 
W110F 53.0 30% 5.91±0.16 
W158F * 40% * 
W192F 52.0 3% 6.03±0.10 
W275F * 90% * 
W341F 54.0 30% 5.73±0.11 
*Data for W158F and W275F could not be collected due to low solubility or low purification yield. 
1Solvent exposure calculated from mouse HSP47 homology model, using ASA-View program 
(http://gibk21.bse.kyutech.ac.jp/netasa/asaview/). 100% represents a completely exposed residue. 
2Inflection point was calculated by fitting the change in λem with pH to a single ionisation model, with GraFit 
Pro v7.0.0. 
 
 
It has been suggested in Section 3.5 that the change in λem upon titration with pH is 
most probably due to the change in the microenvironment of the Trp residues due to 
structural rearrangement. Given the complex nature of intrinsic Trp fluorescence emission in 
proteins, there is also a possibility of interactions between a Trp residue and the neighbouring 
His residue that are mainly responsible for this instead of the actual structural change. The 
interaction between the imidazole and indole side chains of His and Trp residues respectively 
was reported by Shinitzky and Goldman (Shinitzky and Goldman, 1967), where the 
protonated His was found to quench the fluorescence of Trp moiety. Since then, this Trp-His 
pair has been demonstrated in various mutagenesis studies. For example in the case of 
barnase, where mutations of either residue in the neighbouring Trp-His pair abolished the pH 
dependent change of the intrinsic fluorescence (Loewenthal et al., 1991). With the same 
protein, Trp was later found to increase the pKa of a neighbouring His residue (Loewenthal et 
al., 1992) thus increasing its stability. The distance between the side chains of the two 
residues are 4.0 Å. The ability of Trp-His interaction to increase protein/peptide stability was 
then shown in the study using short α-helical peptides where certain positions of Trp and His 
residues along the peptide are preferable for stabilising effect (Fernández-Recio et al., 1997). 
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In the case of the hexadecapeptide anantin, protonated imidazole was found to be a better 
quencher of Trp fluorescence that the non-protonated form (Vos and Engelborghs, 1994) 
while the study with T4 lysozyme showed the opposite (Van Gilst and Hudson, 1996). This 
was suggested to be due to the non-ideal stereo arrangement of the neighbouring Trp and His 
residues during pH change that causes the fluorescence emission to increase instead of 
decrease.       
 In order to investigate the possible presence of important Trp-His pair in HSP47, the 
homology model was used to compute the closest distance between them. Mutation of either 
residue in the pair is known to completely abolish the pH transition when probed using 
intrinsic Trp fluorescence (Loewenthal et al., 1991). This means that W110, W192 and W341 
probably do not form pairs with neighbouring His residues that are ionised during HSP47 pH 
transition as mutation of each of them retains this behaviour (Figure 3.12). As for W158, the 
closest distance to a surface His residue is predicted to be 21.8 Å (H135, side chain-side 
chain) while the closest His residue is H140 (10.1 Å), while for W275 the closest surface His 
residue is H244, which is also the closest predicted His residue (20.5 Å) (Figure 3.13). As the 
effective distances suggested for a His and Trp residues to form pair is less than 8.0 Å (Jas 
and Kuczera, 2004), these suggest that the pairing between Trp residue and an important His 
residue might not exist in HSP47. These further suggest that the change in fluorescence 
properties observed during titration is due to the change in the environment of the Trp 
residues.         
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Figure 3.13: HSP47 homology model showing all five Trp residues (red) and all His 
(blue).  
The predicted closest distance between the side chains of W158 and H135 is 21.8 Å while 
with that of H140 is 10.1 Å. The distance between W275 and H244 is 20.5 Å. 
Trp and His residues are shown in ‘sticks’ representation. Atomic distances computed using 
Deepview Swiss-pdbViewer v4.0.1.  
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3.7 Conclusions 
 
In the previous chapter, mutational work on surface His residues revealed that perturbations 
in biophysical property are mostly observed when residues in the ‘breach’ cluster are 
mutated. This suggests the localisation of the residues plays a crucial role in triggering and 
controlling the transition from the collagen binding state (alkali) to its non binding state 
(acid). This chapter was aimed at further observing this mechanism by means of intrinsic Trp 
fluorescence change. Trp residue is widely used in observing structural changes in proteins as 
it responds to change in its microenvironment, and can be excited independently and separate 
from that of Tyr or Phe excitation. It turns out that much information could be obtained with 
this technique, especially for HSP47 which is among the least understood members of serpin 
superfamily. Firstly, even though Trp-to-Phe mutation is considered to be the most 
conservative mutation, it has the potential to decrease significantly the stability of the 
construct when expressed in E. coli, as in the cases of W158F and W275F mutations. 
Mutation of W110 seems to affect the environment of the other Trp residues. Finally, Trp 
reporter in the ‘breach’ cluster is possibly located in or close to the dynamic region during 
HSP47 pH-switch transition. Any behaviour that would go against this proposal was also not 
observed during the investigation on WF mutants. These further support the findings 
presented in Chapter 2, which were used to construct a model on HSP47 pH-switch 
mechanism as explained in Chapter 4. The results presented here could actually be improved 
should the soluble forms of W158F and W275F are obtained. This could be done by 
employing one of the techniques available for increasing protein solubility, e.g. engineering 
of surface hydrophobic residues or addition of fusion tags. Double and triple WF mutations 
have also been attempted to obtain a better identification of Trp residues responding the most 
to pH-change. This is also restricted by the poor solubility of the mutants constructed; hence 
it is not reported in the thesis.   
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Chapter 4 
Results and Discussion: A Proposed Model for HSP47 pH-switch 
Mechanism 
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CHAPTER 4: A PROPOSED MODEL FOR HSP47 pH-SWITCH MECHANISM 
4.1 Introduction 
Results from the His-to-Ala (HA) and Trp-to-Phe (WF) mutations are being put together in 
this chapter to propose a viable model for the pH-triggered release of HSP47 from its only 
substrate collagen. Full understanding of this behaviour is particularly desirable as it is 
currently widely-accepted that this is the only mechanism governing HSP47/collagen binding 
and release. Unlike many serpin superfamily members, HSP47 does not possess any protease 
inhibitory activity, which suggests a different reactive centre loop (RCL) conformation. But 
serpins usually share a high similarity in the main structural scaffold, especially the highly 
conserved β-sheet A, B and C and the α-helices. This similarity is useful in computational 
prediction of a reliable homology model of HSP47 in which known structures of serpins can 
act as templates. This provides critical information for proposing a binding and release 
mechanism of HSP47 while the three dimensional structures in its bound and unbound states 
have not been worked out yet due to difficulties in obtaining the crystal structure. In this 
chapter, previous reports on serpin structures and functions are reviewed and compared with 
our data for HSP47 presented Chapters 2 and 3 to provide a working model on HSP47 pH-
switch mechanism. This chapter also includes discussion on other proteins carrying similar 
functions as HSP47, which could enrich our understanding on the behaviour of this molecular 
chaperone. 
 
4.2 Role of the ‘Breach’ Region in Serpin Family Members and HSP47  
In Chapter 2, results obtained from our work suggest that both single and double mutations of 
His residues in the ‘gate’ and ‘shutter’ clusters do not significantly affect HSP47 pH-
triggerable release and thus unlikely to participate actively in the process. In addition, our 
study based on intrinsic Trp fluorescence titration in Chapter 3 finds these two clusters less 
dynamic compared to the ‘breach’ cluster. The mutation introduced at the ‘breach’ cluster 
perturbs normal HSP47/collagen interaction significantly. H191, which is predicted to be 
located at the s3A-s4C loop close to the A-sheet, suggests a possibly critical role in HSP47 
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pH-shift. Trp residues located in vicinity to the cluster are predicted to experience the largest 
change in their environment during secondary structural rearrangement, implying that the 
‘breach’ area is very dynamic, compared to the other two regions of HSP47.  
It is interesting to note that the ‘breach’ area is also considered to be important for 
various serpin functions, for example α1-AT.  Mutation of glutamic acid (Glu, E) residue at 
position 342 to lysine (Lys, K) results in the protein being accumulated in the ER of 
hepatocytes, impeding its transport to Golgi for further processing (Bathurst et al., 1984). 
E342 is located at the N-terminal end of strand 5 of β-sheet A, known as the proximal ‘hinge’ 
region of serpin (Kaiserman et al., 2006). This region is the first RCL point-of-entry during 
insertion into β-sheet A for the conversion from native inhibitory to latent form. E341K 
mutation increases the propensity of α1-AT to polymerise probably due to the loss of side 
chain interactions, via insertion of RCL of one molecule into β-sheet A of another molecule 
(so called ‘head’ to ‘tail’ polymerisation) (Lomas et al., 1992).           
Another highly conserved ‘breach’ residue is tryptophan at position 175 of 
plasminogen activator inhibitor-1 (PAI-1) (Blouse et al., 2003). The residue, which is found 
in virtually all known serpins, is located at the N-terminal end of strand 3 of β-sheet A (s3A). 
W175 of PAI-1 is homologous to W192 of mature mouse HSP47 in our predicted model. As 
observed for HSP47, W175F mutation does not cause any significant perturbations in the 
folding of PAI-1 upon expression. PAI-1 is known to exhibit a spontaneous transition from 
‘stressed’ to ‘relax’ conformation (S-to-R) under certain physiological conditions (Carrell et 
al., 1991; Mottonen et al., 1992). The mutant was found to have a stabilised ‘stressed’ 
conformation, even though the association of target proteinase is unaffected. When reacted 
with several substrate proteinases, it was found that W175F/PAI-1 exhibits a significant drop 
in the limiting rate of one proteinase inhibition in particular, namely the tissue-type 
plasminogen activator (tPA). It was postulated that this is due to the disruption of amino acid 
interactions in the breach region of PAI-1, that are responsible for tight exosite interactions 
with the basic residues on tPA loop and as a result, controlling the reversible deacylation of 
P1´ amino acid of RCL and preventing its release from the substrate tPA. The disruptions 
restrict the forward reaction rates and decrease the limiting rate of tPA inhibition by mutant 
PAI-1 (Blouse et al., 2003). Even though this behaviour is not studied in HSP47, it 
demonstrates the importance of the ‘breach’ cluster to inhibitory serpins, and very likely to 
any serpin family members in general. 
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In another study on PAI-1, various mutations introduced in the ‘breach’ cluster and its 
adjacent region cause a change in activity of the protein (Sui and Wiman, 2000). Other than 
the ‘breach’ cluster, the region targeted is the β-sheet B, particularly strands 2 (s2B) and 3 
(s3B). Among the notable effects of ‘breach’ residue modifications is the increased stability 
of the resulting mutant, such as Y228S and T232F which are located on the s2B-s3B loop. 
This is probably due to restriction on RCL insertion caused by the change in the environment 
around those residues. A more significant finding is the involvement of H229 in the pH 
stability effect of PAI-1. PAI-1 was reported to have increased stability at slightly acidic pH, 
than at neutral or alkaline pH. Like HSP47, histidine imidazole group is suggested to be 
responsible for this (Kvassman et al., 1995). Mutation of H229 decreases the stability of PAI-
1 at acidic to about two-fold to that of at alkaline pH, instead of the normal ten-fold increase 
in stability (Sui and Wiman, 2000). H229 is located in the s2B-s3B loop, very close to the 
predicted location of H191 in HSP47 at the C-terminal end of s3A in our homology model. 
Although no pH-switch function has been observed with PAI-1 so far, the fact that the 
‘breach’ residue ionised to help stabilise PAI-1 at acidic pH is a notable finding. This could 
be related to our finding that the His residues in the ‘breach’ cluster in HSP47 play an 
important role in the mechanistic behaviour. The pH regulation of PAI-1 is said to be 
important in stabilising PAI-1 in the cells (pH approximately 6.8) in the event of blood flow 
obstructions to active tissues that lead to acidification via CO2 accumulation and metabolic 
shift towards fermentation (Kvassman et al., 1995).      
As also discussed in Chapter 3, in antichymotrypsin (ACT), the ‘breach’ residue 
W194 is shown to be the main residue that controls the rate of ACT polymerisation (Pearce et 
al., 2007). W194 is located at the N-terminus of RCL, which is also the C-terminal end of 
s3A. Again, this is the exact region where important residues for serpin function should be 
found. Like the residue E342 in α1-AT (Lomas et al., 1992), W194 of ACT is probably 
responsible for preventing serpin polymerisation by increasing the kinetic barrier or 
misfolding.  
It is clear from the works described above that amino acids in the ‘breach’ cluster are 
indispensable for normal serpin functions. These include preventing polymerisation in the 
case of α1-AT and ACT, controlling the formation of latent conformation and proteinase 
binding in PAI-1 and being responsible for low pH-induced stability in PAI-1. In many other 
inhibitory serpins, this region is considered to be the first point-of-contact for RCL 
  
159
translocation before insertion into β-sheet A despite the absence of a more detailed 
mutational work. At the same time, the ‘breach’ residues are also responsible for other 
secondary functions, as proved by the work explained above. For non-inhibitory serpins, 
there are limited mutational works performed to confirm a similar role of residues in the 
‘breach’ cluster as with their inhibitory counterparts, though a few computational studies 
reported tend to support this. 
An example is in the study of pigment epithelium derived factor (PEDF), its structure 
has been discovered relatively recently compared to other serpins (Simonovic et al., 2001). It 
is found as a component of the retinal inter-photoreceptor matrix as well as in the vitreous 
and aqueous liquid in the adult eye (Simonovic et al., 2001). It is also reported to have 
neutrophic and antiangiogenic functions. Computational work done on several sequences of 
this serpin from different species revealed conserved residues in the area predicted to be 
located in the ‘breach’ region (Tombran-Tink et al., 2005). For example Glu at position 342, 
which is homologous to E342 of α1-AT, is highly conserved in PEDF from all species except 
one. It is also found to be conserved in many sequences of non-inhibitory serpins too 
(Tombran-Tink et al., 2005). Given that non-inhibitory serpins probably evolved from their 
inhibitory relatives, it is likely that some structural-related functions are preserved. 
 
4.3 A Proposed Mechanistic Hypothesis of HSP47 Release from Collagen 
The previous chapters have established the significant involvement of His residues in the 
‘breach cluster’ in HSP47 pH-switch behaviour. It is very likely that side chain protonation 
triggers re-arrangement of secondary structures, making this cluster more dynamic than 
others. This then triggers the shift in conformation of the region near collagen binding 
interface causing HSP47 release.  
Homology model predicted that three solvent-accessible His residues are located in 
the ‘breach cluster, namely H191, H197 and H198. A fourth residue, H244 may also be 
located in this cluster and participate in the active mechanism. Analyses on the H244A 
mutant (as presented in Chapter 2) though suggest otherwise. No significant physical 
perturbation can be seen in the structural stability or the pH-induced structural transition. For 
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this reason, all or one of the His residues mentioned above is very likely to be the active 
residue(s) involved.    
H191 is suggested to influence the release of HSP47 from collagen, as its absence 
triggers dissociation at higher pH, based on the gelatin column and CD experiments as 
reported in Chapter 2. This does not abolish dissociation altogether, implying that there are 
some other residues responsible for triggering the release. In the process of identifying these 
‘auxiliary’ residues, mutations were performed on other surface-predicted His residues 
covering various locations of HSP47. In the ‘gate’ cluster, mutations of H255 and H256 do 
not significantly alter the properties of the mutant. This includes its secondary structural 
content and gelatin/collagen binding and release property. This cluster is located in vicinity to 
the flexible loop connecting s3C and s4C critical in the conversion of PAI-1 from native to 
latent structure (Stein and Carrell, 1995). Its opposite location to the ‘breach’ cluster suggests 
that it may play an important part, but experimental result reveals otherwise. Finally the 
‘shutter’ cluster, which is found near the centre of sheet A centred at the start of helix B 
(Stein and Carrell, 1995) accommodating H302 and H135 was found to have little influence 
on collagen binding/release behaviour of HSP47. 
These suggest that only His residues in the ‘breach’ cluster are responsible for the pH-
triggered conformational rearrangement of HSP47 that leads to dissociation from collagen. 
Other than H191, it is likely that H197 and H198 also participate actively in this process on 
two bases: first, the vicinity of these two residues to H191 in HSP47 homology model; and 
second, the effect of mutation of these residues on HSP47 collagen-specific recognition to 
withstand thorough washing in column experiment. However, the direct involvement of these 
residues in the release mechanism could not currently be confirmed as the mutants are not 
available for further analysis. 
The proposed mechanism for HSP47 pH-switch action that triggers dissociation from 
collagen is depicted in Figure 4.1. The simplified diagram only shows the residues pertinent 
for the proposed mechanism, namely H191, in its non-ionised and ionised states. It is also 
based on the prediction of surface His residues according to the constructed homology model 
described earlier in the thesis. At alkaline pH, HSP47 is in its binding state and binds 
collagen at the binding groove/interface. The interface is probably at a different site than the 
‘breach’ cluster, based on the results from the collagen/gelatin binding assay of the mutants 
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(Chapter 2). As proton concentration increases, certain His residues begin to be ionised at pH 
5.9-6.0. Ionisation triggers electrostatic repulsion of their neighbouring positively-charged 
residue(s) and exposure of the side chains to more hydrophobic environment. This triggers 
the formation of a partially non-binding state but is insufficient to proceed to a dissociation of 
collagen molecule. As pH decreases further to 5.7, H191 is in turn ionised and can now 
trigger a sufficient conformational rearrangement causing its release from collagen. This is 
supported by the analyses made with H191A mutant, where it is found to release collagen 
binding at a slightly higher pH value. This conformational rearrangement is complete as pH 
reaches 5.3 where full acid conformation is adopted, based on the minimal secondary 
structural changes at pH lower than 5.3 from CD experiment.  
The mechanism is suggested from the observations made from our HSP47 HA 
mutation work, in particular of H191A. There is also a possibility that full acid state is not 
adopted in the cis-Golgi before HSP47 is recycled back to the ER in vivo. This is because the 
cycle demands rapid structural rearrangement back to alkali, collagen-binding state for 
HSP47 to continue its chaperone function in the ER. The ER-Golgi transport cycle is 
illustrated in Figure 4.2.  
  WT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Schematic representation for the proposed mechanism of the concerted 
action of His residues in the breach cluster in controlling HSP47 pH-switch mechanism. 
The mechanism is based on the mutanegesis work performed on all surface His residues 
predicted from homology model. pH values might differ in different experimental conditions 
though the magnitude is unlikely to. 1. At alkaline pH, all the ‘breach’ residues are non-
ionised and allow the cluster to stay intact. Hydrophobic interactions with neighbouring side 
chains are also possible (black). 2. Binding to collagen triple helix at alkaline condition. 3. 
Upon decrease in pH to 5.9, the side chains of other residues start to ionise and perturb the 
region around the cluster slightly but insufficient to allow dissociation. 4. As pH reaches 5.7, 
H191 subsequently ionises and allows full rearrangement to non-binding state. 5. HSP47 then 
dissociates from collagen, before adopting binding state again at suitable pH condition.
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Figure 4.2: Anterograde transport of collagen from ER to Golgi apparatus and 
retrograde transport mechanism to recycle collagen-bound HSP47 back to ER. 
Adapted from (Paroutis et al., 2004; Vitale and Denecke, 1999). 
 
 
 
163
  
164
4.4 Possible Effects of ‘Breach’ His Residue Mutations to Cellular Processes: Case 
Study on Other Proteins  
Mutations of the His triad in the ‘breach’ cluster were found to perturb HSP47 mechanism 
significantly. H191 is one of the important residues crucial for pH release as its absence 
increases HSP47 sensitivity to pH and triggers release from collagen at a higher pH values. 
As accurate and concerted release of HSP47 from collagen triple helices is crucial during 
biosynthesis, by extrapolation, mutation of H191 can be detrimental to the process. Although 
cellular work is out of the scope of this thesis, it would be very comprehensible to summarise 
the findings up-to-date by discussing some similar studies conducted elsewhere to suggest 
effects of mutations on HSP47-expressing cells.   
It is known that HSP47 binds collagen chain in the ER and assists in the stabilisation 
of the nascent triple helix. Then the HSP47-collagen complex is transported to the Golgi 
apparatus, before HSP47 dissociates from the properly folded collagen. Although the exact 
dissociation location is not yet determined, it has been speculated that it occurs either in the 
cisternal space of cis-Golgi or in the ER-Golgi intermediate compartment (ERGIC) (Nagata, 
2003). HSP47 is then recycled back to the ER via retrograde transport pathway by receptors 
that recognise the C-terminal RDEL ER-retention signal sequence (Figure 4.3). One of the 
receptors that have been identified is erd2, a 26 kDa Golgi membrane protein that was 
initially discovered as the ERD2 gene product in yeast Saccharomyces cerevisiae. The name 
is an acronym of ER retention-defective complementary group 2  (Lewis et al., 1990). erd2 
has been demonstrated to be localised mainly in the cis-Golgi compartment (Elmendorf and 
Haldar, 1993).  
The pH of the Golgi apparatus is variably reported to be in the slightly acidic to near 
neutral region (pH 5.7 to 6.7) (Kim et al., 1996; Paroutis et al., 2004; Wu et al., 2001). The 
accurate method for the measurement of the actual pH value in the cis-Golgi, and the 
secretory pathway generally, is still being actively investigated. One report suggests that pH 
of the ER is around 7.1 demonstrated in resting HeLa cells while that in the Golgi complex is 
reported to be between pH 6.3-6.5 (Kim et al., 1996; Kim et al., 1998). The affinity of erd2, 
as an important component of the secretory pathway, is known to be also affected by pH.  Its 
binding is most optimum at pH between 5.0 and 5.5 (Wilson et al., 1993). This explains its 
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function in retrieving ER resident proteins in Golgi. Upon retrograde transport back to ER, 
the proteins are liberated from the receptor due to the neutral pH condition of ER 
compartment (Figure 4.3). This drop in pH along the secretory pathway is said to be due to 
the increase in active proton pump density (Wu et al., 2001). Also as the mechanism of 
binding-and-release action of erd2 to its partners is mediated by pH difference, it is 
interesting to note that this behaviour is completely opposite to that of HSP47 in terms of pH 
condition (Wilson et al., 1993). In addition, this complex is influenced by other factors such 
as aggregation state of the receptor in the ER and Golgi, or the regulation by ionic 
constituents in Golgi. The latter is taken into consideration as Asp residue in the hydrophilic 
KDEL-binding pocket of erd receptor has been shown to form direct pairing with positively-
charged residue at position -4 from the C-terminus of the ligand (position K in KDEL 
sequence). This position is interchangeably occupied by Arg, Lys or His in different ligands 
(Scheel and Pelham, 1998). 
The multiple function of His residue in pH-control, substrate binding and others has 
been observed before, even in non-ER/Golgi related proteins. For example in the human 
P2X4 purinoreceptor, where mutation of one His to Ala not only abolishes the pH sensitivity 
of the receptor, but also has some effect on its ligand binding. P2X channels mediate fast 
excitatory actions of ATP when it is co-released with other transmitters in the central and 
peripheral nervous systems. There are many different isoforms of the P2X receptor that have 
been found, which involve in the modulation of ATP-gated channels and therefore regulate 
synaptic transmission. Mutant P2X4 carrying H286A mutation, located on the extracellular 
side of the channel, abolishes its sensitivity of the ATP-activated current upon decrease in 
extracellular pH (Clarke et al., 2000).   
A more significant case on ER resident proteins has been reported concerning the 
receptor associated protein (RAP), which is a chaperone of the low density lipoprotein 
receptor (LDLR) family. It is a three-domain, 39-kDa chaperone and each domain carries a 
different function. Generally, it inhibits undesirable premature interaction of the LDL 
receptor family and their ligands in the ER and also facilitates the delivery of newly-
synthesised LDLRs to the cell surface (Willnow et al., 1995; Willnow et al., 1996). The latter 
function is reported to involve a single domain of RAP, namely domain 3 (D3). Very much 
like HSP47, RAP dissociates from LDLR in the Golgi apparatus prompting the suggestion of 
His-controlled mechanism as its possible mechanism of release. The structure of D3 has been 
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solved using NMR, and it revealed the highly-helical content of the chaperone. Its surface 
charge distribution is found to increase significantly at pH lower than 6.5 further supporting 
the His switch hypothesis (Lee et al., 2006). In addition, mutation of His residues in D3 
impairs the dissociation from its client at low pH. This then affects the secretion of LDLR 
outside of the cell. The reason of this probably involves cellular degradation process of the 
RAP-LDLR complex (Estrada et al., 2008). It was also found that in cells transfected with 
RAP carrying D3 mutant His, RAP and LDLR co-localise in the ER. There is a suggestion 
that mutant RAP-LDLR complex is recycled back to the ER via anterograde transport action 
of KDEL-receptors, as its export to the Golgi is shown to be unaffected (Lee et al., 2006). It 
is still not known whether the degradation of the aberrant complex involves the ER-
associated degradation (ERAD) pathway or another degradation mechanism in the cytoplasm.         
 From these studies, there could be an adverse effect on collagen biosynthetic pathway 
of HSP47 upon mutating its critical His residues. Dissociation of HSP47 from correctly 
folded collagen triple helix usually occurs in the Golgi complex or in the ER-Golgi 
intermediate compartment. These compartments definitely have specific pH values, just like 
many other cellular compartments, in order to regulate cellular functions. For that reason, 
premature release of mutant HSP47 from collagen will probably expose the folded collagen 
molecules to degradation due to lack of chaperone to help in stabilisation. This could in turn 
affect the transport of collagen in vivo leading to disrupted formation of extracellular 
matrices, which is potentially lethal.   
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4.5 Conclusion 
This chapter compiled the data obtained from the experimental work presented in the two 
previous chapters. After examining the significance of the ‘breach’ region to serpin structure 
and function, a working model on the mechanistic behaviour of HSP47 during pH-release 
from collagen was proposed. The model is built on the structural rearrangement experienced 
by the region around His residues located in the ‘breach’ cluster, based on findings described 
from Chapters 2 and 3. This chapter also presents the proposed effect of the rearrangement, 
induced by pH change, to HSP47 binding and release behaviour. This model is still at its 
infancy and is constructed based on the knowledge gained from experiments using the 
techniques available in our laboratory. Although far from being a complete model, this is the 
first to date explaining HSP47 pH-switch mechanism, which is the only mechanism known to 
govern HSP47 release from collagen. Finally, a thorough literature review was conducted to 
outline the possible effects of His mutations on cellular behaviour in order to help guiding 
future experiments and investigations on cellular mechanism of HSP47 during collagen 
biosynthesis, until a new study comes to light. 
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CHAPTER 5: FUTURE DIRECTIONS 
5.1 Construction of More His Mutants to Validate pH-switch Model 
The model presented in Chapter 4 is proposed based on the observations made on eight His-
to-Ala mutants targeting eight residues (six single and two double mutants). These are the 
residues predicted to reside at solvent accessible locations of HSP47 molecule. In order to 
validate and confirm the model, a further six mutants could be constructed targeting the other 
residues (H90, 140, 220, 297, 335 and 368). Analyses on the mutants will provide more data 
for considerations towards the pH-switch model, and confirm their predicted locations at the 
non-solvent accessible locations of HSP47 homology model. 
 
5.2 Determination of HSP47-collagen Binding Interface 
Like many non-inhibitory serpins, the binding interface of HSP47 to its partner is still 
unknown. Earlier on, Chapter 2 presented two proposals made for HSP47/collagen binding 
site and interface (Dafforn et al., 2001; Koide et al., 2006a). These two models still have 
plenty of room for improvements. Hence it is of interest to investigate this further, using 
either mutagenesis technique; or co-crystallisation of HSP47 with short collagen mimetic 
peptides with desirable binding motif. In the first approach, all hydrophobic residues 
predicted to be located near the ‘breach’ region and the putative collagen binding groove of 
sB-hA-hG-hH could be mutated. This will probably involve 10-15 mutants.  
In the second approach, the binding of HSP47 to CMPs is known to be quite weak (Kd 
in the μM to nM range). So in order to withstand crystallisation, a stronger HSP47 binding 
motif can be engineered into the CMPs. One residue, namely Arg, is now known to be the 
preferred residue for HSP47 recognition (Koide et al., 2002). The knowledge of collagen 
binding interface will be very useful to guide research on the development of small molecules 
to inhibit collagen expression by blocking the chaperoning action of HSP47. This is actually 
one of the strategies actively investigated in the treatment of fibrotic diseases, alongside 
HSP47 siRNA and oligonucleotides.  
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5.3 Crystallisation and Three-dimensional Structure Determination 
Before co-crystallisation of HSP47 with collagen peptide can be done, the crystallisation of 
HSP47 alone should be attempted. HSP47 is known to be highly resistant to crystallisation, 
mainly due to aggregation problem at high concentration, from our experience. So in order to 
overcome this problem, several strategies can be attempted. Firstly, engineering of HSP47 to 
allow expression in high concentration but retains solubility. Several surface residues can be 
targeted, without affecting the important regions such as the ‘breach’ region known to be 
important for its function. Surface hydrophobic residues can be engineered to hydrophilic 
residues, for example. Secondly, by optimising HSP47 solubility using various protein tags 
commercially available, such as the NusA tag (Novagen). Various additives, such as amino 
acids, can also be attempted during cell lysis. Once high solubility is ensured, crystallisation 
can be attempted. NMR spectroscopy can also be tested, especially on the quality of signal 
when HSP47 sample is run. With the advent of state-of-the-art NMR techniques, more 
proteins can be investigated in this way. 
 
5.3 Investigation on the Effect of Specific His-to-Ala Mutation of HSP47 Behaviour 
in the Cell and Animal Model 
As discussed at the end of Chapter 4, it is interesting to know the effect of His mutation of 
HSP47 on normal collagen synthetic pathway. This is achievable using collagen expressing 
cells, for example the mouse embryonic fibroblast (MEF) is among the most widely-used 
cells for HSP47-related cell work. Then mutant plasmids can be engineered before 
transfection into the cells. The localisation of collagen and HSP47 molecules can be detected 
using cell stains labelled with collagen/HSP47 specific antibodies. Once the behaviour in the 
cell is established, the work can be further extended to include animal model. A good starting 
point for such work is the study reported by Nagai and co-workers (Nagai et al., 2000), which 
demonstrates the requirement of HSP47 for the normal development of mice, using gene 
targeting vector delivered into mouse strain C57BL/6J. Although the study uses gene knock-
out technique targeting hsp47 gene, site-specific mutations on mouse model has been 
documented on other diseases (Bedell et al., 1997; Simmons, 2008). If successful, the finding 
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will corroborate results obtained from in vitro experiments detailed in this thesis, with various 
potential contributions to the study of collagen-related diseases and abnormalities. 
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CHAPTER 6: MATERIALS AND METHODS 
 
6.1 Materials 
Unless otherwise indicated, all commonly used chemicals and reagents were of analytical 
grade and obtained either from Sigma-Aldrich, VWR, Fluka or Merck.   
 
6.2 Bacterial Strains  
Three strains of E. coli were used in this study. Their genotypes are listed below, obtained 
from EcoliWiki database (http://ecoliwiki.net/colipedia/index.php/Welcome_to_EcoliWiki) 
and also from OpenWetWare 
(http://openwetware.org/wiki/E._coli_genotypes#BL21.28DE3.29): 
DH5α: huA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 
thi-1 hsdR17. Used mainly in mutagenesis for plasmid propagation and mutant screening 
works, and also for long-term plasmid maintenance. 
BL21(DE3)pLysS: F- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) pLysS(cmR). A high 
stringency expression host cell, contains the pLysS plasmid that encodes T7 phage lysozyme, 
which is an inhibitor for T7 polymerase which reduces and almost eliminates basal 
expression from transformed T7 promoter containing plasmids when not induced with IPTG.  
BL21(DE3): F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 
nin5]). Non pLysS-containing host. Less stringent than BL21(DE3)pLysS, for higher 
expression level.  
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6.3 Site Directed Mutagenesis of Mouse HSP47 Gene 
This study used the mouse HSP47 gene, the sequence of which has been deposited to 
GeneBank with an accession number X60676.1 (Hosokawa et al., 1993; Takechi et al., 1992). 
The mouse HSP47 cDNA was amplified by PCR using 5´ and 3´ primers with HindIII and 
NdeI restriction sites, respectively. Subsequently, the gene was cloned into the pET-24b(+) 
vector (Novagen) for HA mutants or pET-21a(+) (Novagen) for WF mutants, which 
contained the equivalent restriction sites. pET-21a vector was engineered to allow a co-
expression of a six-histidine tag (His-tag) to the N-terminal of the recombinant protein while 
pET-24b was engineered for expression of a non His-tagged protein. The former carries 
ampicillin-resistance (ampR) gene while the latter is kanamycin resistant (kanR). Both are low 
copy number vectors to avoid too high expression which can result in HSP47 aggregation. 
The presence of T7lac promoter system allows the use of IPTG to induce protein expression. 
All the cloning works have been done previously and the plasmids were kindly supplied by 
Dr Takayuki Homma (pET-21a) and Dr Dee Olerenshaw (for pET-24b) (Imperial College 
Genetic Therapies Centre, UK). In pET-24b(+), the protein is expressed with an initial 
vector-derived Met before the start of the first amino acid of the mature HSP47 sequence Ala, 
with 400 amino acids altogether from the first Ala to the final Leu. This is similar in pET-
21a(+) vector, with an additional six His tag at the N-terminus, and a linker region between 
the tag and the Met residue. 
Mutations were introduced using the method developed by Sawano and Miyawaki 
(Sawano and Miyawaki, 2000) with DH5α as the E. coli host. Table 6.1 shows the primer 
sequences to construct the mutants. Primers were initially phosphorylated at their 5′ end using 
T4 polynucleotide kinase (New England Biolabs). PCR reactions were carried out in a 50 µL 
total reaction volume using 1 µL of 40-50 ng/μL template plasmid, 7 µL of 2 pmol/ μL of 
primer, 1 µL of 2.5 mM of dNTPs, 1 µL of 2.5 U/µL of Pfu DNA polymerase (Stratagene) in 
0.5× Pfu polymerase reaction buffer, and 0.5 µL of 20 U/µL of Taq DNA ligase (New 
England Biolabs, MA, USA) in 0.5× Taq DNA ligase buffer. The thermal cycler 
(Mastercycler Gradient, Eppendorf) was programmed as follows: pre-incubation at 65°C for 
5 min allowing the ligase to repair any nicks in the template; initial denaturation at 95°C for 2 
min; then 23 amplification cycles (denaturation at 95°C for 10 sec, annealing at 55°C for 30 
sec and elongation at 65°C for 13.5 min); and finally post-incubation at 75°C for 7 min. Then 
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1 µL (10 U/µL) of DpnI (Stratagene) was added to the 50 µL reaction mixture, and incubated 
at 37°C for 1 h. For non-mutant strand synthesis, the reaction mixture was then subjected to 
denaturation at 95°C for 30 sec, followed by 2 cycles of (95°C for 30 sec, 55°C for 1 min and 
70°C for 13.5 min), then finally 75°C for 7 min for final extension (Sawano and Miyawaki, 
2000). 10 µL of the final sample was used for transformation into chemically-competent 
E.coli DH5α cells. 
Single E. coli colonies were picked from LB agar plate with appropriate antibiotics 
and 0.4%(w/v) of glucose, and inoculated into sterile 100 mL LB broth containing the same 
antibiotics. Plasmid isolation and purification were carried out using the EZNA Plasmid 
Isolation Kit Midi (Omega Biotek) according to manufacturer’s instruction. DNA 
concentration was measured using the NanoDrop ND-1000 (NanoDrop). Typical DNA yield 
is usually around 100-200 ng/µL with good purity (A260/A280 > 1.8). The plasmid samples 
were sequenced to screen for positive mutants. Each positive mutant construct was then 
sequenced again to confirm the presence of a unique mutation and no other mutations 
between the promoter and terminator regions. Sequencing service was provided by Beckman 
Coulter Genomics (UK). Mutagenesis efficiency varies, but normally between 10-50%. 
HA mutants were expressed in E. coli BL21(DE3)pLysS (Promega) and WF mutants 
were expressed in BL21(DE3) (Invitrogen) hosts . 
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Table 6.1: Primers used for mutagenesis reactions.  
Target amino acids mutated are underlined. Primers were custom synthesised by MWG 
Biotech (Germany) or Invitrogen (UK). 
 
Target mutation Primer sequence 
H135A 5΄- CAGCAGCAAGCAAGCATACAACTGCGAAC 
H191A 5΄- ATGTTCTTTAAGCCAGCATGGGATGAGAAGTTT 
H197A 5΄- CACACTGGGATGAGAAGTTTCACGCAAAGATGGTGG 
H198A 5΄- CACACTGGGATGAGAAGTTTGCACACAAGATGGTGG 
H197A:H198A 5΄- CACACTGGGATGAGAAGTTTGCAGCAAAGATGGTGG 
H244A 5΄- GATGCCCCTGGCTGCAAAGCTCTCCAGC 
H255A:H256A 5΄- GCCTCATCATCCTCATGCCCGCAGCAGTGGAGCCGC 
H302A 5΄- CATGACCTGCAGAAAGCCCTGGCAGGA 
W110F 5΄- ACTGCGCGCAACGTGACCTTTAAACTGGGCAGCCGC 
W158F 5΄- TCCATCAACGAGTTTGCCTCGCAGACCACG 
W192F 5΄- TTCTTTAAGCCACACTTTGATGAGAAGTTTCAG 
W275F 5΄- GAGCAGCTGAAGGCCTTTATGGGAAAGATGCAGAAG 
W341F 5΄- ACTGCCTTCGAGTTCGACACCGAGGGCAAC 
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6.4 Preparation of Chemically-competent E. coli Cells and Transformation 
E. coli cell stock was first cultured in 2 mL of 2×YT medium (tryptone 16 g, yeast extract 10 
g, NaCl 5 g, deionised water 1 L) or LB medium (tryptone 10 g, yeast extract 5 g, NaCl 10 g, 
deionised water 1 L) for DH5α, while supplemented with 0.2%(w/v) glucose (for 
BL21(DE3)) and 20 µg/mL chloramphenicol (for BL21(DE3)pLysS). The culture was grown 
at 37°C with shaking overnight before 1 mL of the culture being transferred into 100 mL of 
fresh medium with glucose and/or antibiotics. Cultivation was continued at 37°C until optical 
density at 600 nm (OD600) reached 0.3. The culture was then aliquoted out into 50 mL Falcon 
tubes and placed on ice for 5 min. E. coli cells were collected by centrifugation at 4000 rpm 
with ALC T534 rotor (ALC) for 10 min. The resulting pellet was resuspended in 20 mL of 
sterile TfbI solution (30 mM potassium acetate, 100 mM RbCl, 10 mM CaCl2, 50 mM 
MnCl2, 15%(v/v) glycerol, pH 5.8) by vortexing. The suspended cell solution was placed on 
ice for 5 min, before being centrifuged as above. The pellet was again resuspended in 2 mL 
of sterile TfbII solution (10 mM PIPES, 75 mM CaCl2, 10 mM RbCl, 15%(v/v) glycerol, pH 
6.5) before being placed on ice for 15 min. The cell suspension was finally dispensed into 
sterile, ice-cold 1.5 mL Eppendorf tubes in 100 µL aliquots and quick-frozen in liquid 
nitrogen before storage at -80°C. 
 Plasmid was transformed into the competent E. coli by adding 0.5-1 µL (or 10 µL 
from mutagenesis reaction) into the frozen cells and placed on ice for 30 min. The tube was 
heat shocked at 42°C for 1 min and returned to ice for another 2 min. Then 1 mL of LB broth 
was added, supplemented with 0.2%(w/v) glucose and 20 mM MgSO4 and grown at 37°C for 
1 h with shaking. The cells were finally plated out on LB agar with glucose and appropriate 
antibiotics and incubated at 37°C overnight. 
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6.5 Bacterial Cultivation and Preparation of HSP47 Crude Sample 
Recombinant E. coli containing WT and mutagenic HSP47 gene was grown on media with 
25 µg/mL kanamycin for BL21(DE3) and both kanamycin and 20 µg/mL chloramphenicol 
for BL21(DE3)pLysS. A loopful of glycerol stock, originally stored at -80°C was scraped off 
and inoculated into a pre-culture of 2×YT medium supplied with appropriate antibiotics and 
0.2%(w/v) of glucose. The culture was incubated at 37°C with shaking at 180 rpm overnight. 
The pre-culture was then inoculated into a larger culture in a volume ratio of 1:20 of a 1 L of 
the same medium with the same antibiotics but without glucose. The main culture was 
incubated at 20°C, 180 rpm until the OD600 reached 0.3 before IPTG was added (0.1 mM of 
final concentration) and continued for further 12-18 h. The cells were then harvested by 
centrifugation at 4000 rpm with GS-3 rotor (Sorvall) for 10 min. When necessary, the pellet 
was resuspended in saline solution (8.4 g/L) and centrifuged at 4,000 rpm with ALC T534 
rotor (ALC) for 15 min before storing at -80°C. For lysis, cell pellet was resuspended in lysis 
buffer (50 mM sodium phosphate pH 8.0, 500 mM NaCl, 0.02%(v/v) Triton X-100, 3 mM β-
mercaptoethanol), supplemented with Complete Mini EDTA-free protease inhibitor tablet 
(Roche, Germany). The inhibitor cocktail contains broad spectrum inhibitors of serine and 
cysteine proteases. Bacterial lysis was carried out using sonication on ice (total sonication 
time of 1.5 min per cycle and the cycle repeated twice, with 5 min of resting period between 
cycles, at 20% amplitude) with a VCX400 sonicator (Sonics and Materials, Inc). When 
needed, DNaseI (Roche) was added to 0.1 mg/mL final concentration with 2 mM MgCl2 
followed by 15 min incubation at on ice. The resulting lysate was then centrifuged at 16,000 
rpm with SS-34 rotor attached to RC-5B Plus centrifuge (both are from Sorvall) for 40 min at 
4°C. The supernatant was filtered through a 0.2 µm syringe filter and purified using the 
gelatin-agarose column, or the HisTrap HP immobilised nickel affinity column (GE 
Healthcare).   
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6.6 Gelatin-agarose Purification of HSP47 
HA mutants were purified using the gelatin-agarose affinity chromatography. Gelatin-agarose 
(Sigma-Aldrich) was packed into a 5 mL HR16/5 column (GE Healthcare) and packed 
columns were stored at 4°C until further use. Before purification, the columns were 
equilibrated with cold buffer A (50 mM sodium phosphate, 100 mM NaCl, pH 8.0) for about 
5 column volumes (CV). All buffers were degassed. The flow rate was fixed at 1 mL/min for 
this step and all the subsequent steps, using the Fast Protein Liquid Chromatography (FPLC) 
system (Pharmacia Biotech). Filtered supernatant was loaded into the column (kept on ice) 
and washed using buffer A before being eluted with a 14 CV gradient of buffer B (50 mM 
sodium phosphate, 100 mM NaCl, pH 4.1). Fractions were collected at 2 mL per fraction and 
the high pH was restored with 200 μL of 1 M sodium phosphate pH 8 before being stored at 
4°C. The columns were then washed and re-equilibrated with buffer A for about 5 CV before 
being stored at 4°C in 20%(v/v) ethanol. 
 
6.7 Immobilised Nickel Affinity Chromatography Purification of HSP47 
WF mutants were purified using the HisTrap HP nickel sepharose column (1 mL) (GE 
Healthcare) according to the manufacturer’s protocol. Before use, the column was first 
washed with 3-5 column volumes (CV) of distilled water. Then it was equilibrated with at 
least 5 CV of binding buffer 50 mM sodium phosphate, 150 mM NaCl, 20 mM imidazole, pH 
8.0) at a flow rate of 1.5 mL/min. Then the filtered supernatant was applied before being 
washed with binding buffer for at least 10-15 CV. Finally, the bound protein was eluted with 
elution buffer (50 mM sodium phosphate, 150 mM NaCl, 250 mM imidazole, pH 8.0) using a 
linear gradient of 30 CV. After 3-4 purifications, the column was stripped with stripping 
buffer (20 mM sodium phosphate, 500 mM NaCl, 50 mM EDTA, pH 7.4) and recharged with 
100 mM NiSO4. 
Imidazole was removed using HiPrep 26/10 desalting column (GE Healthcare) 
equilibrated and eluted with same buffer as the gelatin-agarose column wash buffer.  
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6.8 Determination of Protein Concentration 
Protein concentration was determined using either Bichinchoninic Acid (BCA) Assay Kit 
(Sigma-Aldrich) or calculated from the absorbance at 280 nm using the Beer-Lambert law 
with the molar extinction coefficient of 42,400 M-1cm-1 calculated using ProtParam 
(Gasteiger et al., 2005).  
 
6.9 Protein Visualisation using Denaturing SDS-PAGE 
Samples for SDS-PAGE analysis were initially mixed with the 2× Novex Tris-glycine SDS-
PAGE sample suffer (Invitrogen) and 5%(v/v) of β-mercaptoethanol (β-ME) followed by 
heating at 95°C for 5 min before loading into the wells of a pre-cast 12% SDS-PAGE gel and 
electrophoresed at 200 V for 70 min in 1× Tris-glycine SDS-PAGE tank buffer (25 mM Tris, 
192 mM glycine, 0.1% SDS, pH 8.3) (Fermentas). The gel was then stained with Coomassie 
Brilliant Blue stain for 1 h and de-stained with MilliQ water overnight.  
 
6.10 Immunoblotting Analysis 
Protein samples electrophoresed on 12% SDS-PAGE gel was first transferred to ECL 
Hybond nitrocellulose membrane (GE Healthcare). A wet transfer system was used, at a 
constant voltage of 100 V for 1 h in 5 mM sodium tetraborate buffer kept on ice. The 
membrane was blocked with 5% skimmed milk in PBS(-) buffer (10 mM Na2HPO4, 2 mM 
KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4) at 4°C overnight or at room temperature for 1 
h. Then, after discarding the blocking solution, anti-HSP47 primary antibody (Stressgen) in 
skimmed milk (1:1000 dilution) was added and incubated on a rocking platform at room 
temperature for another 1 h. After washing twice with 0.1% Tween-20 in PBS(-) for 10 min, 
the membrane was probed with goat anti-mouse secondary antibody, alkaline phosphatase 
(AP) conjugate (Biosource) (1:2000 dilution) for an additional 1 h before a 5-min washing 
with Tween-20 in PBS(-) four times and once in MilliQ water for 3 min for the final wash. 
Finally, detection was performed using the 5-bromo-4-chloro-3-indolylphosphate/nitro blue 
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tetrazolium (BCIP/NBT) tablet (Sigma-Aldrich). The substrate solution when dissolved in 10 
mL MilliQ water contains BCIP (0.15 mg/mL), NBT (0.30 mg/mL), Tris buffer (100 mM), 
and MgCl2 (5 mM), pH 9.25-9.75. BCIP is hydrolysed by AP forming an intermediate that 
undergoes dimerisation to produce an indigo dye. Then NBT is reduced to the NBT-formazan 
by two reducing equivalents generated by the dimerisation. Together, two compounds 
generated an intense black-purple precipitate. Where necessary, band quantification was 
performed using NIH ImageJ software (Rasband, 1997-2009) with a built-in gel analysis 
program. 
   
6.11 Gelatin-agarose Pull Down Assay 
This assay was used to determine the binding ability of HSP47 to gelatin. 5.4 mL lysis buffer 
(50 mM Tris-HCl, 150 mM NaCl, 15% glycerol, 0.2% Nonidet P-40, protease inhibitor 
tablet, pH 8.0) was added to a pelleted cell culture (from about 12 mL of culture) and re-
suspended. The cell suspension was then sonicated on ice and 1500 µL of lysate was 
aliquoted out and centrifuged at 13,000 rpm with Biofuge Pico (Sorvall), for 20 min at 4°C. 
400 µL of the supernatant was added to 20 µL (bed volume) of gelatin-agarose beads (Sigma-
Aldrich). The mixture was then rotated for 1 h at 4°C before being centrifuged at 6,000 rpm 
(Biofuge Pico, Sorvall) for 3 min at 4°C. The pellet was washed with 200 µL of wash buffer, 
and centrifuged again. This was repeated twice before 100 µL of MilliQ water was added, 
with 100 µL of 2× sample buffer, 10 µL of β-ME, and heated at 95°C for 5 min. The sample 
was centrifuged before loading to SDS-PAGE, followed by immunoblotting analysis for 
visualisation and quantification.  
 
6.12 Collagen Mimetic Peptide (CMP) Synthesis 
The peptide (Pro-Hyp-Gly)10 [(POG)10] and (Pro-Hyp-Gly)4-Pro-Arg-Gly-(Pro-Hyp-Gly)5 
[(POG)4-PRG-(POG)5] were synthesized using a Symphony Quartet peptide synthesiser 
(Protein Technologies Inc.) using N-(9-fluorenyl)methoxycarbonyl (Fmoc)-protected L-amino 
acids on Gly-wang resin support. The peptides were purified on a reverse-phase high pressure 
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liquid chromatography (HPLC) system with a C18 column. Purity of the peptides was 
determined by mass spectrometry using matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) and electrospray ionisation (ESI). The service was provided by the 
Department of Chemistry Mass Spectrometry Service Unit, Imperial College London. 
 
6.13 Coupling of CMP to Cyanogen Bromide (CNBr)-activated Sepharose Beads 
The coupling of CMP to CNBr-activated sepharose was done according to manufacturer’s 
instruction. First, the required amount of freeze dried CNBr-sepharose powder (GE 
Healthcare) was weighed and resuspended in 1 mM HCl. The medium swelled immediately 
and was washed for 15 min with 1 mM HCl on a sintered glass filter, added in several 
aliquots. Then the peptide to be coupled was dissolved in coupling buffer (0.1 M NaHCO3 
pH 8.3, 0.5 M NaCl). 5 mL of coupling solution was used per gram of freeze dried powder. 
The coupling solution containing the peptide was mixed with the medium in a stoppered 
vessel, rotated end-over-end for 1 h at room temperature or overnight at 4 °C. Excess ligand 
was washed away with at least 5 medium (gel) volumes of coupling buffer. Finally any 
remaining active groups were blocked with 1 M ethanolamine, pH 8.0. Coupling efficiency 
was monitored with HPLC. 
 Analytical HPLC was performed on a Hitachi-LaChrom L-7150 equipped with a 
Polymer Laboratories PL-ELS 1000 evaporative light-scattering detector. A Vydac C18 
column was used (5 µM, 300 Å, 4.6 × 250 mm) (Grace) with a retention time of 60 min. 
Acetonitrile and water were used as solvents. 
 
6.14 HSP47-Collagen Anti-fibrillisation Assay 
The protocol used for collagen fibril formation was similar to that described previously 
(Thomson and Ananthanarayanan, 2000; Williams et al., 1978). 2 µM (final concentration) of  
pepsin-solubilised type I collagen from porcine skin (Nitta Gelatin) was brought to pH 7.3-
7.4 by the addition of phosphate buffer (50 mM sodium phosphate, 100 mM NaCl, pH 8.0). 
The formation of collagen fibrils was then monitored by measuring the turbidity of the 
sample at A313 using a Thermo Varioskan microplate reader (Thermo Fisher Scientific) in the 
presence of different amounts of HSP47 WT and mutants. The absorbance was background-
corrected and buffer-subtracted. Each experiment was monitored over a period of 120 min at 
a constant temperature of 34°C. Measurements were made in triplicates.  
 
6.15 Circular Dichroism Spectroscopy 
Spectrum and Temperature Titration 
Circular dichroism (CD) spectra were recorded on a JASCO J715 spectropolarimeter using a 
thermostatically controlled 10 mm quartz cuvette. HSP47 was studied in phosphate buffer (50 
mM sodium phosphate, 100 mM NaCl, pH 8.0). Far UV CD spectra were recorded from 300-
190 nm at 25°C. Each scan was set at 100 nm/min with a continuous scan mode and a 
standard sensitivity (100 mdeg). The response was set at 4 sec with 2 nm of band width. Each 
spectrum was an accumulation of 16 scans. For the temperature titration experiments, ΔΔA222 
was monitored while the temperature was increased at a constant rate of 1°C per minutes 
from 25 to 90°C. Melting temperatures were estimated from the temperature titration profile 
with HSP47 samples at concentrations ranging from 2.8-3.0 µM. To calculate Tm, the fraction 
unfolded was obtained using the following equation, modified from (Persikov et al., 2004): 
)()(
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−=    (Eq. 6.1) 
where θ is the observed ellipticity and θD and θF are the ellipticities for the denatured and 
folded. Tm was obtained at the midpoint of transition, where F(Tm) = ½. 
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pH Titration 
CD pH titrations were carried out using an autotitrator connected to the spectropolarimeter. 
Sample was added to a stirred, thermostatically controlled 1 cm quartz cuvette. HSP47 WT 
and mutants were studied at a final protein concentration of 3 µM in phosphate buffer (50 
mM sodium phosphate buffer, 100 mM NaCl, pH 8.0) at 25oC. The pH was then 
progressively decreased by the addition of 2.5 μL aliquots of phosphoric acid using the 
autotitrator. The change in ΔA222 was then measured. The actual pH in the cuvette was 
determined using an ultraslim pH electrode (Hamilton). Equation 6.1 was used to estimate the 
inflection point of transition by replacing T, θD and θF with pH, θAc and θAl which are the 
ellipticities at the pHs of full alkaline and acid states. CD spectra for each variant were also 
measured before and after titration to identify any structural variation following the change in 
pH. 
 
HSP47-Peptide Binding Assay 
The binding of HSP47 to PRG peptide was observed by monitoring the changes in CD signal 
as a function of peptide concentration. CD spectra were recorded in the presence of different 
peptide concentration at different pH values and then subtraction was performed with 
concentration matched-peptide spectra from blank titration. Ellipticity at 216 nm was taken 
instead of at 225 nm as the change in CD signal at this wavelength is significantly larger and 
better titration data can be obtained. The ellipticity values were then plotted as a function of 
peptide concentration and the binding isotherms were fitted to a single site binding model 
using OriginPro v8.5 (OriginLab). 
 
Unit Conversion 
Conversion between CD units was performed based on the guidance notes of the DichroWeb 
spectra deconvolution server (http://dichroweb.cryst.bbk.ac.uk). Throughout this thesis, two 
CD units are used, namely ΔA and mean residue ellipticity (MRE). The relationships between 
ΔA, MRE and the machine unit, theta (θ) is explained below. 
 
ΔA is directly related to θ and converted using the equation, with θ in milidegrees: 
98.32
θ=ΔA  (Eq. 6.2) 
 while Δε, also known as molar circular dichroism (mdeg M-1 cm-1) is expressed by this 
equation: 
3298
][θε =Δ  (Eq. 6.3) 
where [θ] is the MRE (deg cm2 dmol-1 residue-1). In most cases the unit is only displayed as 
(deg cm2 dmol-1). Δε also related to θ based on the following equation: 
3298)(
)1.0(
∗∗
∗×=Δ
CONCP
MRWθε  (Eq. 6.4) 
where MRW is the mean residue weight (protein mean weight [Dalton]/number of residues), 
P is the pathlength (cm) and CONC is protein concentration (mg/mL). 
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6.16 Fluorescence Anisotropy 
Conjugation of BODIPY to PRG Peptide 
Similar to the binding experiment with CD, PRG peptide was also used for this experiment. 
Peptide was synthesised using the standard Fmoc method on automated peptide synthesiser 
and analysed using MALDI-MS and reversed-phase HPLC. A modified, two-steps EDC/NHS 
coupling was used to avoid head-to-tail coupling of peptides, adapted from (Hermanson, 
1996). 0.5 mg of BODIPY dye (Invitrogen) was initially dissolved in 0.05 M 2-(N-
morpholino)ethane sulfonic acid (MES) buffer pH 6. Then EDC (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide HCl) (Sigma-Aldrich, MO, USA) and sulfo-NHS (N-
hydroxysulfosuccinimide) (Sigma-Aldrich) were added to the peptide solution to obtain a 
concentration of 2 mM for EDC and 5 mM for sulfo-NHS. The reaction was mixed for 15 
min at room temperature to activate the dye molecules. 2-mercaptoethanol was then added to 
the reaction solution at a final concentration of 20 mM, before being mixed for a further 10 
min at room temperature. This quenches the unreacted EDC and sulfo-NHS in the dye 
solution. Then, 0.46 mg of peptide (10-fold less molar amount than BODIPY) was added to 
the solution, and reaction was allowed to proceed to at least 2 hr at room temperature with 
continuous mixing. Conjugate was purified using size-exclusion chromatography with PD-10 
column (GE Healthcare). PRG-BODIPY conjugate was analysed with reversed-phase HPLC 
system (Gilson) equipped with a UV-vis detector, using a Chromolith RP-18 C18 column (2 
μM, 130 Å, 4.6 × 100 mm) (Merck). Acetonitrile and water were used as solvents.  
(Beauchamp et al., 1998) 
 
Anisotropy Measurement 
Anisotropy experiment was performed on a Perkin-Elmer LS-50B fluorimeter equipped with 
a thermostat. Temperature was maintained at 25°C throughout the measurements. Samples 
were excited at 430 nm and monitored at 510 nm. The excitation slit width was set to 2.5 nm 
and the emission slit was 10 nm, with 2 s integration time. Measurements were performed in 
phosphate buffer (50 mM sodium phosphate, 100 mM NaCl, pH 8.0). HSP47 concentration 
was determined by the absorbance at 280 nm with an extinction coefficient of 42,400 M-1cm-
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1, and conjugate concentration was estimated from initial coupling reaction, taking into 
account all dilution steps assuming more than 95% conjugation efficiency. This is in good 
agreement with the value determined using the extinction coefficient of BODIPY, which is 
68,000 M-1cm-1 at 504 nm (Invitrogen). For anisotropy measurement of conjugate in the 
presence of different HSP47 concentrations, 0.5 μM was incubated with HSP47 in same 
phosphate buffer for up to 5 mins at 25°C. Measurement was performed according to the 
instrumental parameters stated above.  
 Anisotropy measurement in the presence of different concentrations of glycerol were 
performed by addition of 90% (v/v) glycerol to 0.5 μM solution of conjugate to obtain final 
glycerol concentrations ranging from 0-36% (v/v), in 50 mM sodium phosphate buffer pH 
8.0. Solution viscosities were calculated from the glycerol concentration, as the concentration 
of conjugate and buffer are very low, using the data on glycerol-water viscosity obtained 
from the Handbook of Chemistry and Physics (www.hbcpnetbase.com). This database 
supplies absolute viscosity values (η) in mPa s which is equivalent to centipoise (cP) against 
mass %. The viscosity of pure water at 20°C is given as 1.002 mPa s. Samples were 
equilibrated at 20°C for 20 min before measurement. Curve fitting was then performed using 
OriginPro v8.5 (OriginLab). 
 
6.17 Steady-state Intrinsic Tryptophan Fluorescence Spectroscopy 
Intrinsic tryptophan fluorescence emission spectra were recorded on a Shimadzu RF-5301PC 
spectrofluorophotometer (Shimadzu) using a thermostatically controlled 10 mm quartz 
cuvette. HSP47 was studied in phosphate buffer (50 mM sodium phosphate, 100 mM NaCl, 
pH 8.0) at 25oC. Samples were excited at 295 nm and emission detected from 310-410 nm. 
The excitation slit width was set at 3 nm, and the emission slit widths were varied between 
10-15 nm. The pH-titration experiments were performed by the addition of small aliquots of 
phosphoric acid (1-2 µL each) with constant stirring. Protein concentration was fixed to 1 μM 
for all analysis. Each spectrum was the average of three repetitions. All experiments were 
background corrected and performed within 12 hr after purification.  
Averaged individual spectra recorded at various pH values were then fitted to 
polynomial model second order for the purpose of data extraction using OriginPro v8.5 
software (OriginLab). Fitting ensures more accurate and smoother data for maximum 
fluorescence intensity (If) and wavelength at maximum intensity (λem). λem values against pH 
generated from the extraction were then fitted to single pH ionisation model using GraFit Pro 
v7.0.0 (Erithacus Software Ltd.) based on Equation 6.5. The y values vary from one value at 
low pH to another at high pH depending upon the ionization of a group with a certain pKa. 
110
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Ly   (Eq. 6.5) 
L1 represents Limit 1 or the upper limit of the y values while L2 is the lower limit of y values. 
In our case the λem values were taken as the limit values (Leatherbarrow, 2009). 
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